Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39428,0.127133497562011,0.00787225767929764,0.111703872510588,0.142563122613435,3.5445522288422e-58
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),37006,-0.231645877760968,0.0150925305323793,-0.261227237604432,-0.202064517917505,1.09178499866568e-52
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36916,0.0637497769372407,0.00441906248874724,0.0550884144592961,0.0724111394151852,8.44320001039937e-47
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39621,-0.139981817591429,0.0101315145490534,-0.159839586107573,-0.120124049075284,3.70125047208874e-43
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39355,0.0679737224295704,0.00514322751331798,0.0578929965034672,0.0780544483556737,1.1830759778363e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36847,0.103835719481518,0.00815747639386669,0.0878470657495394,0.119824373213497,6.95054945324781e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37203,-0.0396146408922346,0.00313645672156171,-0.0457620960664956,-0.0334671857179737,2.36971999938183e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39601,0.0397100345015984,0.00317418932508729,0.0334886234244273,0.0459314455787695,9.84849113522952e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36880,0.1275221823275,0.010407259106459,0.107123954478841,0.14792041017616,2.54767911739327e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,37243,-0.0512358240083606,0.00419594177021208,-0.0594598698779763,-0.0430117781387449,4.21337035839302e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36955,0.0532778323610656,0.00441644887512125,0.044621592565828,0.0619340721563033,2.52068681548427e-33
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39531,-0.0326597942852836,0.00273897264820642,-0.0380281806757682,-0.027291407894799,1.24245433363332e-32
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39455,0.0425763378401686,0.00363336293098479,0.0354549464954384,0.0496977291848988,1.41229372665336e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,39123,0.123257575867271,0.0107179394184889,0.102250414607032,0.144264737127509,1.77954447145534e-30
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39482,-0.0507457503403229,0.00449215837282603,-0.0595503807510619,-0.0419411199295839,1.79478471196463e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,37164,0.0658983542749279,0.0058910616987923,0.054351873345295,0.0774448352045608,6.50378136783748e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39258,-0.0500316637253739,0.00462145368461607,-0.0590897129472214,-0.0409736145035264,3.27940973085622e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,37243,-0.0427779568711651,0.00408559706958994,-0.0507857271275614,-0.0347701866147688,1.49814926760686e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39455,-0.0294149795651023,0.00290128474915975,-0.0351014976734554,-0.0237284614567492,4.45224389886196e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39509,0.0282851709320905,0.00279164541189454,0.0228135459247772,0.0337567959394038,4.75451432135805e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39462,-0.0419943722321887,0.00414779326781218,-0.0501240470371006,-0.0338646974272768,5.1372560525905e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39636,-0.022671871300633,0.00224890092662091,-0.02707971711681,-0.018264025484456,7.94203079564898e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39526,-0.03220871903346,0.00324358521065948,-0.0385661460463526,-0.0258512920205674,3.63209398144645e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39502,-0.0168012240710891,0.00173306310557373,-0.0201980277580136,-0.0134044203841646,3.69305709830978e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36955,0.0263709956112456,0.00276324136314042,0.0209550425394904,0.0317869486830008,1.63462807939419e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,37243,-0.0195394146770789,0.0020605009916278,-0.0235779966206694,-0.0155008327334884,2.9060402702597e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,37146,-0.0287883950220653,0.00306975267556234,-0.0348051102661675,-0.0227716797779631,7.84522921783601e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39601,0.0203576446724631,0.00217162152521674,0.0161012664830383,0.0246140228618879,7.92168851911962e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39513,-0.0186452934297695,0.0020001431776743,-0.0225655740580111,-0.0147250128015278,1.29747712087398e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39485,-0.0363450840256831,0.00391384484420497,-0.0440162199203249,-0.0286739481310414,1.81226977783379e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38988,0.0808093859856722,0.00873240393985321,0.0636938742635599,0.0979248977077845,2.4598419156808e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39516,-0.0357826223282162,0.00392415210244216,-0.0434739604490028,-0.0280912842074295,8.55816293635689e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36955,-0.0280087987663422,0.00307189885431093,-0.0340297205207917,-0.0219878770118928,8.83052652022794e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36916,0.028791038815155,0.00316524989357485,0.0225871490237483,0.0349949286065618,1.07825635449538e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39524,-0.0397503833931856,0.00442259945089444,-0.0484186783169387,-0.0310820884694325,2.81157540694132e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39589,-0.023136472260289,0.00257523868466176,-0.0281839400822261,-0.018089004438352,2.9087556534703e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,37269,0.0277223348399877,0.00316312071542184,0.0215226182377609,0.0339220514422145,2.11514606448886e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39458,-0.131146221630184,0.0151168539019673,-0.16077525527804,-0.101517187982328,4.53482968433751e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,39106,0.0445482499194744,0.00515022184165795,0.0344538151098249,0.054642684729124,5.68983685493615e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39462,-0.0228596503088241,0.00265484450657457,-0.0280631455417103,-0.017656155075938,7.98590554096781e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39541,-0.0501427323975645,0.00585173917441606,-0.06161214117942,-0.038673323615709,1.14523046627275e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37269,-0.0197605257463918,0.00231469745862756,-0.0242973327653018,-0.0152237187274818,1.53186231312159e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39428,-0.0303445947678636,0.00355909599832109,-0.0373204229245729,-0.0233687666111542,1.65920736986972e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39589,-0.0581761006658318,0.00685562410883919,-0.0716131239191566,-0.0447390774125069,2.33694695155257e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39428,0.026284605303851,0.00309890486973065,0.0202107517591789,0.032358458848523,2.42045264429373e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39428,0.0254056587724872,0.00299591548229384,0.0195336644271913,0.0312776531177832,2.45806908084484e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39485,-0.0247846792177355,0.00292514558140861,-0.0305179645572964,-0.0190513938781746,2.61162029308312e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,37269,-0.0468656760566318,0.00557732108260509,-0.0577972253785378,-0.0359341267347258,4.8120991003838e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,37247,0.0179630139500211,0.00215221340489897,0.0137446756764191,0.0221813522236231,7.76238603041917e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39654,-0.0156057861287724,0.00187130797302908,-0.0192735497559094,-0.0119380225016354,8.09409777353708e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,39187,-0.0360047322179985,0.00432617787750753,-0.0444840408579132,-0.0275254235780837,9.36036458269711e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37269,-0.0183232606145085,0.00220493125575671,-0.0226449258757916,-0.0140015953532253,1.05163983386903e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39438,-0.0379872919319707,0.00457879856380895,-0.0469617371170362,-0.0290128467469051,1.16429711195913e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,37243,-0.0384834956150129,0.00464105531646595,-0.0475799640352861,-0.0293870271947396,1.22455092524853e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39455,-0.0225726446061589,0.00272560951744455,-0.0279148392603502,-0.0172304499519676,1.31611534602911e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39526,-0.0413966866636849,0.00502748083732714,-0.0512505491048462,-0.0315428242225237,1.95665769106732e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39455,-0.0537492475045553,0.00655626132915107,-0.0665995197096914,-0.0408989752994192,2.63713136096365e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39274,0.0209491870505382,0.00255692190570005,0.0159376201153661,0.0259607539857103,2.75177279361327e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,37269,0.0525525977482493,0.00644168036300863,0.0399269042367524,0.0651782912597462,3.71548330506273e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39436,-0.0218722837211658,0.00268763701956504,-0.0271400522795133,-0.0166045151628183,4.32837033430469e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,39344,-0.0161427820978514,0.00199322713444088,-0.0200495072813555,-0.0122360569143473,5.97701788778979e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39531,-0.0283796975503345,0.00351345247013865,-0.0352660643918063,-0.0214933307088628,7.11157804658941e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39016,-0.0264661719456471,0.00327699461329488,-0.0328890813877051,-0.0200432625035891,7.19312462222344e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39475,-0.0354370237704933,0.00438833314073954,-0.0440381567263428,-0.0268358908146437,7.23987186820334e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39470,-0.0222878581788342,0.00277725413577106,-0.0277312762849454,-0.0168444400727229,1.08867718156985e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39541,-0.0467782053770623,0.00585460224022637,-0.058253225767906,-0.0353031849862186,1.44653974928292e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39429,-0.0247457569286416,0.00310740452586973,-0.0308362697993463,-0.018655244057937,1.79221789264241e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39462,0.0691893416134089,0.00870236312518409,0.0521327098880481,0.0862459733387697,1.98699471371353e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39485,0.0233509230636654,0.00293705608862643,0.0175942931299575,0.0291075529973732,1.98976711978816e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39455,-0.016480491147807,0.00208184101727125,-0.0205608995416586,-0.0124000827539553,2.61711107287518e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39499,-0.0203733106999526,0.0025738859219164,-0.0254181271069088,-0.0153284942929965,2.63586213765645e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39427,-0.0187245814742266,0.00236838627416777,-0.0233666185715954,-0.0140825443768578,2.841257962053e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37243,-0.0175598469946863,0.00222375522845288,-0.0219184072424539,-0.0132012867469186,3.10204086998679e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39581,0.023333064176872,0.00296507737582835,0.0175215125202484,0.0291446158334955,3.80686940598075e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37221,-0.0612976970961356,0.0077942459113978,-0.0765744190824753,-0.0460209751097959,4.00319459634385e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39499,-0.0221066796037369,0.0028381304670316,-0.0276694153191189,-0.016543943888355,7.18365329865387e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39411,-0.0277042020164576,0.00355712213061234,-0.0346761613924578,-0.0207322426404574,7.23143968863725e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39485,0.0454878879201545,0.00585401923848292,0.0340140102127279,0.056961765627581,8.33013586070835e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39355,0.0469027058359624,0.00603697899954199,0.0350702269968601,0.0587351846750647,8.40932015516668e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39654,-0.019145355890606,0.00246724802081443,-0.0239811620114023,-0.0143095497698098,9.04515195878335e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39541,-0.0273057489289603,0.00353717835169697,-0.0342386184982864,-0.0203728793596343,1.23950444751332e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39455,-0.026072477280658,0.00339467459965414,-0.0327260394959801,-0.0194189150653359,1.68354978306672e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39531,0.0160351561554148,0.00209728337689872,0.0119244807366933,0.0201458315741363,2.20350858481068e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37162,0.0253914380028459,0.00332702456486222,0.0188704698557159,0.0319124061499759,2.47839364206597e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39458,0.0321518617999942,0.0042179379878523,0.0238847033438037,0.0404190202561847,2.63367210242997e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39307,-0.0285772842997899,0.00375224478684429,-0.0359316840820047,-0.0212228845175751,2.7728839885926e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39589,-0.0303406782223516,0.00399349360760805,-0.0381679256932634,-0.0225134307514398,3.19475431194145e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37164,-0.0665176654648488,0.00877130397272058,-0.0837094212513812,-0.0493259096783165,3.59543406939913e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37249,-0.0126538951880764,0.00167056320487745,-0.0159281990696362,-0.00937959130651659,3.84859893458842e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39355,-0.0374779548864085,0.00496724226909611,-0.0472137497338369,-0.0277421600389802,4.78311529408301e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39636,0.0177165319663555,0.00235517952060167,0.0131003801059763,0.0223326838267348,5.68013664568234e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39455,-0.0189086418346272,0.00251421323827068,-0.0238364997816377,-0.0139807838876167,5.75669654079502e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39123,-0.0303789898944448,0.0040436198021331,-0.0383044847066257,-0.0224534950822639,6.12030541245618e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39413,-0.0210152708105044,0.0027983828445505,-0.0265001011858234,-0.0155304404351854,6.25627984748467e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39433,-0.0253227130458124,0.00337213082459602,-0.0319320894620206,-0.0187133366296042,6.27399366972177e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37255,0.0272555947580438,0.00363047793026005,0.0201398580147341,0.0343713315013535,6.42816241499522e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39498,-0.015622691125055,0.00208423334676293,-0.0197077884847103,-0.0115375937653996,6.96409261757303e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39462,-0.0212340688733818,0.00284150160602086,-0.0268034120211827,-0.015664725725581,8.28121019921007e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,39355,-0.0226817231569786,0.00305606758974395,-0.0286716156328767,-0.0166918306810804,1.21719459001995e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39545,-0.0294044128828872,0.00398785714191648,-0.0372206128810435,-0.0215882128847309,1.74853998983988e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39531,0.0254432148304878,0.00345353095019041,0.0186742941681146,0.032212135492861,1.83132180162938e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,37203,0.0458580028596315,0.00622609984639274,0.0336548471607017,0.0580611585585613,1.87406426748901e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39601,-0.0181676919538184,0.00246829067973126,-0.0230055416860916,-0.0133298422215451,1.92728799586693e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39636,-0.0163975745114241,0.00223158241861649,-0.0207714760519124,-0.0120236729709358,2.11500809282693e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37164,-0.055245880484581,0.00752040156331402,-0.0699858675486764,-0.0405058934204855,2.16467016490019e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39571,-0.0267788634515907,0.00369619799989931,-0.0340234115313933,-0.0195343153717881,4.53409131564913e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39455,-0.0352076038306923,0.00486231924365207,-0.0447377495482503,-0.0256774581131342,4.67341161981503e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39636,-0.0181305797351287,0.00250947027190012,-0.0230491414680529,-0.0132120180022044,5.25460762017634e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39541,-0.0128722197800658,0.00178557199842728,-0.0163719408969832,-0.0093724986631483,5.90307322083879e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39601,-0.0393162961651782,0.00545589876570137,-0.0500098577459529,-0.0286227345844035,6.02492955294002e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37269,-0.0116118815159307,0.00161117524231433,-0.0147697849908668,-0.00845397804099462,6.03621793854839e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36916,-0.0561200764395355,0.00784192147292316,-0.0714902425264649,-0.0407499103526061,8.74501240251698e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36916,0.0347623119266703,0.00487362939110319,0.025209998320108,0.0443146255332325,1.03831200332552e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39330,0.028004870402654,0.00392705933145196,0.0203078341130081,0.0357019066922998,1.04039168351767e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39636,0.0240616377239784,0.00337812809508271,0.0174405066576163,0.0306827687903405,1.10528688384462e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39455,-0.0224450043947147,0.00315870302660854,-0.0286360623268675,-0.016253946462562,1.25046072156152e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39455,-0.0298534007906154,0.00420414114314934,-0.0380935174311881,-0.0216132841500427,1.29466219761101e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,39104,0.0216934565147835,0.00307434756935775,0.0156677352788423,0.0277191777507247,1.78691932696608e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39531,-0.0250669518993181,0.00355778379676814,-0.0320402081409837,-0.0180936956576526,1.92571715100769e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39654,-0.0176432339759373,0.00250438158760674,-0.0225518218876466,-0.0127346460642281,1.93498351218298e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39541,-0.0164735687079915,0.00234268029957086,-0.0210652220951504,-0.0118819153208326,2.12439812481839e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39436,-0.0371627785539112,0.00529990857801056,-0.0475505993668119,-0.0267749577410105,2.45040312392452e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39470,-0.0564273468064016,0.00805006621376909,-0.072205476585389,-0.0406492170274142,2.4927002679882e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39636,-0.0159068953327579,0.00227494609573633,-0.0203657896804011,-0.0114480009851147,2.81880971009565e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39531,-0.0176505856461911,0.00253474978113117,-0.0226186952172082,-0.012682476075174,3.45776229805068e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37057,-0.0250940068993275,0.00360785489064292,-0.0321654024849876,-0.0180226113136673,3.68971057419557e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37255,0.0319539159452986,0.00462172089887203,0.0228953429835094,0.0410124889070878,4.94029169127434e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39561,-0.0221582698973006,0.00321391536823851,-0.0284575440190481,-0.0158589957755531,5.62052962736948e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39636,-0.04551392495962,0.00661086413512007,-0.0584712186644554,-0.0325566312547847,6.01729970269573e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39589,-0.0373612817109015,0.00543361539652745,-0.0480111678880953,-0.0267113955337077,6.39866306347947e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39531,-0.0206380353195737,0.003003852535652,-0.0265255862894516,-0.0147504843496958,6.64724012496318e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39563,0.0180091740274923,0.00262331661631898,0.0128674734595071,0.0231508745954775,6.90618311403982e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36955,0.0214392661517736,0.00314430274609479,0.0152764327694278,0.0276020995341193,9.62600977193405e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,39104,0.0294772510373691,0.00433335884344957,0.020983867704208,0.0379706343705303,1.06875671596976e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39477,0.0224755376423705,0.00330582419938014,0.0159961222115855,0.0289549530731556,1.09493454750003e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,39330,0.0308722837272715,0.00456579762844175,0.0219233203755257,0.0398212470790174,1.41519758292323e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39516,-0.0335039381862009,0.00497051555119202,-0.0432461486665373,-0.0237617277058646,1.63536017430292e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39549,-0.042045730984797,0.00625831560352038,-0.0543120295676969,-0.029779432401897,1.90331964960798e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,39162,-0.0231602615404421,0.00345414976322124,-0.0299303950763557,-0.0163901280045285,2.08668201006637e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39462,0.0225817665654883,0.0033688084835182,0.0159789019377926,0.029184631193184,2.11188653612095e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39337,-0.0233497089133794,0.00348421848879845,-0.0301787771514243,-0.0165206406753344,2.13611256091634e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39518,0.036989711643252,0.00553916352938648,0.0261329511256545,0.0478464721608495,2.50955809031335e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39601,-0.0425621920054281,0.00638957872026122,-0.0550857662971401,-0.0300386177137161,2.80980001162611e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39462,-0.0222979916125454,0.00335584880300273,-0.0288754552664307,-0.01572052795866,3.14690462045126e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39354,-0.0335485353869623,0.00505739924192618,-0.0434610379011376,-0.023636032872787,3.38990045041826e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37164,-0.0646233274149595,0.00974505974827947,-0.0837236445215872,-0.0455230103083317,3.45983319022238e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39390,-0.041467472157968,0.00625807064980155,-0.0537332906315791,-0.029201653684357,3.56133260987122e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37255,0.0264303557610444,0.00399092827736795,0.0186081363374032,0.0342525751846856,3.67012488254482e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,37164,0.0468943923954475,0.00708128994457331,0.0330150641040839,0.0607737206868112,3.67891816589703e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39480,0.0571542475989823,0.00863685788358631,0.0402260061471532,0.0740824890508115,3.77734075105926e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39531,-0.0189457540272851,0.00286352308163757,-0.0245582592672948,-0.0133332487872755,3.80868168355141e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39439,-0.0116138876171334,0.00175805499255979,-0.0150596754025505,-0.00816809983171617,4.07873943200032e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39419,-0.0272884587270287,0.00414542578404556,-0.035413493263758,-0.0191634241902994,4.77072125806076e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39455,-0.0196113545434706,0.00298572854076865,-0.0254633824833771,-0.013759326603564,5.25448455028335e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36934,0.0323724368268904,0.00492979472132646,0.0227100391730905,0.0420348344806902,5.3484560402946e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39455,0.0300269810290749,0.00458701732792479,0.0210364270663423,0.0390175349918075,6.09848186417993e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39608,-0.0118127979371637,0.00180678701249554,-0.015354100481655,-0.00827149539267247,6.43348417103125e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,37247,0.014519262480983,0.00222643100518515,0.0101554577108201,0.0188830672511458,7.23125686950728e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39531,-0.0154328034427092,0.00237103649555596,-0.0200800349739989,-0.0107855719114195,7.81016117835178e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,39107,-0.0315625833127746,0.00486355294644089,-0.0410951470877987,-0.0220300195377504,8.8820904738882e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39589,-0.0208435689795983,0.00322515041380918,-0.0271648637906643,-0.0145222741685323,1.05911930041626e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39462,0.018394753269907,0.00284790303837236,0.0128128633146972,0.0239766432251169,1.08603348221309e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39601,0.0253683294802622,0.00392969275294166,0.0176661316844966,0.0330705272760279,1.11106574902586e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39434,-0.049051785158901,0.00760015152821492,-0.0639480821542022,-0.0341554881635997,1.12244466710796e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39389,-0.0134899742898016,0.00210146148310141,-0.0176088387966803,-0.00937110978292282,1.41006301040554e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39589,-0.0163160962529499,0.00254690174417958,-0.0213080236715418,-0.0113241688343579,1.53544504381486e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39187,0.0193536139765851,0.00302319305871384,0.013428155581506,0.0252790723716643,1.58293583089122e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39455,-0.0131495145477968,0.00205487261671785,-0.0171770648765638,-0.00912196421902987,1.60841204943603e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39495,0.0369305759936655,0.00577146865627869,0.0256184974273592,0.0482426545599717,1.61217246224454e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39541,-0.0654500861577367,0.0102514012904008,-0.0855428326869222,-0.0453573396285512,1.76983686908959e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39187,0.0270853015141985,0.00426511725629434,0.0187256716918616,0.0354449313365354,2.2101774238192e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39601,-0.0317581385177068,0.00500663557933382,-0.0415711442532011,-0.0219451327822125,2.31412808348572e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39498,-0.0138520914190725,0.00218724410712305,-0.0181390898690337,-0.0095650929691113,2.47065735124595e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39477,-0.0153260683802509,0.00242145908189404,-0.0200721281807632,-0.0105800085797386,2.53311128332196e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,37164,-0.061707866900513,0.00975110849546464,-0.0808200395516237,-0.0425956942494023,2.56213639886563e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39654,0.0141605045217203,0.00224319687019103,0.00976383865614589,0.0185571703872947,2.81916915332365e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,39125,0.0269870648101155,0.00429291473765518,0.0185729519243113,0.0354011776959196,3.34059396009085e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39104,-0.0181445693222911,0.00288927303219282,-0.023807544465389,-0.0124815941791932,3.48175267088604e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39636,-0.0396791413425348,0.00632082857437038,-0.0520679653483008,-0.0272903173367689,3.53357820918217e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39654,-0.0228754348032447,0.00366665493969506,-0.030062078485047,-0.0156887911214423,4.52689310138765e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39455,-0.0127567097275386,0.00205131126656247,-0.0167772798100011,-0.00873613964507619,5.14221833423329e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39458,-0.0169188570818317,0.00273035605290826,-0.0222703549455319,-0.0115673592181315,5.92121846219368e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39554,-0.0213822310862029,0.00345158564201657,-0.0281473389445553,-0.0146171232278504,5.9833690991774e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39460,0.0520700651861307,0.00841392549812047,0.0355787712098146,0.0685613591624468,6.22947637997336e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39462,-0.0439147205518981,0.0071117385488426,-0.0578537281076296,-0.0299757129961666,6.7883560542575e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39428,0.0241792536224955,0.0039194277588905,0.0164971752150701,0.0318613320299209,7.04560948914781e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,39123,0.0330788193458136,0.00536284294635791,0.0225676471709521,0.0435899915206751,7.09068291106859e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,39123,-0.0285826024512571,0.0046342903269017,-0.0376658114919845,-0.0194993934105298,7.11382999582324e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39564,-0.0390432273320876,0.0063333517780997,-0.051456596817163,-0.0266298578470122,7.24104582443123e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37243,-0.0280088154519401,0.00454960509968409,-0.0369260414473209,-0.0190915894565593,7.66835289425064e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39531,-0.0197236853051589,0.00320766395993484,-0.0260107066666312,-0.0134366639436866,7.99766377821233e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39194,-0.0215398339420281,0.00351918383423289,-0.0284374342571246,-0.0146422336269317,9.55309956239596e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39401,-0.0178273462253894,0.00291596364396198,-0.0235426349675549,-0.012112057483224,9.97635358361588e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39462,-0.0152171813224784,0.00249659995208485,-0.0201105172285647,-0.0103238454163921,1.12001522190117e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39471,0.016373932816314,0.00269335210082751,0.0110949626986921,0.021652902933936,1.23561972839171e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39541,-0.0449715245670487,0.00740502379621168,-0.0594853712076236,-0.0304576779264738,1.28466371764569e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37164,0.0430827134114039,0.00711103908082775,0.0291450768129815,0.0570203500098263,1.41220519996469e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37144,-0.0457324367806961,0.00755250594199724,-0.0605353484270107,-0.0309295251343815,1.44145345046021e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39482,-0.0207236195525035,0.00343382653322275,-0.0274539195576201,-0.0139933195473869,1.62558450682619e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39455,0.013306149954169,0.00220962678769431,0.00897528145028819,0.0176370184580499,1.76405405787461e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37164,-0.0493055931790805,0.00819766984665367,-0.0653730260785217,-0.0332381602796393,1.8529944941906e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39482,0.0235193666830743,0.00391549594852459,0.0158449946239661,0.0311937387421825,1.93656821907697e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39381,-0.0149178422338188,0.00249010804862908,-0.0197984540091318,-0.0100372304585058,2.13556130332934e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37255,0.0143363993766059,0.00239645669609495,0.00963934425225976,0.0190334545009519,2.25837017985286e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39553,0.0230083504424638,0.00384749611200654,0.0154672580629309,0.0305494428219966,2.28053468399535e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,36360,-0.0127552522778916,0.00213420130637028,-0.0169382868383774,-0.00857221771740587,2.34372770874124e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39636,-0.0235258800876267,0.00394703481046853,-0.031262068316145,-0.0157896918591083,2.57203778589211e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39601,-0.0236441505305696,0.00396746265705903,-0.0314203773384053,-0.0158679237227339,2.58600864616215e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,37203,0.0671924025126322,0.011288516761098,0.0450669096608802,0.0893178953643842,2.71382209756013e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36992,0.0279108472367454,0.00469874735751226,0.0187013024160214,0.0371203920574694,2.92468013026984e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39470,-0.0254366258654507,0.00428690261855112,-0.0338389549978109,-0.0170342967330905,3.02942795482554e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39329,0.0174042926902567,0.00293526029464393,0.0116511825127546,0.0231574028677588,3.10802817943734e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36916,0.0291177535487716,0.00491230011278415,0.0194896453277146,0.0387458617698285,3.15679809477804e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,37247,-0.0495872429183827,0.00836904728916484,-0.0659905756051458,-0.0331839102316196,3.20180024179908e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39428,-0.0147038552699415,0.00248770304516213,-0.0195797532384593,-0.00982795730142377,3.48237594787473e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39428,0.0180705628078419,0.00307403948108808,0.0120454454249092,0.0240956801907745,4.22952720047009e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39549,-0.0171569491196422,0.0029282264057818,-0.0228962728749745,-0.0114176253643099,4.74899229523704e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39601,0.023001367997871,0.00393034312917598,0.015297895464686,0.0307048405310559,4.94970476984209e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39541,-0.066894398695769,0.0114344955065655,-0.0893060098886375,-0.0444827875029006,5.01067623993323e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39204,-0.0214986394906211,0.00367692827651237,-0.0287054189125853,-0.0142918600686569,5.11398974104382e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39428,-0.0434371997482959,0.00743293439197823,-0.0580057511565733,-0.0288686483400186,5.20574551035718e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39194,-0.0363493706723969,0.00622962246100597,-0.0485594306959686,-0.0241393106488252,5.49444987946559e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39654,-0.0127582047957773,0.00218764353701179,-0.0170459861283204,-0.00847042346323415,5.58990974061546e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39455,0.0181808864692421,0.00311895393312895,0.0120677367603094,0.0242940361781748,5.68505230581121e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39400,-0.0397232602662825,0.00682017332026305,-0.0530907999739981,-0.0263557205585669,5.85038611441084e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39498,-0.0170179690827475,0.00292269035952676,-0.0227464421874199,-0.011289495978075,5.9082571449346e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39461,-0.0473378276907084,0.00813065761976862,-0.0632739166254549,-0.0314017387559619,5.92858124514197e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39151,-0.0260752403678025,0.0044833381024839,-0.0348625830486709,-0.017287897686934,6.15129208055301e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39319,0.0366752527688674,0.00631538911526239,0.0242970901029531,0.0490534154347817,6.4791367456028e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39541,-0.0236901787876749,0.00409436550557785,-0.0317151351786075,-0.0156652223967423,7.34924679953293e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39462,0.0198879081195131,0.00344631176195431,0.0131331370660827,0.0266426791729435,8.04621499636752e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39520,0.0319328590842091,0.0055459725168502,0.0210627529511827,0.0428029652172354,8.68534545298446e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39636,-0.0169738218223965,0.00295336796052872,-0.0227624230250327,-0.0111852206197602,9.24331102028483e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,37030,0.0309090580911804,0.00541870065908037,0.0202884047993828,0.0415297113829779,1.19562636481101e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38859,0.0183613388428437,0.0032263399750564,0.0120377124917331,0.0246849651939542,1.28701120094854e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39187,-0.0241633206745987,0.00424676431084749,-0.0324869787238598,-0.0158396626253377,1.29592685198916e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39428,-0.034250532630107,0.0060284854929256,-0.0460663641962412,-0.0224347010639729,1.36042877235148e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39355,-0.0170296520463789,0.00300132477513625,-0.0229122486056459,-0.0111470554871118,1.42058301427058e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39450,0.00958138729295701,0.00169068323028694,0.0062676481615946,0.0128951264243194,1.4784645773229e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39485,0.0205764552794495,0.00363256367695617,0.0134566304726154,0.0276962800862836,1.50203087701443e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36992,0.0215093292263131,0.00379747463511925,0.0140662789414794,0.0289523795111469,1.51035151440978e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39355,0.0138992658790529,0.00245555116839355,0.00908638558900159,0.0187121461691043,1.53852542423327e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37221,-0.0375155808977138,0.00663594584724489,-0.0505220347583138,-0.0245091270371138,1.60685802396788e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39601,0.0220353383853598,0.00389954612745583,0.0143922279755464,0.0296784487951732,1.62630411354853e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36955,-0.020551966072226,0.00364199752242131,-0.0276902812161717,-0.0134136509282802,1.70696322342598e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36955,0.0380514915627763,0.00675153672645248,0.0248184795789294,0.0512845035466232,1.77834755045345e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39589,0.0115292533027811,0.0020479918429274,0.00751518929064341,0.0155433173149188,1.83898016490765e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39033,0.0268350148118022,0.00476875726201892,0.0174882505782451,0.0361817790453593,1.86469718405252e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39477,-0.0193649762076652,0.00344420665071365,-0.026115621243064,-0.0126143311722665,1.91587912855523e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39428,0.0661605670959221,0.0117883668745827,0.0430553680217399,0.0892657661701042,2.03123881174806e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39485,0.0290407370719105,0.00518263810001933,0.0188827663958726,0.0391987077479484,2.13795597028736e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37203,0.0195979957787163,0.00350411997250382,0.0127299206326089,0.0264660709248238,2.27975201180808e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,39294,-0.0187681415932354,0.00335922202289891,-0.0253522167581172,-0.0121840664283535,2.35019309541617e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39355,-0.0141668877738188,0.00253651029705792,-0.0191384479560523,-0.00919532759158529,2.37528689848694e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39526,-0.0484634198833407,0.00868195188148813,-0.0654800455710575,-0.031446794195624,2.4174668787191e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39455,-0.0584931134267876,0.0104855592668874,-0.079044809589887,-0.0379414172636883,2.46873148903252e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37255,0.0148621580798307,0.00266430606735475,0.0096401181878154,0.020084197971846,2.47880587558233e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39355,0.010874080723334,0.00196308687020929,0.00702643045772383,0.0147217309889442,3.08865643512438e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39410,-0.0131858191206049,0.0023815996197465,-0.0178537543753081,-0.00851788386590178,3.13700438150767e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37221,-0.0471129659071911,0.008521033059138,-0.0638141907031015,-0.0304117411112806,3.28347790674913e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36916,-0.0369996356002084,0.0066924140686027,-0.0501167671746697,-0.0238825040257472,3.29302556091748e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39617,-0.0304847970027788,0.00551974128068657,-0.0413034899129244,-0.0196661040926331,3.38995911639221e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39534,0.0163781442922136,0.0029677419901947,0.0105613699914319,0.0221949185929952,3.47102247390949e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,39099,0.0578519349942427,0.0104990702236182,0.0372737573559509,0.0784301126325344,3.64483156124232e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39541,0.0365650585238034,0.00663618634450767,0.0235581332885683,0.0495719837590384,3.64812168502956e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36847,0.0265757023838073,0.00483200162801511,0.0171049791928977,0.0360464255747169,3.87458934303987e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36955,-0.0509251497890631,0.00927254929550781,-0.0690993464082584,-0.0327509531698678,4.05095979912042e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39455,-0.0137225368811849,0.00250422493749116,-0.0186308177586676,-0.00881425600370226,4.32783067575144e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39194,-0.031435415177723,0.00574316242560572,-0.0426920135319102,-0.0201788168235358,4.48345187500577e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39531,-0.0119003405076397,0.00217541658417882,-0.0161641570126302,-0.00763652400264923,4.56243468640609e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36975,-0.0105731438696812,0.00193947528533322,-0.0143745154289343,-0.00677177231042808,5.0879358167732e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39456,0.00832745133129014,0.00152958905706726,0.00532945677943831,0.011325445883142,5.28443480516119e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,39312,-0.0487928975988599,0.00897055201339276,-0.0663751795451097,-0.0312106156526101,5.43573366918113e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39455,-0.0128077167518876,0.00236449964664759,-0.0174421360593169,-0.00817329744445834,6.165442219162e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,37247,0.0171908518280101,0.0031789653337424,0.010960079773875,0.0234216238821452,6.49908228737726e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39462,-0.0570986528044498,0.0105623042885818,-0.0778007692100701,-0.0363965363988295,6.54728675558494e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39387,-0.031180749912262,0.00577700748469138,-0.0425036845822571,-0.0198578152422669,6.86502448007612e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37216,-0.00685292431490895,0.00127062375237009,-0.00934334686955433,-0.00436250176026357,7.03871668202785e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39462,-0.0300060744347201,0.00556724530482827,-0.0409178752321835,-0.0190942736372567,7.16204093264024e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37164,-0.047715417225179,0.00886947567116574,-0.0650995895406638,-0.0303312449096942,7.59183033939506e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39448,-0.0477420737119824,0.0088858227769268,-0.0651582863547589,-0.0303258610692059,7.86650352432689e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36457,0.0513866180629505,0.00958053317270053,0.0326087730444574,0.0701644630814435,8.30708503477752e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39568,-0.0203334674821114,0.00379837197879991,-0.0277782765605592,-0.0128886584036635,8.76713641019938e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37255,0.0229101667068777,0.00428383006000561,0.0145138597892667,0.0313064736244887,9.04324094278446e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39621,0.0282917490532009,0.00529120823313881,0.0179209809162488,0.038662517190153,9.07518109390106e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,39194,0.0139806737180102,0.00261668449902278,0.00885197209992553,0.0191093753360948,9.28328961029748e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,37247,0.0367980208242096,0.00689644246235189,0.0232809935979999,0.0503150480504193,9.67477939435918e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,37162,-0.0174771802554668,0.00327689505314472,-0.0238998945596305,-0.0110544659513032,9.80117617951775e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36972,-0.0141210405136037,0.00265109140194266,-0.0193171796614113,-0.00892490136579611,1.018562994326e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37247,-0.0136996312636252,0.00257371356377305,-0.0187441098486203,-0.00865515267862998,1.03848707499647e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36847,-0.0265129404210002,0.00498184241990301,-0.0362773515640102,-0.0167485292779903,1.04470504263041e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39582,-0.0276364672269611,0.00521555246405029,-0.0378589500564997,-0.0174139843974225,1.18163774637512e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37221,-0.0519315638323276,0.00980889211571748,-0.0711569923791339,-0.0327061352855214,1.21430231971967e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39428,-0.0164054397231749,0.00311430657762813,-0.022509480615326,-0.0103013988310237,1.40005701686891e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39531,0.0111275398793355,0.00211252540822803,0.00698699007920859,0.0152680896794625,1.40263204897667e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,39145,0.028638597407419,0.00543840788022143,0.017979317962185,0.039297876852653,1.41401924967436e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,37058,0.0247000475290726,0.0046904898039037,0.0155066875134213,0.0338934075447238,1.41733012729e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37164,-0.0405439781486489,0.00770608897993653,-0.0556479125493245,-0.0254400437479733,1.45371868538631e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,39095,-0.0499534585809353,0.0095285739426125,-0.0686294635084558,-0.0312774536534148,1.60625646250464e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37221,-0.0270204034344964,0.00515732131848896,-0.0371287532187348,-0.0169120536502581,1.63812345745772e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39516,-0.0401698993090311,0.00767011407558414,-0.0552033228971761,-0.0251364757208862,1.65227413980658e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39654,-0.010998481995392,0.00210080800408501,-0.0151160656833987,-0.00688089830738542,1.66857984972793e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,37164,0.046871808204495,0.00895650039759188,0.0293170674252149,0.0644265489837751,1.69185414092329e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39589,-0.0101431204849809,0.00194016616354694,-0.0139458461655329,-0.00634039480442886,1.73665475714982e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36916,-0.0236516919338977,0.0045418512546307,-0.0325537203929739,-0.0147496634748216,1.94449679580949e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39462,-0.0534307492090476,0.0102659444705887,-0.0735520003714014,-0.0333094980466937,1.96914155038795e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39601,-0.0272402375435259,0.00526134516512586,-0.0375524740671726,-0.0169280010198792,2.27844089352439e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39423,0.0285717817049126,0.00552430335830976,0.0177441471226255,0.0393994162871997,2.3456927392122e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39532,-0.0504747950149319,0.00976650392981786,-0.0696171427173749,-0.0313324473124889,2.39435781994105e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39507,-0.013711338782842,0.00265775392375477,-0.0189205364734013,-0.00850214109228262,2.51432193676906e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39485,-0.0179178721746718,0.00347475940287609,-0.024728400604309,-0.0111073437450347,2.54694944291637e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,39358,0.0235559143811905,0.00457106485363185,0.014596627268072,0.0325152014943089,2.59257527237552e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39191,0.0331965550221625,0.0064503798778736,0.0205538104615302,0.0458392995827947,2.68874225791276e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36880,-0.0221724087481473,0.00431630876386317,-0.0306323739253191,-0.0137124435709754,2.83550980213904e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,39104,0.0263982619477878,0.00514216002757474,0.0163196282937413,0.0364768956018343,2.8775177110389e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39428,-0.0331278187551525,0.00646168381388127,-0.0457927190303598,-0.0204629184799452,2.98366177541022e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36955,-0.0279984956544736,0.00546134901249639,-0.0387027397189666,-0.0172942515899807,2.99328385062923e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39541,-0.0119559182162552,0.00233451869399066,-0.0165315748564769,-0.00738026157603348,3.07070436341614e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36955,0.00993096377437816,0.00194037140496618,0.00612783582064446,0.0137340917281119,3.13253070740671e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39455,-0.0159453630046182,0.00311707284066751,-0.0220548257723265,-0.00983590023690984,3.16782044814158e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36955,-0.0392419527221171,0.00767522999369505,-0.0542854035097594,-0.0241985019344748,3.22102125271618e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39541,-0.0487328028827704,0.00956931466358708,-0.067488659623401,-0.0299769461421397,3.57420095032202e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39601,0.0198771358672831,0.00390361405294506,0.0122260523235108,0.0275282194110554,3.58588637134397e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39428,-0.0152481195118085,0.00300305835983194,-0.0211341138970791,-0.0093621251265379,3.86961884755905e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39319,-0.0416418554069574,0.00823317564685957,-0.0577788796748021,-0.0255048311391126,4.29144535848111e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,37241,0.0157151850113479,0.00310744627053812,0.00962459032109323,0.0218057797016027,4.31198018731294e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39462,-0.0292467315273515,0.00578755585948954,-0.040590341011951,-0.017903122042752,4.39156470949435e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39505,-0.0247089815954253,0.00489082399067939,-0.034294996617157,-0.0151229665736937,4.42072213861029e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39355,-0.0178490081740425,0.00353368254008428,-0.0247750259526077,-0.0109229903954773,4.44448839840063e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39497,-0.0122730164178744,0.00243197453414816,-0.0170396865048048,-0.00750634633094404,4.55170537070388e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36916,0.0228350840503191,0.00452640454664421,0.0139633311388964,0.0317068369617418,4.60238984341051e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37247,0.0276081209550822,0.00547276709421504,0.0168814974504207,0.0383347444597437,4.60613274834113e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39322,0.0124243777696859,0.00246540418558115,0.00759218556594682,0.0172565699734249,4.72255996904818e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,39332,-0.0223409519930705,0.00444432435981517,-0.0310518277383082,-0.0136300762478328,5.04395040346312e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39432,-0.00824184540574024,0.00164015462455332,-0.0114565484698647,-0.00502714234161573,5.09123699834086e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,37221,-0.0330361333395305,0.00657519695060754,-0.0459235193627213,-0.0201487473163398,5.11954568346108e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36916,0.029545253110828,0.00588184806092969,0.0180168309114058,0.0410736753102502,5.15414193457417e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,37221,0.0233125728249345,0.00464906132769871,0.014200412622645,0.0324247330272239,5.38939106382336e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39601,-0.0141142297784405,0.00281787717106953,-0.0196372690337367,-0.00859119052314417,5.53820493899351e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39531,0.0122584768093863,0.00245150484099959,0.00745352732102714,0.0170634262977455,5.78575444367003e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39636,-0.0325685899240948,0.00651509740795335,-0.0453381808436834,-0.0197989990045063,5.82882106451361e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39462,-0.0145532248603765,0.00291549101174664,-0.0202675872433999,-0.00883886247735307,6.05243879544887e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,37114,-0.0400045203658371,0.00801413914508331,-0.0557122330902004,-0.0242968076414738,6.06326788967985e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37203,0.0125434750509554,0.00251505638885052,0.00761396452880839,0.0174729855731024,6.20175929886593e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39589,-0.0256773276942457,0.00515247416481654,-0.0357761770572861,-0.0155784783312053,6.31356415012721e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39428,-0.0405882607384789,0.00814729961575696,-0.0565569679853626,-0.0246195534915953,6.36960420433087e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39601,-0.047465763971457,0.00953166681606784,-0.06614783093095,-0.028783697011964,6.4351414702757e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36916,0.0124456610891577,0.00250114975656138,0.0075434075662974,0.017347914612018,6.57861260452111e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39462,-0.0294818498155903,0.00593118710377991,-0.0411069765389989,-0.0178567230921817,6.74649109587606e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39462,-0.0270723872068898,0.00544834639544789,-0.0377511461419677,-0.0163936282718119,6.80688693717141e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39516,-0.0222784919703148,0.00448832575190738,-0.0310756104440533,-0.0134813734965763,6.99353900598593e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,39104,-0.0447563421627964,0.00904843989797137,-0.0624912843628203,-0.0270213999627725,7.64738477349842e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39462,-0.0261704854980041,0.00529857580632216,-0.0365556940783955,-0.0157852769176126,7.93060823995369e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38992,-0.0516484776806747,0.0104730415145505,-0.0721756390491937,-0.0311213163121557,8.2474424072863e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39182,-0.0177450472725076,0.00359896982962611,-0.0247990281385747,-0.0106910664064404,8.28741403505076e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39456,-0.0191689202955305,0.00389432697570719,-0.0268018011679166,-0.0115360394231444,8.64556326314698e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39459,0.0317930555813942,0.00645933506696278,0.0191327588501472,0.0444533523126412,8.65594302555915e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39428,0.0236995434028325,0.00482647036957885,0.0142396614784579,0.033159425327207,9.18835405106825e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39654,-0.0111806976394121,0.00228262709029303,-0.0156546467363864,-0.00670674854243774,9.77277703774721e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,37255,-0.025564943229437,0.0052205833212171,-0.0357972865390225,-0.0153325999198515,9.85232917045954e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39516,-0.0220080604618428,0.00449471408082628,-0.0308177000602623,-0.0131984208634233,9.86041311033299e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39303,-0.0111868554109047,0.00228597623441512,-0.0156673688303584,-0.0067063419914511,1.00001790022623e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36861,0.0142027696413839,0.00290225549168379,0.00851434887768366,0.0198911904050841,1.00200910312592e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39462,-0.022551525868593,0.00460998392014913,-0.0315870943520853,-0.0135159573851007,1.00908417128063e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39455,-0.017800382274441,0.00365433335218352,-0.0249628756447207,-0.0106378889041613,1.12148101146865e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36595,-0.00968984937085681,0.00199484937041934,-0.0135997541368787,-0.0057799446048349,1.20400675745795e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39455,0.0279001806068915,0.00575111977375687,0.0166279858503281,0.039172375363455,1.23911105827683e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38417,0.016798175044719,0.00346708232542431,0.0100026936868873,0.0235936564025506,1.27941215677282e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39428,-0.0128856656585011,0.00266185952039286,-0.0181029103184711,-0.00766842099853108,1.30573986016869e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39462,-0.0253654418798222,0.00524672821533271,-0.0356490291818743,-0.0150818545777701,1.34785285264025e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,39355,-0.0145497708654553,0.00301079918465938,-0.0204509372673877,-0.00864860446352289,1.36152827512567e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39545,-0.0118104836979888,0.00244565319110437,-0.0166039639525534,-0.00701700344342427,1.38445398297729e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37247,-0.0417201082570213,0.00863943440476316,-0.0586533996903571,-0.0247868168236855,1.38786162460904e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,37040,-0.0136122448248682,0.00282149514291047,-0.0191423753049728,-0.0080821143447637,1.42015098348839e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,39194,0.0213046346721241,0.00442758011564147,0.0126265776454668,0.0299826916987814,1.51057369347992e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39477,-0.015832424737044,0.00329074096290361,-0.0222822770243351,-0.00938257244975289,1.51480908852776e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39589,-0.0278501330702674,0.00580473454372011,-0.0392274127759588,-0.0164728533645759,1.61922736259224e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,37081,-0.0412856912069271,0.0086220704964718,-0.0581849493800118,-0.0243864330338424,1.70047240133082e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36955,-0.016612147904624,0.0034792308207775,-0.0234314403133479,-0.00979285549590011,1.82051351501056e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36955,-0.0211603578028739,0.0044334774823175,-0.0298499736682163,-0.0124707419375316,1.836865344852e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36847,-0.0248750907822457,0.00521316377617143,-0.0350928917835417,-0.0146572897809497,1.84860910650862e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37269,-0.00727981516944545,0.00152710576132276,-0.0102729424616381,-0.00428668787725284,1.88982141607207e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37243,-0.0256729870293793,0.00539295708839127,-0.0362431829226262,-0.0151027911361324,1.95262937056545e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39104,0.0189100843594543,0.00397443438578128,0.011120192963323,0.0266999757555856,1.97453225712405e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,37247,-0.0265665236474482,0.00558833971594718,-0.0375196694907046,-0.0156133778041917,2.01682941781147e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39420,0.0123369941086079,0.00259616837172094,0.00724850410003481,0.0174254841171809,2.03285290798158e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39455,-0.0492187299388535,0.0103647718111576,-0.0695336826887223,-0.0289037771889847,2.06666786689303e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39636,0.0153792510353966,0.00324192772084106,0.00902507270254811,0.0217334293682451,2.11591918388626e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37164,-0.0476240423575264,0.010042898744128,-0.0673081238960174,-0.0279399608190355,2.13852163488145e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37203,0.0291068151953921,0.00614564200671528,0.0170613568622302,0.0411522735285541,2.20140066777092e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39499,0.0108781332084537,0.0022972673485229,0.00637548920534879,0.0153807772115586,2.20781239695973e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39194,-0.0179523678232006,0.00379901458503439,-0.025398436409868,-0.0105062992365332,2.31632318053662e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39654,-0.00953132175550472,0.00202276240476714,-0.0134959360688483,-0.00556670744216112,2.47430531720486e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39654,-0.00633299447438841,0.0013461598928409,-0.00897146786435657,-0.00369452108442026,2.56742537723592e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,37164,-0.031128502933387,0.00661848671741467,-0.0441007368995198,-0.0181562689672543,2.587266121358e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39462,-0.0329284011849232,0.00701405509479558,-0.0466759491707225,-0.0191808531991238,2.6945006788434e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39485,-0.0126127053909482,0.00268842112174094,-0.0178820107895604,-0.00734339999233595,2.73608754968788e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39601,0.0242098854143387,0.00516548318902371,0.0140855383638522,0.0343342324648251,2.79846723048347e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36916,-0.0276737489327719,0.00590591435287862,-0.0392493410644139,-0.0160981568011298,2.81861686523399e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39104,0.0223025235771375,0.00478351922349982,0.0129268258990778,0.0316782212551971,3.15350365255091e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,37269,-0.00617766744889725,0.00132547057546676,-0.00877558977681211,-0.00357974512098239,3.18256688556939e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39418,-0.0174539704971028,0.00374581588804734,-0.0247957696376756,-0.01011217135653,3.19568151770791e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36648,-0.0189414366623071,0.00406618769009885,-0.0269111645349008,-0.0109717087897133,3.22234331474974e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39455,0.0151310444252156,0.00325015189154302,0.00876074671779128,0.0215013421326399,3.25982297946129e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39479,0.0308682972160412,0.00663409436099695,0.0178654722684871,0.0438711221635952,3.29966990180504e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39589,-0.0137117936776261,0.00295360945253533,-0.0195008682045953,-0.00792271915065682,3.4730201590996e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36955,-0.0166480517092141,0.0035871986863049,-0.0236789611343717,-0.00961714228405653,3.50315739163911e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36955,-0.0473569576389983,0.0102049061048032,-0.0673585736044126,-0.027355341673584,3.50916767115527e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39478,-0.0201070661005565,0.00433464127174236,-0.0286029629931715,-0.0116111692079415,3.53578413263149e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36955,0.0159223736479932,0.00343714903995534,0.00918556152968071,0.0226591857663056,3.65034470189358e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37230,-0.0292994350458983,0.00632584931676461,-0.0416980997067569,-0.0169007703850397,3.66254254891045e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37203,-0.0420074217830495,0.00907338375000455,-0.0597912539330585,-0.0242235896330406,3.69736698528331e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39601,0.0153865362563181,0.0033271858881043,0.0088652519156337,0.0219078205970026,3.78626876847863e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36847,0.0252286048575152,0.00547067705447047,0.0145060778307531,0.0359511318842773,4.03567962991146e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,39355,-0.0100073731150473,0.00217084359481293,-0.0142622265608806,-0.00575251966921393,4.06206698450634e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39498,-0.00896628713596285,0.00194623369831144,-0.0127809051846533,-0.00515166908727242,4.11883304696047e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39194,-0.0336379316814892,0.00732439013017776,-0.0479937363366376,-0.0192821270263408,4.41397545057611e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36919,0.0191377142307054,0.00417720662457722,0.010950389246534,0.0273250392148768,4.66214117812305e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,39187,0.00933428399066258,0.00204243537992503,0.00533111064600952,0.0133374573353156,4.9127936026664e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39102,-0.0185448488916545,0.00406956302294384,-0.0265211924166245,-0.0105685053666846,5.23178694560631e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36955,0.0150497240808571,0.00330957252337339,0.00856296193504524,0.0215364862266689,5.48408262515013e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39194,-0.0149235923846171,0.00328877993448364,-0.0213696010562051,-0.00847758371302921,5.73124776287843e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39365,-0.0116832753165188,0.00257507807365146,-0.0167304283408756,-0.00663612229216191,5.74899961814696e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,39187,0.0200685896080445,0.00442475710295782,0.0113960656862472,0.0287411135298418,5.79141168202618e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,39187,-0.0149447696832435,0.0032990140966119,-0.0214108373126028,-0.00847870205388414,5.94267702917815e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39485,-0.0299568775274731,0.00661365450350828,-0.0429196403543494,-0.0169941147005969,5.95642495368594e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39633,-0.0164167309965087,0.00362454643534842,-0.0235208420097916,-0.00931261998322577,5.96245031203739e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39079,0.0271783626097086,0.00601494284062936,0.0153890746420751,0.0389676505773421,6.27748611771602e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39541,-0.0138567911064473,0.00306887723261964,-0.0198717904823818,-0.00784179173051279,6.37167744818876e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39462,-0.0358080389917807,0.00793406298059545,-0.0513588024337477,-0.0202572755498136,6.43410065363096e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36916,0.0141969205659642,0.00314673265607745,0.00802932456005236,0.020364516571876,6.49169733599106e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39497,-0.010481102965569,0.00232487022603165,-0.015037848608591,-0.00592435732254698,6.58570879320429e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39654,-0.0280148168052702,0.00621459229973372,-0.0401954177127483,-0.0158342158977921,6.59586240830582e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39435,-0.0261188141270693,0.00579569649616088,-0.0374783792595446,-0.014759248994594,6.63771848302489e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,37247,0.0113455851176695,0.00251880771867394,0.00640872198906862,0.0162824482462705,6.7166540562847e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37243,-0.0280528632473611,0.00623614702114171,-0.0402757114087988,-0.0158300150859233,6.90606396660119e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39589,0.0120332583432802,0.00267680029261153,0.00678672976976158,0.0172797869167988,6.99582798024431e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39531,-0.0277929936012615,0.00618397636745204,-0.0399135872814676,-0.0156723999210555,7.03001015506041e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,39166,0.0168374604886533,0.00374830860343893,0.00949077562591295,0.0241841453513936,7.10894276759611e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39499,-0.0130104641136201,0.00289695193224307,-0.0186884899008165,-0.00733243832642364,7.13875955899873e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39043,-0.0222868642637405,0.00497255001792353,-0.0320330622988706,-0.0125406662286104,7.45170169881837e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,39194,0.0170037322130592,0.00379635900424448,0.00956286856474001,0.0244445958613784,7.55719787625841e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39462,-0.0234459519739509,0.00526347399563279,-0.0337623610053912,-0.0131295429425107,8.47110683503375e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37247,-0.0375132385999345,0.00842218145053902,-0.054020714242991,-0.021005762956878,8.49601314237607e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39463,-0.0199234101746855,0.00447600635663955,-0.0286963826336991,-0.011150437715672,8.60239980173864e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39589,-0.0174301166946172,0.00391954867001138,-0.0251124320878395,-0.00974780130139488,8.77099008594488e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36916,-0.033142106907873,0.00745954907488473,-0.0477628230946471,-0.018521390721099,8.95153336364045e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39541,-0.0126405094133924,0.00284638174545027,-0.0182194176344749,-0.00706160119230982,9.02180397902291e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37247,0.0148379023485247,0.0033437819692092,0.00828408968887468,0.0213917150081748,9.17869736983688e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39428,-0.0315553384628714,0.00711170513468503,-0.0454942805268541,-0.0176163963988887,9.18300347598604e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,39332,0.0173975010200334,0.00392545646521859,0.00970360634820492,0.0250913956918618,9.40440970515488e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37247,-0.0344087621638764,0.00776838536544166,-0.0496347974801421,-0.0191827268476108,9.5309682061306e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37255,-0.0314385031389692,0.00711632426118102,-0.045386498690884,-0.0174905075870544,1.00529043264005e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39187,-0.0422029114240186,0.00955412958378803,-0.0609290054082432,-0.0234768174397941,1.0068049794572e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39420,-0.0111269611623266,0.00252092890586209,-0.0160679818178163,-0.00618594050683696,1.02266507037318e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39187,-0.0354514492995269,0.00804646797411914,-0.0512225265288004,-0.0196803720702534,1.06118584344551e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,39104,-0.0168882985311694,0.00384008604412684,-0.024414867177658,-0.00936172988468076,1.10075969402353e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39499,0.0112594732669135,0.00256583374633119,0.0062304391241044,0.0162885074097227,1.15053767777062e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39455,-0.0155274029685114,0.00353979581829594,-0.0224654027723714,-0.00858940316465135,1.15961005345223e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37164,-0.0368518252830458,0.00841586983420617,-0.0533469301580899,-0.0203567204080017,1.2026146889438e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36955,0.0123114601358032,0.00281403904500153,0.0067959436076002,0.0178269766640062,1.22408441635695e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37255,0.00869952142770312,0.00199030197036898,0.00479852956577992,0.0126005132896263,1.24679162147943e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36853,-0.0102767204677885,0.00235859731826735,-0.0148995712115925,-0.00565386972398452,1.32837319206199e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39453,-0.0366886172424585,0.00842526473433572,-0.0532021361217566,-0.0201750983631605,1.34196829216563e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39623,-0.019155569242484,0.00441198959265972,-0.027803068844097,-0.0105080696408709,1.42295817064985e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39428,-0.0435511409306758,0.0100326828760769,-0.0632151993677865,-0.0238870824935652,1.4281396472221e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36880,0.0161684317810912,0.00372535275758689,0.00886674037622091,0.0234701231859615,1.43538678754517e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36916,-0.00964546944317278,0.00222290016026511,-0.0140023537572924,-0.00528858512905316,1.44169456038843e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36880,0.0130500517341496,0.00300810167020986,0.00715417246053826,0.0189459310077609,1.44721334074826e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,37247,-0.0195695658843729,0.004514919371884,-0.0284188078532656,-0.0107203239154803,1.472599427454e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39428,-0.0285470904264324,0.00659248327395688,-0.0414683576433879,-0.0156258232094769,1.49909264417161e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39455,0.0171935562189931,0.00397657072875864,0.00939947759062615,0.02498763484736,1.54413538830969e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39455,-0.018972555715675,0.00438943691241076,-0.0275758520640001,-0.0103692593673499,1.55390985685788e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37247,-0.0229562567361227,0.0053157485056797,-0.0333751238072549,-0.0125373896649904,1.58249937714136e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39424,-0.0295566572595829,0.00684488084818771,-0.0429726237220308,-0.016140690797135,1.58413683921624e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37255,-0.0225360611664257,0.00522637361351258,-0.0327797534489104,-0.0122923688839411,1.63003946090544e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39391,-0.0139664012612236,0.0032391657037292,-0.0203151660405329,-0.0076176364819144,1.63021960625644e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39437,-0.042823851700539,0.00994310959673331,-0.0623123465101363,-0.0233353568909417,1.66621434293392e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39601,0.0117202584330251,0.00272333135933661,0.00638252896872534,0.0170579878973248,1.69063199202215e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39462,-0.0198440877249009,0.00461604022047403,-0.02889152655703,-0.0107966488927718,1.72698074078514e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39498,-0.00671505457469587,0.00156277459650858,-0.00977809278385269,-0.00365201636553906,1.74307027124922e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39194,-0.0181489004995316,0.00422444958207062,-0.02642882168039,-0.0098689793186732,1.74897532238497e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,37228,0.0169484075702348,0.00395362351288931,0.00919930548497177,0.0246975096554978,1.82591732361247e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36916,0.00859751121161481,0.00201817900500054,0.00464188036181375,0.0125531420614159,2.05896065557337e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39455,-0.00977349021623196,0.00229461568332356,-0.0142709369555461,-0.00527604347691778,2.06303658354401e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37203,0.0110332267754975,0.00259340154055797,0.00595015975600382,0.0161162937949911,2.11157679324828e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39123,-0.0282012194520908,0.00663160828068135,-0.0411991716822262,-0.0152032672219554,2.1266237252985e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39636,-0.0253688374283429,0.00597051143024729,-0.0370710398316276,-0.0136666350250582,2.1598564870092e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39477,-0.00941081098762758,0.00221651761542,-0.0137551855138508,-0.00506643646140439,2.19158695795418e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,39355,0.0149479445896599,0.00352829046717274,0.0080324952740013,0.0218633939053184,2.28296432768609e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39496,-0.0171969433299859,0.00405920265105861,-0.0251529805260608,-0.00924090613391106,2.28349196941407e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39480,-0.0211373849071315,0.00498961810722166,-0.0309170363972859,-0.011357733416977,2.28614008247706e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37221,-0.0306573662890507,0.0072386383038623,-0.0448450973646208,-0.0164696352134806,2.29907926255723e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39623,-0.013895565964437,0.00328745538128105,-0.0203389785117479,-0.00745215341712613,2.38376714423782e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39495,-0.033831773905611,0.00800898944618985,-0.0495293932201432,-0.0181341545910789,2.41175645750994e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,37237,-0.0122065753698277,0.00290001426842224,-0.0178906033359353,-0.00652254740372011,2.58092831523211e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39531,-0.0202585236677513,0.00482354780733444,-0.0297126773701268,-0.0108043699653758,2.68540926787898e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39401,-0.0379193996780386,0.00903404441584457,-0.0556261267330939,-0.0202126726229832,2.71570722681936e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39654,-0.0145679825878723,0.00347892347120027,-0.0213866725914248,-0.00774929258431977,2.83636374244621e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39531,0.0162618950668189,0.00388446884714096,0.00864833612642257,0.0238754540072151,2.85036458084955e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39428,0.0215033037142336,0.00513770749984224,0.0114333970145428,0.0315732104139244,2.86303270561388e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39455,0.0190717733362293,0.00455790079491289,0.0101382877782001,0.0280052588942586,2.87632981778916e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,39330,-0.0188121222666732,0.00449784610996673,-0.0276279006422079,-0.00999634389113837,2.90006995754618e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39462,0.0172347902080492,0.00413364871406633,0.0091328387284792,0.0253367416876192,3.07131237882109e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,37255,-0.00828263523132849,0.00198955857928618,-0.0121821700467294,-0.00438310041592757,3.16077276234203e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37164,-0.0499532892737794,0.012003962417997,-0.0734810556130536,-0.0264255229345053,3.18384169086231e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,39123,-0.0292325566915752,0.0070370792776656,-0.0430252320757998,-0.0154398813073506,3.2845514476432e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39453,-0.00805000541820212,0.00193787259194264,-0.0118482356984097,-0.00425177513799455,3.28461093013942e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39401,-0.0214302798587467,0.00515918631584726,-0.0315422850378073,-0.0113182746796861,3.28801296406879e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39531,-0.00979184697015259,0.00235926508068166,-0.0144160065282886,-0.00516768741201653,3.33745920547649e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,37196,-0.0167225123022602,0.0040316848804246,-0.0246246146678924,-0.00882040993662796,3.37902107888387e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39526,-0.0159349782990826,0.00384468599965894,-0.0234705628584141,-0.00839939373975105,3.42153526187933e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39355,0.0185016717245873,0.00446497345097351,0.00975032376067922,0.0272530196884954,3.43579605142126e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39418,-0.0102662674636665,0.00248054759088234,-0.0151281407417959,-0.00540439418553713,3.51175388741539e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39068,-0.0168551581567852,0.00407455953630925,-0.0248412948479513,-0.00886902146561906,3.54334556490877e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37243,-0.0100850762596187,0.00243839227087194,-0.0148643251105277,-0.00530582740870969,3.55742862563429e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37162,0.0193601909926938,0.00468311953131262,0.010181276711321,0.0285391052740665,3.58733553082708e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39485,0.0203143940142677,0.00491554631617335,0.010679923234568,0.0299488647939675,3.60496079667929e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39433,-0.0238834267438364,0.00579660024314945,-0.0352447632204093,-0.0125220902672635,3.80500230603693e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39485,-0.0282272919672474,0.00685632800864135,-0.0416656948641845,-0.0147888890703104,3.85937289610616e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39396,-0.0137787659469131,0.00335221155537515,-0.0203491005954484,-0.00720843129837776,3.97167637358163e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39410,-0.0254819088013114,0.00621740006820939,-0.0376680129350018,-0.0132958046676209,4.18060861650783e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39438,-0.0165724262899475,0.00404600109875043,-0.0245025884434983,-0.00864226413639663,4.22555906818947e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39428,-0.0277858209516991,0.00679451562515804,-0.0411030715770088,-0.0144685703263893,4.34659897565445e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37269,-0.0061738257930869,0.00151118667898007,-0.00913575168388784,-0.00321189990228596,4.42657043078316e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37203,-0.0187193368367145,0.0045869123923744,-0.0277096851257683,-0.00972898854766066,4.51092876133941e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39462,-0.0118537206093454,0.00290759384410333,-0.017552604543788,-0.0061548366749029,4.58921649599709e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39462,0.0180569287058426,0.00443067354846816,0.00937280855084505,0.0267410488608402,4.61644757672137e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37203,0.0094016032540801,0.00230789479186614,0.00487812946202246,0.0139250770461377,4.65579012321452e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39428,-0.031402814506796,0.00773277066664171,-0.0465590450134137,-0.0162465840001782,4.9110741647972e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37221,-0.0437532916330153,0.0107934883707082,-0.0649085288396035,-0.0225980544264271,5.07182645814548e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39552,-0.0209238310484389,0.00516450999380205,-0.0310462706362909,-0.0108013914605868,5.11525630385368e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39541,-0.0305692527997319,0.00754702854169754,-0.0453614287414591,-0.0157770768580048,5.13635235598019e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36954,0.00734803385309811,0.00181408494369491,0.00379242736345608,0.0109036403427401,5.14069142553683e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,37162,0.0124716705608872,0.00307922222961594,0.00643639499083997,0.0185069461309344,5.14631360079105e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,37203,-0.0160482055062827,0.00396580489289873,-0.0238211830963642,-0.00827522791620121,5.22633841924608e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,37164,0.0107896119509822,0.00266733952081246,0.00556162649018978,0.0160175974117746,5.26134436383362e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39485,-0.0301253118377436,0.0074556413126163,-0.0447383688104716,-0.0155122548650157,5.35783358418952e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39426,-0.020281104371353,0.00502101950862346,-0.030122302608255,-0.010439906134451,5.38920226064849e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,37221,-0.0357910562465017,0.00886084926359475,-0.0531583208031474,-0.018423791689856,5.39394184181124e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39636,-0.0194843406669631,0.00482435650650446,-0.0289400794197118,-0.0100286019142144,5.40023344739346e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,39079,-0.0312196873138282,0.00773648077067432,-0.0463831896243499,-0.0160561850033066,5.4789870118203e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36955,-0.0327416814075256,0.00813715161475617,-0.0486904985724477,-0.0167928642426035,5.76214565859125e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39066,-0.0263742823758851,0.00656079568150762,-0.03923344191164,-0.0135151228401301,5.84945838978351e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36906,0.0097539937328677,0.00242781748130564,0.00499547146950864,0.0145125159962268,5.91400151128157e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39194,-0.0144777775760299,0.00361294449041977,-0.0215591487772526,-0.00739640637480713,6.17457850580937e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36992,-0.0445855283713632,0.0111280796943955,-0.0663965645723784,-0.022774492170348,6.19604064319666e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37183,-0.0133410086772048,0.00333049796001605,-0.0198687846788363,-0.00681323267557336,6.2182980693666e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36916,-0.0262125147393378,0.00656126676700181,-0.0390725976026614,-0.0133524318760143,6.50554914000182e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36880,0.0193992073568758,0.00487376038908488,0.00984663699426941,0.0289517777194822,6.9208936131371e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36992,-0.0123993553593585,0.0031162712825807,-0.0185072470732167,-0.00629146364550035,6.96221680736964e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36916,-0.0221403723897432,0.00556550085949828,-0.0330487540743599,-0.0112319907051266,6.98477264479794e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,37255,-0.00850599221868269,0.00213844955480152,-0.0126973533460937,-0.00431463109127172,6.99843814375336e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39485,-0.00914416969761679,0.00229949017071466,-0.0136511704322175,-0.00463716896301605,7.02326782610476e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39355,-0.0272532266527695,0.00685413352026348,-0.040687328352486,-0.0138191249530531,7.0363505679335e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39526,-0.0105096494929027,0.00264917325194826,-0.0157020290667213,-0.00531726991908411,7.30758483289286e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39531,-0.00942768868780488,0.00237781567031121,-0.0140882074016148,-0.00476716997399491,7.37802400051617e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,39319,-0.0275352847272288,0.00695023806724614,-0.0411577513390312,-0.0139128181154263,7.47416038996878e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,37241,-0.00935193954956341,0.00236075414509981,-0.013979017673959,-0.00472486142516778,7.49094300197132e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39482,0.012390682758874,0.00313344914612982,0.00624912243245957,0.0185322430852885,7.710216034117e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39462,0.00837374202842658,0.00211783098636521,0.00422279329515076,0.0125246907617024,7.72326769944803e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39214,-0.0117193032115307,0.00296411865268379,-0.017528975770791,-0.00590963065227051,7.73034735152628e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39499,-0.00822073475882789,0.00208385233216498,-0.0123050853298713,-0.00413638418778452,8.0172143231912e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39428,-0.00680846268443207,0.00172588228401912,-0.0101911919611095,-0.0034257334077546,8.01914882829297e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39440,-0.00964971832528968,0.00244729167897945,-0.0144464100160894,-0.00485302663448996,8.08280354045802e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36955,-0.0297075835210509,0.00753869727664317,-0.0444834301832715,-0.0149317368588303,8.16934280912115e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39541,-0.0147386045855705,0.00375328249762916,-0.0220950382809236,-0.00738217089021732,8.6445729151078e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,37221,-0.0232769355401624,0.00593331024510752,-0.0349062236205731,-0.0116476474597517,8.78767466408898e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39404,-0.0204986564775672,0.00523722100575059,-0.0307636096488383,-0.010233703306296,9.11694931691584e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,37269,-0.00781055281693146,0.00199625656562289,-0.0117232156855523,-0.0038978899483106,9.17794208444809e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,37247,-0.0241429821831615,0.00617372087331362,-0.0362434750948562,-0.0120424892714668,9.25407296526903e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39485,-0.0165502860452574,0.00423248854959686,-0.0248459636024672,-0.00825460848804751,9.25877360187782e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37221,-0.0269514728457686,0.0069021553390718,-0.0404796973103494,-0.0134232483811879,9.47921569328234e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36955,-0.0383518461332334,0.00982179818903167,-0.0576025705837355,-0.0191011216827313,9.48113222386747e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37221,-0.0286652417892309,0.00734246241552245,-0.0430564681236549,-0.0142740154548069,9.50878736070609e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36916,0.00989430467556598,0.00253475008471779,0.00492619450951911,0.0148624148416129,9.53250453890544e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38967,0.026340411551026,0.00674911343938174,0.0131121492098378,0.0395686738922142,9.55174031180662e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39497,-0.0134685333738763,0.00345286781762506,-0.0202361542964214,-0.00670091245133116,9.63398758481322e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37243,0.0202743780525118,0.00520640123859679,0.0100698316248621,0.0304789244801615,9.90547618439343e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39564,-0.00939728472509596,0.0024138193373312,-0.0141283706262651,-0.00466619882392682,9.93890681865056e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39194,0.0186284857172016,0.0047940190629087,0.0092322083539006,0.0280247630805027,0.000102449572976577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37247,-0.0237176269886335,0.00610738876732305,-0.0356881089725867,-0.0117471450046804,0.000103510471976746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36955,-0.0126849960216754,0.003267827452676,-0.0190899378289203,-0.00628005421443042,0.00010422638252815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39526,-0.0370297753760687,0.00954767500177744,-0.0557432183795524,-0.0183163323725849,0.000105588988621545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39462,0.020562423268689,0.00530587487838889,0.0101629085070468,0.0309619380303312,0.00010689943202229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39559,0.0142231545507982,0.00367035367510575,0.00702926134759087,0.0214170477540054,0.00010701115180095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,39355,-0.0112759515335226,0.00291043855604253,-0.016980411103366,-0.00557149196367926,0.00010738317831265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39428,0.0273612694331115,0.00706438673034466,0.0135150714416359,0.041207467424587,0.000107904614758847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39532,0.011227682019572,0.00290443470516164,0.00553498999745516,0.0169203740416888,0.000111234122011991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37019,-0.018574862559715,0.00480483044575013,-0.0279923302333853,-0.00915739488604476,0.000111249901463625
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39462,-0.0139188519858013,0.0036031209875855,-0.0209809691214689,-0.00685673485013372,0.000112474150392233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39601,-0.0188203564797919,0.00488042082718911,-0.0283859813010825,-0.00925473165850123,0.000115593287006063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39654,0.0166223519315089,0.00431863050330956,0.00815783614502214,0.0250868677179956,0.000119092703294846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39601,0.0196310040512241,0.00510109579863402,0.00963285628590145,0.0296291518165468,0.000119384777486256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,37243,-0.0214603853775335,0.00557689963937348,-0.0323911086707055,-0.0105296620843615,0.000119623185604517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39355,-0.0137099222076692,0.00356467181730554,-0.020696678969588,-0.0067231654457503,0.000120534647849998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39104,0.0174897777827652,0.00455223379538241,0.00856739954381572,0.0264121560217148,0.000122539943510569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39477,-0.0167823422736796,0.00436944107880979,-0.0253464467881468,-0.00821823775921241,0.000123115517666959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39390,-0.0282531715432642,0.00735619274458436,-0.0426713093226496,-0.0138350337638789,0.000123174218359153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39531,-0.0101844095067405,0.00265268057363038,-0.015383663431056,-0.00498515558242493,0.000123894902243586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36928,-0.033859709632663,0.00882164297254525,-0.0511501298588516,-0.0165692894064743,0.000124523604016192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36993,-0.0127067171041518,0.00331129485643509,-0.0191968550227646,-0.00621657918553904,0.000124960816733489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,37195,-0.0321222460155504,0.00837870523963102,-0.0485445082852272,-0.0156999837458736,0.000126787811875293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36916,-0.0320860295490639,0.0083713664133644,-0.0484939077192582,-0.0156781513788697,0.000127299610581113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39589,-0.0114872809421247,0.00299983442140706,-0.0173669564080825,-0.00560760547616687,0.000129023624119925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39455,-0.0244778418621271,0.00640381389102271,-0.0370293170885316,-0.0119263666357226,0.000132700974185706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,37197,-0.0276795320266384,0.0072474148826439,-0.0418844651966205,-0.0134745988566564,0.000134504494999087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39589,-0.0432218697954908,0.0113331303133917,-0.0654348052097385,-0.0210089343812431,0.00013741014790977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39541,-0.0109696379593008,0.00287946161870763,-0.0166133827319677,-0.00532589318663383,0.000139735736495566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36823,-0.015392445313865,0.00404611629653085,-0.0233228332550655,-0.00746205737266451,0.000142917949191907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39636,-0.019240232447748,0.00506123007777999,-0.0291602434001967,-0.00932022149529919,0.000144388845528212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39415,0.0232492052699597,0.00612387907693288,0.0112464022791713,0.0352520082607482,0.000147342502924948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39187,0.0124217510069324,0.00327529119749486,0.00600218025984243,0.0188413217540223,0.000149695232833938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37247,0.0194608012695756,0.00513413384114217,0.00939789894093696,0.0295237035982143,0.000151050126966529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36916,-0.0200873975438693,0.00530179472902439,-0.0304789152127571,-0.00969587987498147,0.000152093662588962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39636,-0.0144432688550984,0.0038134922411013,-0.021917713647657,-0.00696882406253988,0.000152810959736868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39428,-0.00929616291167626,0.00245650833799272,-0.014110919254142,-0.00448140656921053,0.000154742799767426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39355,-0.0342767327400514,0.00906079010464223,-0.0520358813451501,-0.0165175841349526,0.000155571615977559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36955,0.0294158267758227,0.00777922786844217,0.0141685401536761,0.0446631133979694,0.000156718868958822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39568,0.0137426993259504,0.00363615664007581,0.00661583231140183,0.020869566340499,0.00015777423777343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36916,0.0136047644902222,0.00359974032752546,0.00654927344827232,0.0206602555321721,0.000157955869746765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36847,-0.0219842099124512,0.00582520495856381,-0.0334016116312363,-0.0105668081936662,0.000161412142657214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37162,0.0197269630613085,0.00522834588706277,0.00947940512266551,0.0299745209999516,0.000161977294958231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36880,-0.0298000237285488,0.00791196203802224,-0.0453074693230724,-0.0142925781340252,0.000166347956011683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37203,-0.0323362372389194,0.00858846087301297,-0.0491696205500248,-0.015502853927814,0.000167243778260818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39485,-0.022883336066415,0.00607892495059103,-0.0347980289695734,-0.0109686431632566,0.000167603370220698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36916,-0.028880139760002,0.00768251767967035,-0.0439378744121558,-0.0138224051078481,0.000171234284207295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37162,-0.0305401303006638,0.00812483387221029,-0.046464804690196,-0.0146154559111316,0.000171452008327176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39552,-0.022427399136857,0.00597009847694586,-0.0341287921516709,-0.0107260061220431,0.000172870180934329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39516,-0.00989686218762769,0.00263630660417418,-0.0150640231318091,-0.0047297012434463,0.000174644714748056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39531,-0.0236015324923318,0.0062919205494184,-0.0359336967691919,-0.0112693682154718,0.000176729668633675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37221,-0.0233763561041983,0.00623204456576802,-0.0355911634531036,-0.0111615487552929,0.000176914270053967
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39568,0.0381567566072515,0.0101732455011823,0.0182171954249342,0.0580963177895689,0.000177002261660268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39601,-0.0105978436260926,0.00282638373036101,-0.0161375557376002,-0.00505813151458506,0.00017776699564116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39485,-0.0118759968343199,0.00316995230838795,-0.0180891033587603,-0.0056628903098795,0.000180041093675446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39104,-0.0158053781432333,0.00422139203468709,-0.02407930653122,-0.00753144975524656,0.000181723138299478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39355,-0.019739383402269,0.00527711810426423,-0.0300825348866269,-0.00939623191791114,0.000184297927697549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39654,0.00877828591607386,0.00234965648139867,0.00417295921253247,0.0133836126196153,0.000187664173758377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,37255,0.0239844567459957,0.00642766883631407,0.0113862258268201,0.0365826876651713,0.000191211946596607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,37269,-0.0101043486035482,0.00270815914267933,-0.0154123405231997,-0.00479635668389676,0.000191486522586952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39428,0.00683855561118745,0.00183357525808134,0.00324474810534803,0.0104323631170269,0.000192469178928138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37173,0.0131663389939346,0.00353033702411479,0.00624687842666961,0.0200857995611996,0.000192704779039551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39462,-0.0121516713037303,0.00325847700249377,-0.018538286228618,-0.00576505637884247,0.000192758011481606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39428,-0.0103946887077128,0.00278864915731357,-0.0158604410560474,-0.0049289363593782,0.000194100644767444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39428,-0.0269951915178746,0.00725314850593695,-0.041211362589511,-0.0127790204462382,0.000198485699780882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39541,-0.00833441758701017,0.00224077902981481,-0.0127263444854472,-0.00394249068857313,0.000200397489386107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37247,0.00848291260187215,0.00228222870780385,0.0040097443345766,0.0129560808691677,0.000202508085788279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36916,0.00717667299600573,0.00193138407221581,0.00339116021446274,0.0109621857775487,0.000203432269933929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39636,-0.0122946369368994,0.00330912518833969,-0.0187805223060452,-0.0058087515677536,0.00020363114357637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39436,-0.0110912425346754,0.00298646806617666,-0.0169447199443816,-0.00523776512496911,0.000204884519945176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39485,-0.0270448916492693,0.00728934409598931,-0.0413320060774084,-0.0127577772211303,0.000207845455535806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39462,-0.0284121046795826,0.00766156999844793,-0.0434287818765405,-0.0133954274826246,0.000209330918227238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,37243,-0.0289219312304366,0.0078057278772158,-0.0442211578697795,-0.0136227045910936,0.000212098240699437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,37269,-0.00610569747957931,0.00165069346758568,-0.00934105667604725,-0.00287033828311137,0.000217467995391644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37221,-0.0201075781585731,0.00544235929840437,-0.0307746023834457,-0.00944055393370054,0.000221115003264499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37247,-0.0106545644181975,0.00289003658559099,-0.0163190361259558,-0.00499009271043915,0.000228161473454951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36847,-0.0103529954485946,0.00281596985257362,-0.0158722963596389,-0.00483369453755027,0.000237427410847727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,39187,-0.0238910401903147,0.00650201032972261,-0.036634980436571,-0.0111470999440584,0.000239246345823339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37044,-0.00258009901588069,0.000702155551117369,-0.00395632389607073,-0.00120387413569065,0.000239266497640255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,39104,-0.0230017886072327,0.00626032345107668,-0.035272022571343,-0.0107315546431224,0.000239429935690277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39636,0.0154834787576253,0.00421733757232256,0.00721749711587309,0.0237494603993775,0.000242064845300885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39516,-0.024267136886722,0.00661132590597431,-0.0372253356624316,-0.0113089381110123,0.000242874334044055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39462,0.00871129020737046,0.0023736339626251,0.00405896764062526,0.0133636127741157,0.000243369168780575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39462,-0.0154879870980065,0.00422222858543047,-0.0237635551254502,-0.00721241907056274,0.000245106768232988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36955,0.0153897495342126,0.00419771225103408,0.00716223352218577,0.0236172655462394,0.000247179131059212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,37203,-0.0291415126834684,0.00796698764427122,-0.04475680846624,-0.0135262169006969,0.000255430856780073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37255,0.0110391824823001,0.00301912453872663,0.00512169838639589,0.0169566665782043,0.000256788283615757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39104,-0.0354373913950607,0.00970428742944938,-0.0544577947567814,-0.0164169880333399,0.000261391686598046
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37164,-0.0462723077028621,0.0126815565748475,-0.0711281585895633,-0.021416456816161,0.000264535388507939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,39187,-0.0267506648600492,0.0073351762490578,-0.0411276103082024,-0.0123737194118959,0.00026633629882213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39386,-0.00841088136304738,0.00230997297971111,-0.0129384284032812,-0.00388333432281361,0.00027237544037058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39434,0.0276374002402628,0.00759439434887486,0.0127523873164681,0.0425224131640575,0.0002744226587792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37243,-0.00696208843573953,0.00191523807392491,-0.0107159550606324,-0.00320822181084671,0.000278959070834884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37247,-0.0281738142499505,0.00775276636506996,-0.0433692363254876,-0.0129783921744133,0.000280117280151012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,37164,-0.0320900318612575,0.00884421650079725,-0.0494246962028201,-0.0147553675196948,0.000286341451077008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39414,0.0127138853896217,0.00350677187872549,0.00584061250731971,0.0195871582719236,0.000289333472777619
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,37164,0.0175123210368448,0.0048373261740969,0.00803116173561491,0.0269934803380748,0.000295464545140415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36757,0.0193950668884173,0.00536179072232656,0.00888595707265723,0.0299041767041773,0.000298913714509987
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39636,-0.0169142514831186,0.00468744366401336,-0.0261016410645847,-0.00772686190165238,0.000309061013659302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,37146,-0.0275296278074484,0.00763369767750915,-0.0424916752553664,-0.0125675803595305,0.000311750364948486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39564,-0.0217621146153442,0.00603841298018524,-0.0335974040565073,-0.00992682517418117,0.000314429441792407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39414,-0.0274009578033944,0.00761058768793869,-0.0423177096717542,-0.0124842059350345,0.000318788133887836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39428,0.0171217081644662,0.00475617694642345,0.00779960134947625,0.0264438149794562,0.000319381386701469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39477,-0.0289973800186586,0.00807186213699375,-0.0448182298071663,-0.0131765302301509,0.000328689357988018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,39194,-0.0265307546592231,0.00738664014550726,-0.0410085693444173,-0.0120529399740288,0.000329569328122536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39531,-0.0213308056336116,0.00594245597448661,-0.0329780193436054,-0.00968359192361789,0.000332286886842683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39445,0.0257831019929429,0.00718561481245803,0.0116992969605252,0.0398669070253607,0.000334087101266816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39589,0.0067148055575599,0.00188368118478169,0.00302279043538779,0.010406820679732,0.000365359537516435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39282,0.011360250999685,0.00318953885722874,0.00510875483951667,0.0176117471598533,0.000369584808103931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37164,-0.0278575810318604,0.00782113744930358,-0.0431870104324955,-0.0125281516312254,0.000369622140290882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39194,-0.0110893063628577,0.00311574026900926,-0.0171961572901159,-0.00498245543559956,0.000373263444689847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39428,-0.0278652109076715,0.0078304114448994,-0.0432128173396743,-0.0125176044756686,0.000374006577878646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36483,0.0378672882783062,0.0106481585697223,0.0169968974816506,0.0587376790749618,0.000377661640348196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39460,-0.0201630919764017,0.00567166764023659,-0.0312795605512654,-0.00904662340153799,0.000379061617469274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,37269,-0.00635883426190783,0.00178985710615845,-0.00986695418997838,-0.00285071433383727,0.00038266149257828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39485,-0.0389918863498901,0.010983868374574,-0.060520268364055,-0.0174635043357252,0.000386520453974054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39355,0.0147783086850418,0.00417037796955,0.00660436786472377,0.0229522495053598,0.000395854554906042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39123,-0.0145509543629925,0.00410797239850209,-0.0226025802640566,-0.00649932846192835,0.000398147996652004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39601,-0.0187048274936357,0.0052810207520688,-0.0290556281676906,-0.0083540268195809,0.000398455194911399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37162,-0.0214095320015591,0.00605103152735851,-0.0332695537951818,-0.00954951020793641,0.000404359570298862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39485,-0.0138284081935806,0.00390939181757755,-0.0214908161560326,-0.00616600023112861,0.000405569357934029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39388,-0.012877131222576,0.00364148953761358,-0.0200144507162986,-0.00573981172885334,0.000407116184810483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39355,-0.0178751471179333,0.00505559924796875,-0.027784121643952,-0.00796617259191453,0.00040791037183484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,37243,0.0111129425381182,0.00314473346263773,0.0049492649513483,0.0172766201248882,0.000411035039777042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37164,-0.0233932097739173,0.00663383830854226,-0.0363955328586601,-0.0103908866891745,0.000422820107635843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39400,0.0102126277909003,0.00289814915433822,0.00453225544839739,0.0158930001334032,0.000426603830632795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39601,0.00869121495272044,0.00246689975721993,0.00385609142856938,0.0135263384768715,0.000427733993761752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39123,0.0134188609809435,0.00381016805274881,0.00595093159755588,0.0208867903643312,0.000429839325514338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37221,0.0131822588917266,0.0037503343538242,0.00583160355823111,0.020532914225222,0.00044135125172648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39433,-0.0269070128656178,0.00765720441914262,-0.0419151335271374,-0.0118988922040983,0.000442802518150774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,37221,-0.00993169842391474,0.00282760730744337,-0.0154738087465037,-0.00438958810132573,0.000445607212753521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39485,-0.0241342460000087,0.00687778296330914,-0.0376147006080946,-0.0106537913919228,0.000451083960809323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38700,-0.0116105316042171,0.00331012661221942,-0.0180983797641671,-0.00512268344426701,0.000453596464377184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39485,-0.0118329225709565,0.00337362323498977,-0.0184452241115365,-0.00522062103037659,0.000453689519465274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39498,-0.00823556984001114,0.00235210645800127,-0.0128456984976936,-0.00362544118232865,0.000464232534041727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,39308,-0.0212724553113686,0.00608147006956987,-0.0331921366477255,-0.00935277397501167,0.000470284485740089
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39531,-0.00833622012764386,0.00238627891565414,-0.013013326802326,-0.00365911345296175,0.000478283704189026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,37247,-0.0193464250560042,0.00553947596576436,-0.0302037979489024,-0.00848905216310608,0.000480200103140843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39319,-0.00941602900947092,0.00269643833910686,-0.0147010481541204,-0.00413100986482148,0.000480765886524079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39415,-0.0143171615100231,0.0041025221186364,-0.0223581048625504,-0.00627621815749575,0.000484693827830592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39455,-0.00841788239451876,0.00241463364346813,-0.0131505643357163,-0.00368520045332122,0.000491345550065216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36955,0.0160876749079674,0.00462113033927564,0.00703025944298714,0.0251450903729477,0.000500635456276502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36955,0.0125139045279831,0.00359558635980656,0.00546655526276225,0.0195612537932039,0.000502463846505647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36823,-0.0186150783163507,0.00535136078572547,-0.0291037454563726,-0.00812641117632876,0.000505832464575837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39455,-0.0233169110993556,0.00670782051692809,-0.0364642393125347,-0.0101695828861766,0.000510242257475054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,37203,-0.00821119940548937,0.00236406008052254,-0.0128447571633136,-0.00357764164766519,0.000515717404617076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37164,-0.0192425499338275,0.0055411378678589,-0.0301031801548309,-0.00838191971282403,0.000517020317208217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36916,-0.0112185031177163,0.00323087946436073,-0.0175510268678633,-0.00488597936756925,0.000517816804742386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,39104,0.0106767533778383,0.00307793654241019,0.00464399775471433,0.0167095090009623,0.000524286245107514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39123,0.0154800913509832,0.00446467890999656,0.00672932068738991,0.0242308620145764,0.000527348326752208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39516,-0.0258588443183163,0.00746874568168035,-0.0404975858544098,-0.0112201027822228,0.000537118021125102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,39163,-0.0167961042320806,0.00485554849376033,-0.0263129792798509,-0.00727922918431039,0.000543403914173451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39654,0.0158783108329309,0.0045925468815369,0.00687691894511856,0.0248797027207432,0.000546889395360822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39123,0.0178261785105033,0.00516039180258642,0.00771181057743396,0.0279405464435727,0.000553029037600381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39123,0.0172803719350707,0.00500329981882111,0.00747390429018137,0.0270868395799601,0.000554318256282467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39291,0.0175694280149714,0.00508867881356985,0.00759561754037447,0.0275432384895683,0.00055665615156396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36947,0.0136122769106273,0.00394444578373035,0.00588116317451585,0.0213433906467388,0.000560362964072706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39485,0.00769726967779286,0.00223080973525363,0.00332488259669574,0.01206965675889,0.000561215402607845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39636,-0.0105325267202093,0.00305380470423339,-0.0165179839405067,-0.00454706949991184,0.000564225166921222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39462,0.0232333994683943,0.00674125505010423,0.01002053957019,0.0364462593665986,0.000569558649336591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39453,-0.0269923837564211,0.00783424382807799,-0.0423475016594539,-0.0116372658533882,0.000571699860889883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39485,-0.0171617770139114,0.00498926203679618,-0.0269407306060319,-0.00738282342179085,0.000583848145218615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39541,-0.031120119749685,0.00905782810946812,-0.0488734628442425,-0.0133667766551275,0.000592582562597395
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39427,-0.0066649089756148,0.00194048186308348,-0.0104682534272584,-0.00286156452397118,0.000594890111498201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36955,-0.036980960777712,0.0107858831606682,-0.0581212917726217,-0.0158406297828023,0.000608559418453568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36916,-0.0344087037590977,0.010044106170554,-0.0540951518533835,-0.0147222556648119,0.000615057506225706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,39280,0.0106627164286668,0.00311764881300901,0.00455212475516915,0.0167733081021645,0.000627633607472818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39654,0.00875680325179318,0.00256265737382373,0.00373399479909867,0.0137796117044877,0.000634626186849324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39391,0.0167515798730715,0.00490638407291056,0.00713506709016677,0.0263680926559762,0.000641297880795093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37203,-0.0315164127058156,0.00923089417875403,-0.0496089652961735,-0.0134238601154577,0.000641612377931067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39654,-0.00925829191499816,0.00271197504173574,-0.0145737629968002,-0.00394282083319612,0.000642175950743261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37164,-0.0257460554761451,0.0075447716503209,-0.040533807910774,-0.0109583030415161,0.000645855346688184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39589,-0.0283297265122479,0.008321130256639,-0.0446391418152603,-0.0120203112092354,0.00066444443260048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39462,0.0208601610729419,0.00614497659522351,0.00881600694630381,0.03290431519958,0.000688894743556571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36880,-0.0172638340615375,0.0050973695123534,-0.0272546783057502,-0.00727298981732486,0.000709289016899491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39324,-0.00845374067164865,0.00249622525093775,-0.0133463421634866,-0.00356113917981066,0.000709451954621438
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39281,-0.0339541175968322,0.0100316743508796,-0.0536161993245563,-0.0142920358691082,0.000714430803455322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37024,-0.00395064670910239,0.00116952211862726,-0.00624291006161182,-0.00165838335659296,0.000732364194128017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39462,-0.0293561699343578,0.00869119629512331,-0.0463909146727994,-0.0123214251959161,0.000732830343447275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37143,-0.0204743745162449,0.00606977557014103,-0.0323711346337213,-0.00857761439876847,0.000745307071047978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39601,-0.0103698979707632,0.00308317982521044,-0.0164129304281756,-0.00432686551335072,0.000771857369836159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39194,-0.0268483982216339,0.00798291840628952,-0.0424949182979614,-0.0112018781453065,0.000772319982466317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39516,0.0247042543382713,0.00736964347821057,0.0102597531209786,0.039148755555564,0.000803797989398995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37255,0.00950464448007216,0.00284398969729616,0.00393042467337168,0.0150788642867726,0.000834119720485675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39608,-0.00928676256489454,0.00277963934407792,-0.0147348556792873,-0.00383866945050182,0.000836802480813396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39104,0.011866026755684,0.00355453445560664,0.00489913922269496,0.018832914288673,0.000845091748550997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39485,-0.00862199144993127,0.00258564947282032,-0.0136898644166591,-0.00355411848320345,0.000856424846066821
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39123,0.0159124024206158,0.00477382999990241,0.00655569562080708,0.0252691092204245,0.000860479994624482
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,39019,-0.0201394833992042,0.00604276280874752,-0.0319832985043494,-0.00829566829405911,0.000861825021405326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37235,-0.00703634517672509,0.00211203939124593,-0.0111759423835671,-0.00289674796988307,0.000866115034775618
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39104,-0.008724873075335,0.00262458156651746,-0.0138690529457092,-0.00358069320496077,0.000888610685433163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36992,-0.0210066604210024,0.00631960881480928,-0.0333930936980286,-0.00862022714397623,0.000889763161029445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36880,-0.0173306542916041,0.00521490385968831,-0.0275518658565932,-0.00710944272661499,0.000892183943613692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36880,-0.00755950785803753,0.00227908281775286,-0.0120265101808331,-0.00309250553524193,0.00091280708667984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37221,-0.0122925989413451,0.00370809682999113,-0.0195604687281277,-0.0050247291545625,0.000918755959565917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39601,0.00470360475365105,0.00141911760922417,0.00192213423957168,0.00748507526773043,0.000920366600117502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39485,0.00501462930458542,0.00151315093413904,0.0020488534736729,0.00798040513549794,0.000921786238181615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37162,0.0164719015070553,0.00497176562675924,0.00672724087860722,0.0262165621355034,0.000925293578942079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39636,-0.00932435864848002,0.00281666288352531,-0.0148450179001896,-0.00380369939677042,0.000933706417638372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36955,0.0211063981117379,0.0063843668409308,0.00859303910351357,0.0336197571199623,0.000949215567410648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39589,-0.0153954960987861,0.00466072949550829,-0.0245305259099824,-0.00626046628758985,0.000957970796708195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37247,0.00936381102094986,0.0028381323417213,0.00380107163117612,0.0149265504107236,0.000971958111372334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37221,-0.0272261737528326,0.00825666026442579,-0.0434092278711072,-0.0110431196345581,0.000978230604225829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36847,-0.0240244652186257,0.00728813492552754,-0.0383092096726597,-0.0097397207645917,0.000982145937202081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39654,-0.019249109560424,0.00584068553797999,-0.0306968532148647,-0.00780136590598317,0.000984038554966191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36861,-0.0153912402166039,0.0046715782877918,-0.0245475336606758,-0.00623494677253193,0.000988186126768529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36775,-0.0155471499630893,0.00472194455085108,-0.0248021612827574,-0.00629213864342121,0.000995693745954101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39487,-0.0141198926920348,0.00429103193653702,-0.0225303152876474,-0.00570947009642224,0.00100218777226242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36533,-0.0304775506027555,0.00928190655879129,-0.0486700874579864,-0.0122850137475246,0.00102801959639815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39462,-0.0133285831668482,0.00405977381132095,-0.0212857398370373,-0.00537142649665915,0.00102912398551549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36955,0.00796526147293424,0.00242747530246592,0.00320740988010103,0.0127231130657674,0.00103614864672313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39462,-0.027303761876185,0.00832205234998921,-0.0436149844821639,-0.0109925392702062,0.00103715060289364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39485,-0.0238015487546545,0.00726769540379593,-0.0380462317460946,-0.0095568657632145,0.00105908915197545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39440,-0.0309804274682924,0.0094727044987913,-0.0495469282859234,-0.0124139266506615,0.00107602001706084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37164,0.016284489423615,0.00498030291144205,0.00652309571718853,0.0260458831300414,0.00107917841852121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36916,-0.0130018314347625,0.00398273351418263,-0.0208079891225604,-0.00519567374696453,0.00109933890411775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,39251,-0.00780202594211651,0.00239028093652754,-0.0124869765777105,-0.00311707530652252,0.00110076273064543
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39418,-0.0115176685543036,0.00354455698712153,-0.0184650002490618,-0.0045703368595454,0.0011590571222225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,37255,-0.0146445286308504,0.00450677504261035,-0.0234778077143666,-0.00581124954733408,0.00115927834932705
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39589,-0.0125940411096612,0.00387659510443804,-0.0201921675143598,-0.00499591470496269,0.00116171045704722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36916,-0.0140513779127449,0.00432557104751231,-0.022529497165869,-0.00557325865962072,0.00116345047592041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39551,0.00722495004226841,0.00222789337708085,0.00285827902318994,0.0115916210613469,0.00118555290964446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,37221,0.0122366880448149,0.0037732082402575,0.00484119989391022,0.0196321761957196,0.00118562868014294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39531,-0.0197600364543942,0.00610215118656756,-0.0317202527800666,-0.00779982012872176,0.00120543131603642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39462,-0.0104254414642084,0.00322304232310519,-0.0167426044174946,-0.00410827851092225,0.00122051837589516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,39256,-0.0188575033646536,0.00583822929400963,-0.0303004327809125,-0.00741457394839473,0.001240587138095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39462,-0.029078268108049,0.00901981278253439,-0.0467571011618164,-0.0113994350542816,0.00126762507574133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39654,-0.0245384511957391,0.00761562180769313,-0.0394650699388176,-0.00961183245266052,0.0012751362827203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39582,0.017142901618382,0.00532501313975116,0.00670587586446976,0.0275799273722943,0.00128767735198035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39541,-0.0079416883028129,0.00247204222199337,-0.0127868910579199,-0.0030964855477059,0.0013181444610383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37247,0.00805323236329704,0.00250719020707102,0.00313913955743785,0.0129673251691562,0.00132115295069792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36916,0.0202772036749386,0.00632225050738514,0.00788559268046377,0.0326688146694135,0.00134336746502451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,37203,0.0196450401474408,0.00613008211155103,0.00763007920880074,0.0316600010860808,0.00135538770781673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39589,-0.00831380368699565,0.00259806608210904,-0.0134060132079294,-0.00322159416606194,0.00137712434673917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37221,-0.0206252856557722,0.00645521992718957,-0.0332775167130637,-0.00797305459848061,0.00140106277721546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36847,-0.0112468440828453,0.0035228705409233,-0.018151670343055,-0.00434201782263563,0.00141388069105646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39582,-0.00551885393069752,0.00172967044354939,-0.00890900800005433,-0.00212869986134072,0.0014221985939635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,37269,-0.00907696807250865,0.00284648930724257,-0.0146560871147041,-0.00349784903031322,0.00143193785938658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37162,-0.0135505104027653,0.00425160795874779,-0.0218836620019109,-0.00521735880361959,0.00144030202963617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38827,-0.00625548687022745,0.00196409595069234,-0.0101051149335844,-0.00240585880687046,0.00145103459736866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,37165,-0.00776583774416588,0.0024449514767543,-0.0125579426386043,-0.00297373284972745,0.00149536011923353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39428,-0.00804486828915972,0.00253749926558053,-0.0130183668496976,-0.00307136972862188,0.00152539865638097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39123,0.0111758219003806,0.00352568469208561,0.00426547990389278,0.0180861638968684,0.0015284145281345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39355,-0.027557593614625,0.0087025523984228,-0.0446145963155337,-0.0105005909137163,0.00154537562136733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39428,-0.0150607162922696,0.0047578330027245,-0.0243860689776096,-0.00573536360692962,0.00155149597810588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36847,-0.0135388830381126,0.00427825481993442,-0.0219242624851841,-0.00515350359104116,0.00155682009918053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39499,-0.00820624703589707,0.00259458474009363,-0.0132916331264806,-0.00312086094531356,0.00156550599616604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39541,-0.00721088747937682,0.00228528717718737,-0.0116900503466641,-0.00273172461208959,0.00160619008428037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39458,-0.00788692002953881,0.00250276317440895,-0.0127923358513803,-0.00298150420769727,0.00162873379825103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39455,-0.0101970737803781,0.00323609091605161,-0.0165398119758392,-0.00385433558491692,0.00163006266447091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39485,-0.00755850386253766,0.00240161415016884,-0.0122656675968686,-0.00285134012820674,0.00165130327519168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37055,-0.0167594595432614,0.00532666593960386,-0.0271997247848849,-0.00631919430163782,0.00165717041086859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39206,0.00815534554557111,0.00259307787259389,0.00307291291528708,0.0132377781758551,0.00166391163447571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39541,0.0120492017543394,0.00383136878320029,0.00453971893926682,0.019558684569412,0.00166476420159706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39344,0.0102240493419189,0.00325166445224508,0.00385078701551856,0.0165973116683193,0.00166839701993102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39568,-0.0180370387921188,0.00573760324755698,-0.0292827411573305,-0.00679133642690713,0.00167175412889511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,37164,-0.0193661373170895,0.00616501102685576,-0.0314495589297268,-0.00728271570445223,0.00168586615396231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39601,0.00729378933219092,0.00232256760170714,0.00274155683284492,0.0118460218315369,0.00169042199302189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37203,-0.00836876934217571,0.00266626661351226,-0.0135946519046597,-0.00314288677969168,0.00170051589166751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39526,0.00925879830644925,0.00295338461547526,0.00347016446011774,0.0150474321527808,0.00172196514107056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39608,0.0123033546794719,0.00392551889256495,0.00460933765004462,0.0199973717088992,0.00172653151318386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36880,-0.0279961244993815,0.00893918692368545,-0.045516930869805,-0.0104753181289581,0.00174116239635118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39427,0.0131859226767739,0.0042150473872778,0.00492442979770937,0.0214474155558384,0.00176159237331302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39485,-0.0184157981801531,0.00588709907955642,-0.0299545123760837,-0.00687708398422255,0.00176239332251381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39617,-0.00808026621630299,0.00258579693704088,-0.0131484282129031,-0.00301210421970286,0.00178222220751492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39123,-0.0294853305275131,0.00943795941481192,-0.0479837309805445,-0.0109869300744818,0.00178684279493822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39455,0.0110190886029236,0.00353113630618702,0.00409806144279707,0.0179401157630502,0.00180855843668845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39104,-0.00747233367960426,0.00239458675972647,-0.0121657237286681,-0.00277894363054037,0.00180888360139315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36955,0.00672037479947952,0.0021582975194903,0.00249011166127854,0.0109506379376805,0.00185150082725982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37164,-0.0125579136457263,0.00403579602234087,-0.0204680738495144,-0.0046477534419382,0.00186468226232809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39526,-0.0127866380589741,0.00411031365501175,-0.0208428528227971,-0.00473042329515103,0.00186887264211589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39428,-0.0161770634603682,0.0052002161431877,-0.0263694871010161,-0.00598463981972033,0.00186903652755721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39636,0.00886517034079329,0.00285768525646324,0.00326410723812534,0.0144662334434612,0.00192426987630947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39432,-0.00805790641074549,0.00259821585438753,-0.0131504094853451,-0.00296540333614592,0.00193015843713291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,39104,-0.0101439441290541,0.00327267110693615,-0.016558379498649,-0.00372950875945929,0.00194154785648263
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39485,-0.0323628821108514,0.010455818889984,-0.05285628713522,-0.0118694770864829,0.00197039564265355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,37162,0.0107190702276157,0.00347363514242971,0.00391074534845346,0.0175273951067779,0.00203416613373375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37203,-0.0199774208173015,0.00647765559294277,-0.0326736257794693,-0.00728121585513368,0.00204639043011058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39462,-0.0161568512166289,0.00524202615213711,-0.0264312224748176,-0.00588247995844011,0.00205865073308818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,37255,-0.0220183308495868,0.00714825333791401,-0.0360289073918983,-0.00800775430727537,0.00207272696959034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37709,0.00836946028822907,0.00272384804240755,0.00303071812511027,0.0137082024513479,0.00212590039797663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39462,-0.0180112595595416,0.0058641517956187,-0.0295049970789542,-0.00651752204012893,0.00213425963448285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39526,-0.015381839433915,0.00500837598215271,-0.0251982563589343,-0.0055654225088957,0.00213563487968962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37203,-0.025533920889795,0.00831630737615273,-0.0418338833470543,-0.00923395843253562,0.00214262316254292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,37162,0.00544770595176457,0.00177622561909191,0.00196630373834444,0.00892910816518471,0.00216664264657225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,39123,-0.0200367444227608,0.00653571157515336,-0.0328467391100614,-0.00722674973546022,0.00217532049003852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39187,-0.0129514487416623,0.00422530241025123,-0.0212330414657547,-0.00466985601756987,0.0021790897124938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,39123,-0.0195518994614316,0.00638368196862756,-0.0320639161199416,-0.00703988280292158,0.00219678520687317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39123,-0.022391895796793,0.00731256251824853,-0.0367245183325602,-0.00805927326102592,0.0022017791925138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37221,-0.0176958744527283,0.00577953380865658,-0.0290237607176952,-0.00636798818776138,0.00220455290224389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39104,-0.0143945761137976,0.00470146886514623,-0.0236094550894842,-0.00517969713811098,0.00220468620679153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39485,-0.0174751725800789,0.00572650696140568,-0.0286991262244341,-0.00625121893572382,0.00228000482181182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,39104,-0.00832202489627916,0.00273407945482979,-0.0136808206277456,-0.00296322916481277,0.00234014905035888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37247,0.00740027955890343,0.00243294406860524,0.00263170918443716,0.0121688499333697,0.00235724683927151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39079,-0.0141596299015953,0.00465618043917868,-0.0232857435623855,-0.00503351624080509,0.00236179968439297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36861,0.0118679959414938,0.00390451587885022,0.00421514481894733,0.0195208470640402,0.00237420351183958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37164,0.00787242715906644,0.00259266257968394,0.00279080850288591,0.012954045815247,0.00239886029565734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37162,0.0171891070767854,0.00566185867348773,0.00609186407674948,0.0282863500768214,0.00240266368922458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,37162,-0.013786845437558,0.00454452115959891,-0.0226941069103718,-0.00487958396474413,0.00242039072702492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,37077,-0.0279718756962244,0.00922062954787633,-0.046044309610062,-0.00989944178238675,0.0024213063222025
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39589,-0.0189580916990936,0.00625243282839055,-0.0312128600427391,-0.00670332335544812,0.00243258027793894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,37203,0.0162655424484147,0.00536541500603114,0.00574932903659365,0.0267817558602357,0.00243787225304121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37247,-0.00708987827276907,0.00234076905970253,-0.011677785629786,-0.00250197091575211,0.00245962158854702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39123,-0.0210730398884204,0.00696738254789805,-0.0347291096823006,-0.0074169700945402,0.00249452621525592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36847,0.0103265628877904,0.00341674551520852,0.00362974167798168,0.0170233840975991,0.00251341801533441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37203,-0.00924447498103711,0.003060580905036,-0.0152432135549077,-0.00324573640716654,0.00252860195561766
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36847,0.0143100131793975,0.00473831267576688,0.00502292033489437,0.0235971060239005,0.00253234973822351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37057,0.0145829641452862,0.00483357587400851,0.00510915543222955,0.0240567728583429,0.00255787707741765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39506,-0.0312347012360386,0.0103664243345104,-0.051552892931679,-0.0109165095403982,0.00259054242049604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39123,0.0153014256422998,0.00508223600201935,0.00534024307834184,0.0252626082062577,0.00261032524462841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,39104,-0.017520126630086,0.00582430509182297,-0.028935764610059,-0.00610448865011298,0.00263327854236411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36880,-0.0307993790985611,0.0102387866578299,-0.0508674009479077,-0.0107313572492145,0.00263405714383346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39541,-0.00714179504565285,0.00237489500530379,-0.0117965892560483,-0.00248700083525742,0.00264096525985582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36955,-0.0288915017194413,0.0096141220785467,-0.0477351809933928,-0.0100478224454898,0.00266010530003121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39103,0.00734447905696195,0.00244575116119449,0.00255080678102074,0.0121381513329032,0.00267823725643484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39304,-0.00733208737044208,0.00244370966239542,-0.0121217583087371,-0.00254241643214706,0.0027007962680646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39455,-0.00645633642894049,0.00215338225576993,-0.0106769656502496,-0.00223570720763142,0.00271997089674614
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39462,-0.0259940911047253,0.00868440613308658,-0.043015527125575,-0.00897265508387559,0.00276525756607008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39636,-0.00687580317175676,0.00229860313665897,-0.0113810653196083,-0.00237054102390518,0.00278241688484776
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39434,-0.0177433580526704,0.00593242112851236,-0.0293709034645547,-0.00611581264078622,0.00278596628685055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39355,-0.0209610552004649,0.00701170705575891,-0.0347040010297524,-0.00721810937117747,0.00279948327355899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39462,0.0160956666264142,0.00538943715018663,0.00553236981204843,0.02665896344078,0.00282627102568811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36955,0.0140424293326192,0.00470277293796691,0.00482499437420401,0.0232598642910343,0.00283210126682338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39495,-0.0274884918582335,0.00921313955063641,-0.0455462453774809,-0.00943073833898611,0.00285319133123972
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36955,-0.0216149922415287,0.00724948578125687,-0.0358239843727921,-0.00740600011026524,0.00287308489091609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,39355,-0.0336437751471545,0.0113168365829778,-0.0558247748497908,-0.0114627754445181,0.00295476397264302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39462,-0.0117566643336702,0.00395724114628222,-0.0195128569803834,-0.00400047168695706,0.00297375105975201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39589,-0.00668115325341254,0.00225051072967995,-0.0110921542835852,-0.00227015222323984,0.00299503978218659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37203,0.0101054020169502,0.00340510508225461,0.00343139605573118,0.0167794079781693,0.00300573693623993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,37269,-0.00511035998898978,0.00172647647949361,-0.00849425388879725,-0.00172646608918231,0.00308208121166817
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,37183,0.00812523413821224,0.00274549699855376,0.00274406002104687,0.0135064082553776,0.0030872956409186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36690,-0.0202124287151073,0.00683530034044219,-0.033609617382374,-0.00681524004784065,0.00311175653369938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39458,-0.00986062722078386,0.00334249081858725,-0.0164119092252149,-0.00330934521635285,0.00318178560929059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39428,0.0140917212365558,0.00478440887208101,0.00471427984727697,0.0234691626258345,0.00323093912243156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39568,-0.00794573695070482,0.00269926869606259,-0.0132363035949875,-0.00265517030642215,0.00324846425738404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39485,-0.0197198111786493,0.00670468876388454,-0.0328610011558629,-0.00657862120143555,0.00327444872278668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36847,0.0201726203045534,0.0068599227258714,0.00672717176184547,0.0336180688472614,0.00328131393217978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37164,-0.0149308724763536,0.00507775042826249,-0.0248832633157481,-0.00497848163695913,0.00328326014953688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39526,0.0116596666076331,0.00396967531599617,0.00387910298828062,0.0194402302269856,0.00331708661699605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,37247,-0.0117906699154717,0.00401510533027915,-0.0196602763628189,-0.00392106346812457,0.00332446450086708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,39187,0.0057954959050915,0.00197430703035732,0.00192585412559115,0.00966513768459185,0.00333569772076238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39296,-0.0082020713874309,0.00279441952151657,-0.0136791336496034,-0.00272500912525843,0.0033388548198747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37255,-0.0157735603315548,0.00537735866623414,-0.0263131833173737,-0.00523393734573587,0.00335943214160834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39428,-0.0114361150366501,0.00390287914092463,-0.0190857581528624,-0.00378647192043784,0.00339283647223954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39578,-0.00762990179302724,0.00260552812491327,-0.0127367369178573,-0.00252306666819723,0.0034127290165617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37243,-0.00608056838032534,0.00208213159115306,-0.0101615462989853,-0.00199959046166534,0.00350240684027109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39485,0.01622110682898,0.00555566196957045,0.0053320093686219,0.0271102042893381,0.00350839865747605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,39355,-0.00842438748304527,0.00288560468353366,-0.0140801726627712,-0.00276860230331929,0.00351171062232664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36880,-0.019358246144092,0.00663191626667244,-0.03235680202677,-0.00635969026141402,0.00351840231575322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39428,-0.0226455385715878,0.0077670014055019,-0.0378688613263715,-0.00742221581680403,0.00355521452348544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39541,-0.0232586092768346,0.0079808272250622,-0.0389010306379565,-0.00761618791571271,0.00356998723675831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39654,0.00874116508300705,0.00300222360153417,0.00285680682400008,0.014625523342014,0.0036014720906965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39330,-0.00610627363388152,0.00209725632011406,-0.0102168960213051,-0.00199565124645795,0.00360170468947598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37221,-0.0173658772025352,0.00597013236522561,-0.0290673366383774,-0.00566441776669304,0.0036345296147382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36823,-0.025045674221314,0.00861056116665473,-0.0419223741079573,-0.00816897433467076,0.00363562545042742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39654,-0.0104464613374484,0.00359543992777145,-0.0174935235958804,-0.00339939907901636,0.00367224783417692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39589,-0.0130925314328716,0.00451300085376332,-0.0219380131062477,-0.00424704975949546,0.00372426425089908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,37203,-0.0208895000108405,0.00720611739695306,-0.0350134901088685,-0.0067655099128125,0.00375164957163573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39436,-0.00983843259441815,0.00339422279361025,-0.0164911092698942,-0.00318575591894206,0.00375398180644431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,37221,0.00640344635664071,0.00221071864886385,0.00207043780486757,0.0107364549084139,0.00377936970391872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39654,0.00735642864543216,0.00254087685386813,0.00237631001185062,0.0123365472790137,0.00379417495147868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39123,-0.0120303680100108,0.00416603923546471,-0.0201958049115217,-0.00386493110850001,0.00388608321313588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36861,0.0196420626765494,0.00680236289073318,0.00630943141071235,0.0329746939423864,0.00388943842562502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,37203,-0.00984738913329316,0.00341215617848424,-0.0165352152431223,-0.00315956302346405,0.00390860883004546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36916,0.0141694984304682,0.00490982891383561,0.00454623375935036,0.023792763101586,0.00390909620166774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37203,-0.0592990245188096,0.0205694837593081,-0.0996152126870535,-0.0189828363505658,0.00394736156354607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36916,-0.0143923312624048,0.00499413186457313,-0.0241808297169681,-0.00460383280784146,0.00396024928852138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39194,0.0108806934761294,0.00378134018174336,0.00346926671991237,0.0182921202323463,0.00401453398739976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36882,-0.00960500105218361,0.00333895362185754,-0.0161493501510244,-0.00306065195334284,0.00402604799942542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36823,-0.0120188909515318,0.00418839299837973,-0.020228141228356,-0.00380964067470749,0.00411725389714144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39549,0.0182925115319069,0.00637726126089626,0.00579307946055023,0.0307919436032636,0.00413130443022217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39601,0.0111310702173232,0.00388525154615312,0.00351597718686309,0.0187461632477833,0.00417642290875928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37221,-0.0291076657974652,0.0101603170033277,-0.0490218871239876,-0.00919344447094289,0.00417902839566326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39589,-0.0317354671621726,0.0110869750268141,-0.0534659382147283,-0.010004996109617,0.00421009566898313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39530,0.0144220545111971,0.00504118391405852,0.00454133403964238,0.0243027749827518,0.00423092028565465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36861,-0.00796871140682783,0.0027858874593503,-0.0134290508271544,-0.00250837198650124,0.0042383299366203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39428,-0.00744085427945736,0.00260292598454397,-0.0125425892091635,-0.00233911934975118,0.00426035107617554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,39194,-0.0120803838874009,0.00423236999950806,-0.0203758290864367,-0.00378493868836513,0.00431941590498593
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,39194,-0.0146678758802379,0.0051450463186542,-0.0247521666648001,-0.00458358509567565,0.00436598457919589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37164,0.0193986273300318,0.00680681728308327,0.00605726545518856,0.032739989204875,0.00438057514763184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39485,0.0158238509103881,0.00555291034316745,0.00494014663777991,0.0267075551829963,0.00438268538034985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39474,-0.0191219822666616,0.00671108768480949,-0.0322757141288882,-0.00596825040443501,0.00438734708896264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39623,-0.00932199895993997,0.00327245096211603,-0.0157360028456874,-0.00290799507419255,0.00439671000942384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39601,-0.00851608569304031,0.00299086464775691,-0.0143781804026439,-0.00265399098343677,0.00441419642805609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36955,-0.0072400075052371,0.00254792325149806,-0.0122339370781733,-0.00224607793230091,0.0044969858173963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37221,0.00973463357064231,0.00343786798479594,0.00299641232044226,0.0164728548208424,0.00463895928981063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39571,-0.00850010873591661,0.00300522371714162,-0.0143903472215142,-0.00260987025031903,0.0046836329584615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,39104,-0.0173492626744378,0.00613666320794576,-0.0293771225620115,-0.00532140278686406,0.00470280803009143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,37196,-0.0184025825210796,0.00651113878757426,-0.0311644145447252,-0.0056407504974341,0.00471590191125284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39578,-0.00640425731568172,0.0022670165010833,-0.010847609657805,-0.00196090497355845,0.00473466986788106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37182,0.0203170999999669,0.00719468629771966,0.0062155148564364,0.0344186851434975,0.004751635932459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,39104,-0.0179278833336055,0.00636405137697023,-0.0304014240324672,-0.00545434263474386,0.00485310473382094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39568,-0.0125918744418251,0.0044712973506393,-0.0213556172490782,-0.00382813163457209,0.00486648879818936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,37162,0.0116755996930543,0.00414975036700694,0.00354208897372072,0.0198091104123879,0.00490704357824042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36880,-0.0214695373821994,0.00763964624500115,-0.0364432440224017,-0.00649583074199715,0.00495759655101455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36861,0.014755604762588,0.00525194770549313,0.00446178725982147,0.0250494222653545,0.00496885728937271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36916,-0.023023938439635,0.00821413125961449,-0.0391236357084794,-0.00692424117079056,0.00507130613274264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39462,-0.027058723836703,0.0096565099612055,-0.0459854833606658,-0.00813196431274025,0.00508326262129626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37221,-0.0173077705587326,0.00617778356671917,-0.0294162263495022,-0.00519931476796306,0.0050924050737883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,39312,0.0160378668720213,0.0057444923984187,0.00477866177112066,0.027297071972922,0.00524715803459495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36992,-0.00839156616105313,0.00301392712460215,-0.0142988633252733,-0.00248426899683291,0.00537298828982076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,37247,0.00701633827525413,0.00252199072689399,0.00207323645054192,0.0119594400999663,0.00540935740737718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39123,0.00809096340774535,0.00290856413781329,0.0023901776976313,0.0137917491178594,0.00541319586630933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39589,-0.0158343589116917,0.00569641649234389,-0.0269993352366858,-0.00466938258669769,0.00544753944212892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36955,0.0168673679184736,0.00606788653372621,0.00497431031237022,0.028760425524577,0.00544776132530895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39187,0.00866939448263477,0.00311919322065981,0.00255577577014154,0.014783013195128,0.00545333309741416
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36861,-0.0285923512929609,0.0102938922413656,-0.0487683800860376,-0.00841632249988431,0.00548436047415316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,37203,0.0160175073570663,0.00576855395365793,0.00471114160789678,0.0273238731062359,0.00549950395944432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36955,0.00508571537920863,0.00183393073941295,0.00149121112995924,0.00868021962845802,0.00556033881469556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39458,0.0175507706588303,0.00634251164175515,0.00511944784099025,0.0299820934766704,0.00566155288526472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39187,-0.00822900672541925,0.00297399433948729,-0.0140580356308143,-0.00239997782002417,0.00566473780011378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36955,-0.00735899348623222,0.00266556548194698,-0.0125835018308483,-0.00213448514161613,0.00577506369485321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37162,-0.010647934140035,0.00386049219113639,-0.0182144988346623,-0.00308136944540764,0.00582071656554659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37243,-0.00609142989198119,0.00220943654567743,-0.010421925521509,-0.00176093426245343,0.00584159843297686
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,37269,-0.00519723146978286,0.00189102659341767,-0.0089036435928815,-0.00149081934668423,0.00599770746400878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39636,-0.00984349573114291,0.00358170372139052,-0.0168636350250683,-0.0028233564372175,0.00599810443200146
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39428,-0.0127932959459657,0.00465691499990389,-0.0219208493457773,-0.00366574254615405,0.00601854543237015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36763,0.0130466042269845,0.00475074632965706,0.00373514142085667,0.0223580670331123,0.0060373517360658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,37162,0.00971538205868031,0.00354004840621001,0.00277688718250869,0.0166538769348519,0.00607028858243093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39654,-0.00461234953384163,0.00168245430193222,-0.00790995996562879,-0.00131473910205448,0.00612418104652218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39531,-0.0226618979615276,0.00826871841836124,-0.0388685860615156,-0.00645520986153953,0.00613846672879125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39194,-0.00845507794925352,0.00308568570271734,-0.0145030219265795,-0.00240713397192754,0.00614949707315397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39123,0.0130927527298204,0.00478020646925485,0.00372354805008085,0.0224619574095599,0.00617099125206459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39462,-0.0137286279886601,0.00501649493239293,-0.0235609580561502,-0.00389629792116994,0.00621323864614859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39531,-0.0145744489227811,0.00533173362393875,-0.025024646825701,-0.0041242510198611,0.00627326661944624
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39504,-0.00753896888713529,0.00275999879558643,-0.0129485665264847,-0.00212937124778588,0.0063117972823288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36847,-0.0104343633766371,0.00382181911594519,-0.0179251288438897,-0.00294359790938453,0.00633836785774343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36880,0.0165775394956267,0.00607270817717688,0.00467503146836004,0.0284800475228934,0.00634537407205033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37255,0.00607774782037763,0.00222688322411508,0.00171305670111208,0.0104424389396432,0.00635629503615159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39479,0.0137661318088803,0.0050443331524369,0.00387923883010397,0.0236530247876566,0.00635950032766391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39601,-0.00820493276888756,0.00300755191169897,-0.0140997345158175,-0.00231013102195758,0.00637717615033813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39432,-0.0162343414659693,0.00595143313851268,-0.0278991504174542,-0.00456953251448448,0.00638318196743614
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,39355,-0.0227331058245452,0.00833912749393538,-0.0390777957126586,-0.00638841593643189,0.00641668864023735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39355,-0.0129253301676067,0.00474249416992533,-0.0222206187406604,-0.0036300415945531,0.00642930017513572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36916,0.00769919726950537,0.00283213062886846,0.00214822123692319,0.0132501733020876,0.00656658603318149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37203,0.00513729670707685,0.00189191402945376,0.00142914520934748,0.00884544820480621,0.00662856111785506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39397,-0.00812497749321017,0.00299296739598037,-0.0139911935893317,-0.00225876139708864,0.00664140584583012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36861,-0.0306982872352557,0.0113099249909668,-0.0528657402175507,-0.0085308342529607,0.00665120595871633
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36847,-0.0154250389369691,0.00569456589032414,-0.0265863880820044,-0.00426368979193378,0.00676341167743128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36992,0.0078751556066803,0.00291012940004585,0.00217130198259045,0.0135790092307702,0.00681667860478066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,39208,-0.0125566030918782,0.00464293011056052,-0.0216567461085769,-0.00345646007517963,0.00684946678819739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36992,-0.0167046432672071,0.0061815073262471,-0.0288203976266515,-0.00458888890776281,0.00689423338915861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,37216,0.00843413554576449,0.00312195531475674,0.00231510312884129,0.0145531679626877,0.00691071207377936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39589,-0.00827378166542186,0.00306828844350006,-0.014287627014682,-0.00225993631616175,0.00701401828474484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39428,-0.00907482748503317,0.00336592746110539,-0.0156720453087997,-0.0024776096612666,0.00702381090461032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39589,0.00544010176319368,0.0020184261978809,0.00148398641534712,0.00939621711104023,0.00704199491010662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36835,0.0160147640135876,0.00594481646097059,0.00436292375008523,0.0276666042770899,0.00707157085873917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37255,-0.00490275801256042,0.00182086415490656,-0.00847165175617727,-0.00133386426894356,0.00710013061212047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39123,-0.00938740449885961,0.00349096722171089,-0.016229700253413,-0.00254510874430627,0.00717354933129359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,37269,0.00433067094986737,0.00161055719957759,0.0011739788386953,0.00748736306103945,0.00717747839263319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36861,-0.0142526623898172,0.00530179655050026,-0.0246441836287977,-0.00386114115083673,0.00719190967932211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37162,-0.0191353602396098,0.00711996636939772,-0.0330904943236293,-0.00518022615559023,0.00720691729459943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36916,0.00896089737831093,0.00333581522117807,0.00242269954480191,0.0154990952118199,0.00723506354811829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39654,-0.00525289434412852,0.00195717253113789,-0.00908895250515878,-0.00141683618309826,0.00728433542278069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36880,-0.00997499203980062,0.00372025012348846,-0.017266682281838,-0.00268330179776323,0.00734403339826923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37203,0.0149698940335844,0.00558429722285791,0.00402467147678291,0.0259151165903859,0.00735601327233886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39309,0.0069089162505854,0.00257921840057969,0.00185364818544922,0.0119641843157216,0.00739930195306914
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39413,-0.0206053450923842,0.00769304328838151,-0.035683709937612,-0.00552698024715647,0.00740470836153353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39477,-0.00911773107633669,0.00340436943657098,-0.0157902951720158,-0.00244516698065756,0.00740898455672294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37221,-0.00907813858829541,0.00339217053884987,-0.0157267928444412,-0.00242948433214967,0.00745564709322021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,39213,0.0127617147709169,0.00477171752140262,0.00340914842896777,0.022114281112866,0.00749346337564176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37057,0.00596905268468702,0.00223689516165989,0.00158473816783365,0.0103533672015404,0.00762986438439877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39428,0.00856553119564277,0.00321185008789111,0.0022703050233762,0.0148607573679093,0.00766475025961718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36823,-0.0210325200405276,0.00790428811700747,-0.0365249247498622,-0.00554011533119293,0.00780326988352244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36916,0.014409883203424,0.00542860460390444,0.00376981817977129,0.0250499482270767,0.00795420152252979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39455,-0.00871579686600968,0.0032844932748236,-0.0151534036846639,-0.00227819004735542,0.00797173897178415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39194,0.00731406552849695,0.00275676124621483,0.00191081348591589,0.012717317571078,0.00798329530273029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39355,-0.0217481364248787,0.0081971760270764,-0.0378146014379484,-0.00568167141180892,0.00798347801468639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36847,-0.0142619217078288,0.00538224776231201,-0.0248111273219603,-0.00371271609369724,0.00806398084289278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36847,-0.0202992625995993,0.00766308474614352,-0.0353189087020406,-0.00527961649715798,0.00808404467754511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36916,0.0136764684239275,0.00516609453188074,0.00355092314144122,0.0238020137064137,0.00812270209086975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36955,-0.0129662453254599,0.00490256635629281,-0.0225752753837938,-0.00335721526712598,0.00818444329292623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,37164,0.025220531100184,0.00954581927004923,0.00651072533088749,0.0439303368694805,0.00825068251313323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37247,0.00570148437698155,0.00216146054869058,0.00146502170154801,0.00993794705241509,0.0083548578000018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,39314,-0.0077125463030149,0.00292869368864183,-0.0134527859327529,-0.00197230667327691,0.00846116654759679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39462,0.00775686043615163,0.00294978725206559,0.00197527742210307,0.0135384434502002,0.00855640439323018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39428,-0.00972751928803765,0.00369968597870968,-0.0169789038063086,-0.00247613476976668,0.00856526857535473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,39104,-0.0140143523720285,0.00533308869692713,-0.0244672062180057,-0.00356149852605136,0.00860256536244855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39507,-0.0069370629144608,0.00264141869076198,-0.0121142435483543,-0.00175988228056732,0.00864151984653152
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39636,-0.0103666662830471,0.00395235126536865,-0.0181132747631696,-0.00262005780292451,0.00872690916420954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,37255,-0.0113058671068851,0.00431411481882235,-0.0197615321517769,-0.00285020206199333,0.00878610707780166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39485,0.00646385890098228,0.00246829905037053,0.00162599276225603,0.0113017250397085,0.00883410627246699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39455,0.00897289630937708,0.00342876244002968,0.00225252192691891,0.0156932706918352,0.00888085781107561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,37136,-0.00574092754165482,0.00219391783467806,-0.0100410064976238,-0.00144084858568581,0.00888774321952259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38961,0.00910977433622549,0.00348291460605388,0.00228326170835988,0.0159362869640911,0.00891733058751517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39636,0.00769393420068595,0.00294965424054504,0.00191261188921768,0.0134752565121542,0.0091050624047973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36955,-0.0160192969166586,0.00614200358271863,-0.0280576239387871,-0.00398096989453004,0.00911399860062707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,39187,-0.00749053015622181,0.00287282446266082,-0.013121266103037,-0.0018597942094066,0.00913313807435273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37247,-0.0166973508218093,0.00640794635619385,-0.0292569256799493,-0.00413777596366937,0.00917860086507807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36916,-0.0230069535870101,0.00883041655394972,-0.0403145700327516,-0.00569933714126866,0.00918704502176958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39531,-0.020535321774477,0.00788979906936311,-0.0359993279504287,-0.0050713155985253,0.00925648302724403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37247,-0.0183247803556677,0.00704236901758835,-0.0321278236301409,-0.00452173708119457,0.00927680536935436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39428,-0.00634147092643193,0.00244364077555356,-0.0111310068465169,-0.00155193500634694,0.00946580043916229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37203,-0.0107272519160699,0.00413489629507571,-0.0188316486544183,-0.00262285517772154,0.00948861425614956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39477,-0.0413936360898399,0.0159812937407709,-0.0727169718217508,-0.0100703003579289,0.00960321709782698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36847,-0.0150084928238333,0.0057973846572395,-0.0263713667520227,-0.00364561889564389,0.00964127258005293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39589,-0.0135369787940848,0.00523622065577002,-0.023799971279394,-0.00327398630877554,0.00973989053385601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39526,-0.00941038584046705,0.00364492173136284,-0.0165544324339382,-0.00226633924699587,0.00983857304413214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39355,0.015601865642404,0.00604576677418385,0.00375216276500369,0.0274515685198044,0.00987159650803998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39485,-0.0142387083661238,0.00552151044066594,-0.0250608688298291,-0.00341654790241857,0.00992468087459478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37203,-0.00860742786718496,0.00333780219556149,-0.0151495201704855,-0.00206533556388444,0.00992634993713545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39428,-0.0228518624147621,0.00886296831696544,-0.0402232803160144,-0.00548044451350988,0.00993670777510333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,37221,-0.00678393311758987,0.00263201343899605,-0.0119426794580221,-0.00162518677715761,0.00996379008507121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39654,-0.0118162085718383,0.00458462741160018,-0.0208020782985746,-0.00283033884510195,0.00996532139134599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,37203,0.00676066592452339,0.00262769647170371,0.00161038083998413,0.0119109510090627,0.010097727557447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37162,0.010606465861965,0.00412342190378334,0.00252455893054969,0.0186883727933804,0.0101152834301483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36955,-0.0182072852347126,0.00710388824650487,-0.0321309061978621,-0.00428366427156303,0.0103887182895084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37255,-0.00573257986020911,0.00223862184576415,-0.0101202786779068,-0.00134488104251137,0.0104556218935024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39588,-0.00586121123937247,0.00229044689400652,-0.0103504871516252,-0.0013719353271197,0.0105075688569574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39464,0.0100921249117975,0.00394434265250287,0.0023612133128919,0.0178230365107031,0.0105181850775299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36861,-0.0144753611290455,0.00565755431137607,-0.0255641675793426,-0.00338655467874844,0.010521526412909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36955,-0.0187383947243774,0.0073503376059127,-0.0331450564319663,-0.00433173301678851,0.0108050204942144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39455,-0.00779929865291307,0.00307239448465363,-0.0138211918428342,-0.00177740546299196,0.0111426386819028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37203,0.0140349893909521,0.0055377365461775,0.00318102576044423,0.02488895302146,0.0112749973905992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36992,-0.0190406314731081,0.00751941169720277,-0.0337786783996255,-0.00430258454659069,0.0113471291047274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36992,-0.00908773711807157,0.00359328520070251,-0.0161305761114485,-0.00204489812469466,0.011448064964651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,37203,0.00804960645957804,0.00318691041416321,0.00180326204781815,0.0142959508713379,0.0115544119877734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,37269,-0.00321467503178111,0.00127340224594729,-0.00571054343383779,-0.000718806629724428,0.0115990203306573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39654,-0.00600171116642386,0.00237930551890207,-0.0106651499834719,-0.0013382723493758,0.0116637282608028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36992,-0.0107642108509584,0.00426784979214576,-0.019129196443564,-0.00239922525835267,0.0116758563134522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37243,-0.0102080269154289,0.00404741333245425,-0.0181409570470392,-0.00227509678381854,0.0116773151525673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39510,0.00609400820792704,0.00242348361694163,0.00134398031872145,0.0108440360971326,0.0119282523728275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39428,-0.0123980070140259,0.00493075790505505,-0.0220622925079338,-0.00273372152011798,0.0119331551044106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39428,-0.012234072201898,0.00487058360848462,-0.0217804160745279,-0.00268772832926818,0.0120211661225789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39477,-0.00733299382220301,0.00292240790423079,-0.0130609133144954,-0.00160507432991065,0.0121099014199566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37164,-0.0165523128381607,0.00659655993691088,-0.029481570314506,-0.00362305536181538,0.0121116646145976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37173,-0.0123928368578955,0.00495246207012143,-0.0220996625153335,-0.00268601120045748,0.0123493319817791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36847,-0.0128187882173731,0.00513059890923702,-0.0228747620794776,-0.00276281435526851,0.0124849498499579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,37241,-0.00482360810116536,0.00193270085501222,-0.00861170177698932,-0.00103551442534141,0.0125803300296203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39531,-0.0181029249218457,0.00725373261777384,-0.0323202408526824,-0.00388560899100897,0.0125825404752971
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39187,-0.0208969335640695,0.00837788382888313,-0.0373175858686805,-0.0044762812594586,0.012631545441223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39462,-0.0180289584424981,0.00722823722472604,-0.0321963034029611,-0.00386161348203507,0.0126333870341718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37162,0.00982193733787473,0.00394265147157147,0.00209434045359464,0.0175495342221548,0.0127438627377982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36880,-0.0198529018960108,0.007970658145782,-0.0354753918617435,-0.00423041193027808,0.0127603962101371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37162,-0.0170784758759918,0.00687180716065141,-0.0305472179108686,-0.00360973384111504,0.0129571303558985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37247,-0.0154742498420386,0.00624248008476649,-0.0277095108081809,-0.00323898887589632,0.0131929992859685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36763,-0.0203246477284221,0.00820957896560609,-0.0364154225010101,-0.00423387295583419,0.013309999886756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39485,0.00814848580282183,0.00329302628066129,0.0016941542927257,0.014602817312918,0.0133544550933603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39654,-0.00634366845051866,0.00256485069607196,-0.0113707758148197,-0.00131656108621761,0.0133976784877756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39455,-0.0111725381192214,0.0045238674508799,-0.020039318322946,-0.0023057579154968,0.0135341644815971
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36955,-0.00568674443291923,0.00230284678915074,-0.0102003241396547,-0.00117316472618378,0.0135456891324287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36955,-0.0220380852158735,0.00893564373849938,-0.0395519469433323,-0.00452422348841466,0.0136645528417191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39187,0.0115558753245048,0.00469840327737786,0.00234700490084419,0.0207647457481654,0.0139232146670752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36916,-0.0118242385172327,0.00480895620157704,-0.0212497926723237,-0.00239868436214174,0.0139539049701828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39582,0.00624121523906016,0.0025429153370012,0.00125710117853781,0.0112253292995825,0.0141249667805646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39428,-0.00477958377728348,0.00194830419031822,-0.0085982599903072,-0.00096090756425977,0.0141703948695305
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36880,-0.00678852936643714,0.00277370115006618,-0.0122249836205669,-0.00135207511230743,0.0144003533596071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,37162,0.00840094799906296,0.00343390021872761,0.00167050357035684,0.0151313924277691,0.0144395696052028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36880,0.00982485001922274,0.00401737578622205,0.00195079347822752,0.017698906560218,0.014475350851278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39123,-0.0143683449521316,0.00589179583348041,-0.0259162647857532,-0.00282042511851003,0.0147518207509957
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36955,-0.0183139599811684,0.00751182386219582,-0.0330371347510722,-0.00359078521126456,0.0147818800695254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39455,-0.00565296063501192,0.00231891936367226,-0.0101980425878095,-0.0011078786822143,0.0147902578134756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37203,-0.0171300579337481,0.00703252382814199,-0.0309138046369064,-0.00334631123058979,0.0148711187220077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39319,-0.0160749578959493,0.00660455735175601,-0.0290198903053911,-0.00313002548650751,0.0149480305879065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,39351,0.0152478751201117,0.00626534051591539,0.00296780770891757,0.0275279425313059,0.0149576040426963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36823,0.0112739428944786,0.00463573873643417,0.00218789497106766,0.0203599908178896,0.0150313523710809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36992,-0.00864376077771746,0.00355835909971834,-0.0156181446131654,-0.00166937694226952,0.0151485421001266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39428,0.0144354375695461,0.00594365690743725,0.00278587003096905,0.0260850051081231,0.0151642061161481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36992,-0.0154848658979442,0.00637684976328507,-0.0279834914339829,-0.00298624036190546,0.0151840098654337
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37221,-0.0160738374461007,0.00662160834039277,-0.0290521897932705,-0.00309548509893089,0.0152177589714312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36880,0.00915905750233091,0.00377839239149659,0.00175340841499759,0.0165647065896642,0.0153621569470357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,39274,-0.00976671926750156,0.0040296664393554,-0.0176648654886382,-0.00186857304636497,0.0153750046034186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,39299,-0.0122181143775749,0.00505344871600178,-0.0221228738609384,-0.00231335489421141,0.015627584882721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,39104,0.00916518704491415,0.00379365410922032,0.00172962499084233,0.016600749098986,0.0157074062745878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38989,0.0123174604151895,0.00509914363534725,0.00232313888990885,0.0223117819404701,0.0157218206439097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36861,-0.00755590016788677,0.00313305774013636,-0.013696693338554,-0.0014151069972195,0.0158940883081345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,39079,0.0129223661947916,0.00536005718936481,0.00241665410363654,0.0234280782859466,0.0159270536446762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,37221,0.00745581679910405,0.00309326112309308,0.00139302499784162,0.0135186086003665,0.0159516205050536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,39074,-0.0141861194723279,0.00588637112169224,-0.0257234068708447,-0.00264883207381107,0.0159650477408497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39462,-0.0117205985392349,0.00487074464220358,-0.0212672580379539,-0.00217393904051587,0.0161258936005374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36847,-0.0253573464001764,0.0105567428156547,-0.0460485623188595,-0.00466613048149325,0.0163201177733266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36916,0.00747091788009886,0.00311169126707268,0.00137200299663641,0.0135698327635613,0.016368527944574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39477,0.0109768730856426,0.0045879299798214,0.00198453032519264,0.0199692158460925,0.0167437443820416
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37243,0.00533669455781075,0.00223135857420152,0.00096323175237577,0.00971015736324573,0.016785835906396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39401,-0.00562097372402452,0.00235028732071246,-0.0102275368726209,-0.00101441057542809,0.0167868805852411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,37164,-0.0138693488812664,0.0058072042718703,-0.0252514692541322,-0.00248722850840064,0.0169410012555954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39485,-0.0179232638987932,0.00751062341609969,-0.0326440857943486,-0.00320244200323779,0.0170270705191355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,37255,0.0186078508503521,0.0078421458639909,0.00323724495692999,0.0339784567437743,0.0176684603969553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,37243,-0.00458174576252919,0.00193405667640132,-0.00837249684827577,-0.000790994676782614,0.0178518806746681
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36992,-0.0107537193069874,0.00454306751099636,-0.0196581316285402,-0.00184930698543451,0.0179450606420116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39462,-0.0100402533830853,0.00424644644294299,-0.0183632884112536,-0.00171721835491704,0.018072468636586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37243,0.012103164211706,0.00513376501394654,0.00204098478437079,0.0221653436390412,0.018410406822057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,37122,-0.014578261024166,0.00619090880683094,-0.0267124422855547,-0.00244407976277736,0.0185485790704114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,37247,0.00714926039576551,0.00303655489104016,0.0011976128093268,0.0131009079822042,0.0185677350029099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36847,-0.00522455832260351,0.00221958130966555,-0.00957493768954798,-0.000874178955659034,0.018595700332313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39194,0.0118077523135319,0.00502407178323663,0.00196057161838807,0.0216549330086757,0.0187746400045217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,37203,-0.0274586080924104,0.0117079934311742,-0.0504062752175117,-0.00451094096730903,0.0190276692636496
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39455,-0.010859522165993,0.00463616145343329,-0.0199463986147222,-0.00177264571726374,0.0191756333419261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36880,0.00686369705253641,0.0029307681423954,0.00111939149344142,0.0126080026116314,0.0191992588633128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36847,-0.00792003300218496,0.00338738258579811,-0.0145593028703493,-0.00128076313402067,0.0193979746543177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39462,0.0108477970595779,0.00464042056757713,0.00175257274712675,0.0199430213720291,0.0194171612814984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37235,-0.00970493634094637,0.00415432898225963,-0.0178474211461752,-0.0015624515357175,0.0195012992135423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39462,0.0162134009477147,0.00694589659799372,0.00259944361564705,0.0298273582797824,0.0195961954378418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39187,-0.0151391994900022,0.00648745414129346,-0.0278546096069374,-0.00242378937306704,0.0196294352694068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39608,-0.00987904244996935,0.00423364103957259,-0.0181769788875316,-0.00158110601240707,0.0196368936193674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39502,0.00959523468325977,0.00411260466464363,0.00153452954055825,0.0176559398259613,0.0196545122504042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,37243,-0.00523430642766162,0.00224663905297803,-0.00963771897149855,-0.000830893883824692,0.019830160873228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,37247,0.0183206710518721,0.00787632553871796,0.00288307299598487,0.0337582691077593,0.0200318053575838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,39306,-0.0116525456480417,0.00502483769979701,-0.0215012275396439,-0.00180386375643961,0.0204091066361849
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36861,-0.0120652192668765,0.00520820236610859,-0.0222732959044493,-0.00185714262930363,0.0205428065485469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36880,-0.00768826249973478,0.00332410222570609,-0.0142035028621187,-0.00117302213735084,0.0207452717881637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39187,0.0168291344687211,0.00729660018417856,0.00252779810773114,0.0311304708297111,0.0211001407572466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39476,-0.0107219012241932,0.00466115702939786,-0.019857769001813,-0.00158603344657341,0.021446787996977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36992,-0.0138536876999479,0.00603754531494021,-0.0256872765172307,-0.00202009888266511,0.0217731063289975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36880,-0.00828011913370958,0.00361601896922035,-0.0153675163133815,-0.00119272195403769,0.0220470436934078
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39635,-0.00539634856016686,0.00235688829212933,-0.0100158496127403,-0.000776847507593371,0.0220577491781217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36916,-0.00593257963251192,0.00259453840831793,-0.0110178749128151,-0.000847284352208767,0.0222379422409066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39428,0.0203745403531369,0.00891102077385276,0.00290893963638545,0.0378401410698883,0.0222422534528687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39428,-0.00547265171522262,0.00239554233280934,-0.0101679146875289,-0.000777388742916318,0.0223552220849702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39104,0.00527844894090069,0.00231457376314375,0.000741884365138934,0.00981501351666244,0.0225907206422044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39579,-0.0115567042490603,0.00507149234903758,-0.0214968292531739,-0.00161657924494661,0.0226953217529396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39247,-0.0041011045981754,0.00180030108115817,-0.00762969471724541,-0.000572514479105384,0.0227401532241408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39654,-0.0119929755854593,0.0052711775808878,-0.0223244836439994,-0.00166146752691926,0.0229078802482021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39187,-0.0110560773294405,0.00487024824285367,-0.0206017638854337,-0.00151039077344735,0.0232143144325532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37203,0.0118957830654209,0.00524320909247351,0.00161909324417278,0.0221724728866689,0.0232972424522211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36763,0.00988290158411394,0.00435600244721428,0.00134513678757395,0.0184206663806539,0.0232976791725161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36916,0.00801496635878299,0.00353291483501216,0.00109045328215916,0.0149394794354068,0.023306313556833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36880,0.0095582512091305,0.00421520701709008,0.00129644545563395,0.017820056962627,0.0233728949228677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36823,-0.0158913764523831,0.00702476349220115,-0.0296599128970974,-0.00212284000766888,0.0237027050213147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36916,-0.0180972288902043,0.00800370740799746,-0.0337844954098793,-0.00240996237052928,0.0237698733930793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36861,-0.0133700516140889,0.00592920920214121,-0.0249913016502857,-0.0017488015778921,0.0241540200123136
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36948,0.0061502897858613,0.00272823217130007,0.000802954730113168,0.0114976248416094,0.0241937174859536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39537,0.020259345251465,0.00898829717456671,0.00264228278931426,0.0378764077136158,0.0242123947595533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36763,0.00806652745779912,0.00357979711970639,0.00105012510317459,0.0150829298124236,0.0242547599816024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36763,-0.0276917097829954,0.0122918937818785,-0.0517838215954773,-0.00359959797051343,0.0242865673240297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37241,-0.00361585373930103,0.00160560408061682,-0.00676283773731,-0.000468869741292067,0.0243378513332615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36992,-0.0217287089600356,0.00965071265413375,-0.0406441057621378,-0.00281331215793347,0.024370275139651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36955,-0.00556787858453984,0.0024733488611693,-0.0104156423524317,-0.000720114816648008,0.0243933508742176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39516,-0.00572108444335798,0.00254597528717135,-0.0107111960062138,-0.000730972880502141,0.0246474659453299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39428,-0.0165606124896087,0.00738951981436254,-0.0310440713257593,-0.00207715365345813,0.0250345446117191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36955,0.00553640973885418,0.00247219485811051,0.000690907816957569,0.0103819116607508,0.025142767659788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39104,-0.0119365599353291,0.0053444155777077,-0.0224116144676362,-0.001461505403022,0.0255333947957383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36916,-0.0196414082892843,0.00879574709175433,-0.0368810725891228,-0.00240174398944582,0.0255628399521206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,37196,0.00495844541771485,0.00222286181888621,0.000601636252697886,0.00931525458273182,0.0257211006394927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39428,-0.0141516380080898,0.0063446024110059,-0.0265870587336614,-0.00171621728251823,0.0257289978513221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,37247,-0.00526083697412161,0.00236113119408106,-0.00988865411452048,-0.000633019833722739,0.0258911444003006
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,37247,0.00585750186481486,0.0026301715017345,0.000702365721415245,0.0110126380082145,0.0259618124030873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36847,-0.0212237855669324,0.00953007792765416,-0.0399027383051345,-0.00254483282873025,0.0259630472171251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39636,0.00978235613555722,0.0043940601043332,0.00116999833106414,0.0183947139400503,0.0260108406940484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,37141,0.00800583740555911,0.00360180286461065,0.000946303790922241,0.015065371020196,0.0262515261222845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36847,0.00890996387760099,0.00400906166050337,0.00105220302301438,0.0167677247321876,0.0262704677020614
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,37162,-0.0148841500531141,0.00669922547750554,-0.028014631989025,-0.00175366811720322,0.0263162757914733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37221,0.0109841306560506,0.00494453727331906,0.0012928376003452,0.0206754237117559,0.026336755731638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36847,0.0090746771482306,0.00408699173825371,0.00106417334125332,0.0170851809552079,0.0264109569981639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39589,-0.00539830563225106,0.00243152561819796,-0.0101640958439191,-0.00063251542058306,0.0264246242443699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,39194,0.00618933904923288,0.00278785290741618,0.000725147350697163,0.0116535307477686,0.0264264775084635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39428,-0.0140392724888042,0.00632774403709064,-0.0264416508015018,-0.00163689417610652,0.0265230786831704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39455,0.00467989750451657,0.00210967114783371,0.000544942054762492,0.00881485295427064,0.0265488458362013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39123,0.0121450567931944,0.00547530519252888,0.00141345861583776,0.022876654970551,0.0265597534428687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36823,-0.0112775766504922,0.00508587260513915,-0.0212458869565649,-0.00130926634441945,0.0266116882857974
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39636,-0.0120751184205494,0.00545609584482541,-0.0227690662764072,-0.00138117056469158,0.0269026257641279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37209,-0.013039923135893,0.00589316799321172,-0.024590532402588,-0.00148931386919803,0.0269346833277039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37164,0.0178904293898139,0.00808999856661648,0.00203403219924559,0.0337468265803822,0.0270241082551338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36847,-0.0223173607752848,0.0100919934048854,-0.0420976678488603,-0.00253705370170932,0.027026832186891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36916,0.0100889542390663,0.00456881549077862,0.00113407587714022,0.0190438326009924,0.0272470082710048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38915,0.0125094191502909,0.00566732712575634,0.00140145798380849,0.0236173803167733,0.0273096382440236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39428,-0.0262840268010647,0.0119086045594363,-0.0496248917375598,-0.00294316186456953,0.027318983364015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37203,0.00871194420450648,0.00394999230162769,0.000969959293316213,0.0164539291156968,0.0274326119101049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,39309,-0.013226191009015,0.00599847470628475,-0.0249832014333331,-0.00146918058469694,0.0274745740116366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37203,0.0144521905525265,0.00655776294779214,0.0015989751748539,0.0273054059301991,0.0275541523776529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39520,-0.00649417375196428,0.00294705372933347,-0.0122703990614579,-0.000717948442470684,0.0275664557528586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36861,-0.00785102554955395,0.00356849763280497,-0.0148452809098517,-0.000856770189256199,0.0278186842325756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36847,0.00676275905082042,0.00307519635319585,0.000735374198556559,0.0127901439030843,0.027887025219673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36861,-0.0152111464168057,0.00691714030462255,-0.0287687414138659,-0.00165355141974548,0.0278926580610482
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,37203,-0.00414710622914825,0.00189168172674851,-0.00785480241357532,-0.000439410044721177,0.0283769156011282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37221,-0.00894744491410966,0.00408759993151402,-0.0169591407798771,-0.000935749048342177,0.0286204205058429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39541,-0.0236944207587957,0.0108289259785342,-0.0449191156767228,-0.00246972584086872,0.0286799697210889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39123,0.011581306814427,0.00529838592837579,0.00119647039481042,0.0219661432340435,0.0288446826740603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39531,0.00634709506512227,0.00290691624976222,0.000649539215588316,0.0120446509146562,0.0290183324625427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39591,-0.0154572120254048,0.00708157995590993,-0.0293371087389883,-0.00157731531182135,0.0290706459027139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,37255,0.00750375303759247,0.00345433578963728,0.000733254889903405,0.0142742511852815,0.0298535246653554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39187,0.0158821323886685,0.00731725348359011,0.00154031556083187,0.0302239492165051,0.0299845562279995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37164,0.00973448703970869,0.00448643625467543,0.000941071980544836,0.0185279020988725,0.0300435431417208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39428,0.00778697271427392,0.00358980937068438,0.00075094634773253,0.0148229990808153,0.0300840657776513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39370,-0.0129756191115542,0.00599682423039071,-0.02472939460312,-0.00122184361998843,0.0304994822099175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36916,-0.00602811447467682,0.00279586844693899,-0.0115080166306772,-0.000548212318676406,0.0310965356184698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,37243,-0.00449698097454101,0.00208776279593839,-0.00858899605458025,-0.000404965894501765,0.0312610507546903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39524,-0.00753482365846916,0.0034987287840862,-0.0143923320752781,-0.000677315241660213,0.0312882302850861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36880,0.00909235985057407,0.00422508054069678,0.000811201990808388,0.0173735177103398,0.0314168061674526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39462,0.0122039444460886,0.00567136693188143,0.00108806525960098,0.0233198236325762,0.0314248823197702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39589,0.00545891402769937,0.00253885254895339,0.00048276303175073,0.010435065023648,0.0315591358843176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39462,-0.0102707500961512,0.00477955674783256,-0.019638681321903,-0.000902818870399391,0.0316589245071781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39123,0.00955581118230866,0.00445637778327316,0.000821310727093266,0.0182903116375241,0.0320252315762178
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36823,-0.0134985945115674,0.00629503127766274,-0.0258368558157864,-0.00116033320734844,0.0320262604141676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,39330,-0.00546285350134628,0.00255096669944473,-0.0104627482322579,-0.000462958770434609,0.0322512485699148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,39356,-0.00526044611838889,0.00245667992210913,-0.0100755387657228,-0.00044535347105499,0.0322674189922544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36847,-0.00686555491581796,0.0032082598611908,-0.0131537442437519,-0.000577365587884001,0.0323772842445633
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39499,-0.00547862239156114,0.00256098641312087,-0.010498155761278,-0.000459089021844236,0.0324304528319831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36916,-0.0134026646101604,0.00627151383191106,-0.0256948317207061,-0.0011104974996147,0.0326116990843495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36955,-0.0112522519574846,0.0052655034827637,-0.0215726387837014,-0.000931865131267752,0.032619332767531
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36916,-0.0132844061516163,0.00621781850761671,-0.025471330426545,-0.00109748187668751,0.0326576150830742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,37243,0.0126471686414277,0.00592169029712821,0.00104065565905642,0.024253681623799,0.0327198518675315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,39123,-0.00702386088140598,0.00329198024504288,-0.01347614216169,-0.000571579601121925,0.0328897916166331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37203,-0.0166733891401472,0.00782680555991249,-0.0320139280375757,-0.00133285024271873,0.0331665169480615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39498,-0.00550767179281347,0.0025856675040605,-0.0105755801007721,-0.000439763484854891,0.0331814056711606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,37162,-0.00620167993936467,0.00291271313480788,-0.0119105976835881,-0.000492762195141228,0.0332588392107057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36823,0.0115077795152002,0.00540550413963016,0.000912991401525107,0.0221025676288754,0.0332822049797214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39123,-0.0140919831634035,0.00663235225944347,-0.0270913935919128,-0.00109257273489434,0.0336254999687047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39149,-0.00565091627392196,0.00266295088332266,-0.0108703000052344,-0.000431532542609546,0.0338501771344545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39455,-0.00421161733966021,0.00198504843796065,-0.00810231227806309,-0.000320922401257334,0.0338818211509073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39194,0.00707411730615207,0.00333702855678657,0.000533541334850393,0.0136146932774538,0.0340323924139207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39104,0.00916488490343337,0.00432360862937271,0.000690611989862857,0.0176391578170039,0.0340455483968803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39123,0.00834360347874152,0.0039364113071552,0.000628237316717336,0.0160589696407657,0.0340568369751826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39428,0.00937949561763199,0.0044253125330015,0.000705883052949054,0.0180531081823149,0.0340637678951345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,37193,-0.0116882165207797,0.00552121274599078,-0.0225097935029216,-0.000866639538637746,0.0342821088075776
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36847,-0.0130137070538625,0.0061547820709188,-0.0250770799128634,-0.000950334194861702,0.0345005315711383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39194,0.0110089751419976,0.00521556550075662,0.000786466760514611,0.0212314835234805,0.0348069673985441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36880,-0.00478377913683255,0.00226870935519732,-0.00923044947301929,-0.000337108800645816,0.0349998961762121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39589,0.0054009836905593,0.00256676159045246,0.000370130973272472,0.0104318364078461,0.0353773180714068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36823,0.0157223168909412,0.007473601650595,0.00107405765577499,0.0303705761261074,0.0354235776260102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39485,-0.00621965205369754,0.00295781630360099,-0.0120169720087555,-0.000422332098639608,0.0355011405951468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36880,-0.00602198432544703,0.00286862845397263,-0.0116444960952334,-0.000399472555660683,0.035814493323278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,37145,-0.00832897056590168,0.00396796698185114,-0.0161061858503299,-0.000551755281473442,0.0358319838697492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39428,0.017076447211599,0.00814704730232741,0.00110823449903728,0.0330446599241607,0.0360963607783492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,39045,-0.00851929390234141,0.00406642206810638,-0.0164894811558299,-0.000549106648852906,0.0361851332100513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39485,0.0116259413306802,0.0055502559378243,0.000747439692544601,0.0225044429688159,0.0362172463573535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39654,-0.00446817102459721,0.0021361851096159,-0.00865509383944438,-0.000281248209750042,0.0364855734204845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39589,0.00664914842774991,0.00318542819967302,0.000405709156390784,0.012892587699109,0.0368719180268395
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36823,-0.00798741823993725,0.00382976217020023,-0.0154937520935297,-0.000481084386344789,0.0370337449995694
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39123,-0.00879622792573363,0.00421854762186054,-0.0170645812645803,-0.000527874586886962,0.0370745797251095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39123,-0.00893708921790564,0.00428650221356646,-0.0173386335564959,-0.000535544879315376,0.037092220823268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39654,-0.00570802632330164,0.00274103754025526,-0.011080459902202,-0.000335592744401331,0.0373196390395445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39554,-0.0050511107547893,0.00242730771535243,-0.00980863387688007,-0.000293587632698545,0.0374551128130308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39531,0.00942436707756694,0.00453938804830645,0.000527166502886287,0.0183215676522476,0.0378986807241357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39319,0.00426037342773351,0.00205237893272249,0.000237710719597421,0.0082830361358696,0.0379275598776352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36823,-0.00985387435528227,0.00475164856562542,-0.0191671055439081,-0.000540643166656442,0.0381203767055149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36880,0.00640924372080159,0.00309528829250256,0.00034247866749658,0.0124760087741066,0.0384125668332504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37269,0.00350160234749653,0.00169195979453073,0.000185361150216292,0.00681784354477676,0.0385141097051406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,37221,-0.0097781014146245,0.00472903650615168,-0.0190470129666818,-0.000509189862567219,0.0386908721577227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36847,-0.00770762471445095,0.00373644451508968,-0.0150310559640267,-0.000384193464875173,0.0391502042116782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39123,-0.00740164041382933,0.00358840590288228,-0.0144349159834786,-0.000368364844180056,0.0391630572932745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39582,-0.00594930968595936,0.0028885443909355,-0.0116108566921929,-0.000287762679725779,0.0394517563677798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36847,-0.00713981452318157,0.00347064263194691,-0.0139422740817975,-0.00033735496456562,0.0396876308292212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36852,-0.00759583616577879,0.00369233538492491,-0.0148328135202316,-0.000358858811325972,0.0396888004990384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,37203,-0.0124499044665529,0.00605366210505752,-0.0243150821924657,-0.000584726740640208,0.03974592668806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36637,0.00789528028509829,0.00383927669468619,0.000370297963513361,0.0154202626066832,0.0397604150028031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36955,-0.00947150651787869,0.00461307645257264,-0.0185131363649211,-0.000429876670836314,0.0400752480568942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,37241,-0.00260135555447115,0.00126737808520461,-0.00508541660147218,-0.000117294507470115,0.0401366485757423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,37164,0.0189537829190396,0.00923518290077305,0.000852824433524413,0.0370547414045548,0.040156561716521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36955,-0.00448688999221229,0.00218705367870751,-0.008773515202479,-0.00020026478194557,0.0402324214646502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36955,0.00466765694387475,0.00227547091994488,0.000207733940782782,0.00912757994696673,0.0402592386236929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,37162,0.0143353424066266,0.00701129381962707,0.000593206520157565,0.0280774782930957,0.0409141480648849
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36880,-0.0189308373660736,0.00926792888972184,-0.0370959779899284,-0.000765696742218824,0.0411113342247819
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36847,-0.00853867489558021,0.00418170863466127,-0.0167348238195163,-0.000342525971644117,0.0411815301179203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39123,-0.0224862316835307,0.0110144396983923,-0.0440745334923796,-0.000897929874681784,0.0412167240321586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,37221,-0.00784122741082393,0.00384140931897536,-0.0153703896760156,-0.000312065145632227,0.0412477756281348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39485,-0.00428163916231825,0.00209839833227431,-0.00839449989357589,-0.000168778431060608,0.0413247505845322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,39194,0.00728775594405209,0.00358481592308752,0.000261516734800561,0.0143139951533036,0.0420753310259872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37269,0.00570106110323312,0.00280894177661843,0.000195535221060996,0.0112065869854052,0.0424166419640426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,39092,-0.0152391058897003,0.00752327798158214,-0.0299847307336012,-0.000493481045799273,0.0428245224573926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36823,-0.0201188468864557,0.00995966969416335,-0.0396397994870159,-0.000597894285895524,0.043401628557063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37221,-0.0090764766924747,0.00449548831846637,-0.0178876337966688,-0.000265319588280613,0.0435060934097159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,37162,0.0112909766469091,0.00560278962826869,0.000309508975502491,0.0222724443183158,0.0439003163078028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37125,-0.0188194272460641,0.00934350674330764,-0.0371327004629471,-0.000506154029181183,0.0440125944808514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39601,-0.00590637660289364,0.00293264270655036,-0.0116543563077323,-0.000158396898054932,0.044025953481387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37162,-0.0100174251120297,0.00497439544140184,-0.0197672401771773,-0.000267610046882047,0.0440518314196585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39601,0.0114587382365673,0.00569160373686059,0.000303194912320517,0.022614281560814,0.044103827328402
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36861,0.0122150941159224,0.00606911066570789,0.000319637211134949,0.0241105510207099,0.0441713147829996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37243,-0.00468735038542452,0.00233069501876476,-0.00925551262220345,-0.000119188148645594,0.0443317740696418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39123,-0.00921214567636345,0.00458119840803364,-0.0181912945561094,-0.000232996796617519,0.0443585748127791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39428,0.00782669065381583,0.00389587918850565,0.00019076744434475,0.0154626138632869,0.0445586025159161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39355,-0.0164186847624338,0.00817984593131959,-0.0324511827878202,-0.000386186737047427,0.0447451191720388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39104,-0.0126788702269259,0.00632401193417788,-0.0250739336179146,-0.000283806835937282,0.0449944898229348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39455,0.00747786106146134,0.00373401949163157,0.000159182857863458,0.0147965392650592,0.0452349318777883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,37255,-0.00811996981131528,0.00405851788499528,-0.016074664865906,-0.000165274756724532,0.0454433318682274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36955,-0.0116320805338074,0.00582821264072073,-0.02305537730962,-0.000208783757994756,0.0459748529854391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35538,0.0180258618529972,0.00903227273775641,0.000322607286994646,0.0357291164189998,0.0459891410497031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36847,0.00617152109239228,0.00309351169458279,0.000108238171010017,0.0122348040137745,0.0460659608956008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36823,-0.0164391090934075,0.00825067108443526,-0.0326104244189006,-0.000267793767914439,0.0463428525646094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36880,-0.0156915091972042,0.00787570567072751,-0.0311278923118301,-0.000255126082578295,0.0463496758892929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39123,0.0130774486687694,0.00656378791323017,0.000212424358838293,0.0259424729787006,0.0463497346929229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,39104,0.0088887332375318,0.00446204612556389,0.000143122831426572,0.017634343643637,0.0463812896979743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37162,-0.0105640133350428,0.00530463164295288,-0.0209610913552304,-0.000166935314855116,0.0464506364540923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39473,0.00735337820719458,0.00369512909119853,0.000110925188445453,0.0145958312259437,0.0466069065316829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36957,0.0113222801072038,0.00569376870298113,0.000162493449360831,0.0224820667650468,0.046773890179179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37135,-0.0046353898497334,0.00233484232957747,-0.00921168081570523,-5.90988837615644e-05,0.0471313025320614
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39462,0.00913977584957576,0.00460496608270404,0.000114042327475845,0.0181655093716757,0.0471887901499675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,37243,0.00436491818863389,0.0022062919300191,4.05860057964592e-05,0.00868925037147132,0.0479055185996417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36880,-0.0129400524802847,0.00654968583326406,-0.0257774367134822,-0.000102668247087129,0.0482136504168862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37162,0.00820666969227451,0.00415598465549989,6.09397674947131e-05,0.0163523996170543,0.0483279989980828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39355,0.0125674565621506,0.00640187586252653,1.9779871598586e-05,0.0251151332527026,0.0496543220619396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37247,0.0110175666690667,0.00561352699806322,1.505375286278e-05,0.0220200795852706,0.0497048067122421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,37255,0.00693165876385841,0.00353502127865402,3.0170576965317e-06,0.0138603004700203,0.0499177646650333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39601,-0.00529675384543934,0.00270155124328132,-0.0105917942822707,-1.7134086079491e-06,0.049940003318108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36992,-0.00627995995420354,0.00320396076135561,-0.0125597230464605,-1.96861946541969e-07,0.0500107212639048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39123,0.00911226242877394,0.00466413324255856,-2.94387266408357e-05,0.0182539635841887,0.0507570706677705
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,37269,-0.00439297435628758,0.0022494881289077,-0.00880197108894666,1.60223763715026e-05,0.0508558664392289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36823,-0.0120075647826282,0.00615995364631699,-0.0240810739294095,6.59443641531192e-05,0.0512828125385939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39455,-0.0095476604019445,0.00490173847659475,-0.0191550678160702,5.97470121812098e-05,0.0514562006596449
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,37164,0.0101223436817031,0.00519922463860282,-6.81366099584083e-05,0.0203128239733647,0.0515693366843789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39428,-0.00711068613769536,0.00365629346347703,-0.0142770213261103,5.5649050719626e-05,0.0518201649271445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39428,0.0102373986718686,0.00530026622938309,-0.000151123137722226,0.0206259204814595,0.0534416227365603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39187,-0.00349802482198218,0.00181163809174257,-0.00704883548179762,5.27858378332646e-05,0.0535191671909884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36847,-0.00840126768876387,0.00435380578211227,-0.0169347270217039,0.000132191644176185,0.0536745414882466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37203,0.00933789681848668,0.00484023311427178,-0.000148960085486,0.0188247537224594,0.0537251486958134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37162,-0.0091019865502935,0.00472641371523025,-0.0183657574321448,0.000161784331557798,0.0541553583190823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39654,-0.00719128808285955,0.00374002401022026,-0.0145217351428913,0.000139158977172154,0.0545248435524039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36916,0.00895244170574375,0.00465744027001509,-0.000176141223485828,0.0180810246349733,0.0546057952973672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39123,-0.00972740843401082,0.0050665982331589,-0.0196579409710023,0.000203124102980611,0.0548887415213806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39187,-0.0121174090068256,0.0063225831612395,-0.0245096720028551,0.000274853989203778,0.0553172178915962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39123,-0.00899556068900496,0.00469719791768601,-0.0182020686076695,0.000210947229659626,0.0555003427949535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36847,-0.006257391985668,0.00326919346198667,-0.0126650111711619,0.000150227199825883,0.0556370733626331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39541,-0.00526533195052104,0.00275173504841942,-0.0106587326454231,0.000128068744381023,0.0557082308856639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,37269,-0.00431982332642263,0.00225774199308862,-0.00874499763287632,0.000105350980031067,0.0557270629967513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39485,0.00757803261679322,0.0039660709927992,-0.000195466529093222,0.0153515317626797,0.0560601766810648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36861,-0.00643339972419779,0.00337181419668773,-0.0130421555497057,0.000175356101310163,0.0564151061627556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36847,-0.00845163665437755,0.00443343713305297,-0.0171411734351614,0.000237900126406275,0.0566292661171777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,39123,-0.00512578955228324,0.00268905980374506,-0.0103963467676236,0.000144767663057081,0.0566484251179084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37164,-0.00907393322540005,0.00477055142888332,-0.0184242140260114,0.000276347575211257,0.0571842974315719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37164,0.00646632767599921,0.00340010612677671,-0.000197880332483147,0.0131305356844816,0.0572196653186757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,39104,-0.00862272759592361,0.00453918580849943,-0.0175195317805825,0.000274076588735274,0.0575026386444255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36847,0.00602377622656612,0.00317375519747792,-0.000196783960490607,0.0122443364136228,0.0577197541821841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36992,-0.0104496597100384,0.00550687487761511,-0.0212431344701641,0.000343815050087183,0.0577761955290471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36880,-0.00926352302578199,0.00488316096712274,-0.0188345185213426,0.00030747246977858,0.0578465938495386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,39050,-0.00699354168024439,0.00368909646747177,-0.0142241707564891,0.000237087396000273,0.0580150991671129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36847,0.011104216211062,0.00585896497270221,-0.000379355135434294,0.0225877875575584,0.0580822430406695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36880,-0.00514539714479517,0.00271532713388498,-0.0104674383272097,0.000176644037619382,0.0581227986854284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36990,0.00686679414228189,0.00362974286497836,-0.000247501873075682,0.0139810901576395,0.0585389445695044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39516,-0.0135860897024709,0.00718308537590628,-0.0276649370392472,0.000492757634305452,0.0585900968407034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39530,-0.00976374930323343,0.00516438743041336,-0.0198859486668436,0.000358450060376768,0.0586979919611266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39485,0.0045565439061054,0.00241019897461439,-0.000167446084138798,0.0092805338963496,0.0587068565773503
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36823,-0.012334258094179,0.00652466985078784,-0.0251226110017232,0.000454094813365124,0.058727379039835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36847,-0.00662807066080997,0.0035072524050587,-0.013502285374725,0.000246144053105084,0.0588055440838088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36823,-0.0100554698341607,0.0053299512967343,-0.0205021743757599,0.000391234707438537,0.0592379557723621
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36847,0.0102376424852003,0.00543054065671423,-0.000406217201959571,0.0208815021723602,0.0594265277128775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39462,0.0149617435208041,0.00794709449867775,-0.000614561696604309,0.0305380487382125,0.0597646471271921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39455,-0.00763213582309673,0.00405740668517178,-0.0155846529260334,0.000320381279839962,0.0599861103799663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37247,-0.0087955575117315,0.00467671631868048,-0.0179619214963452,0.000370806472882238,0.0600337693339319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36847,-0.00525951233712164,0.00279821177625358,-0.0107440074185787,0.000224982744335371,0.0601863691616456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37221,-0.018501695881093,0.00985296124586547,-0.0378134999229893,0.000810108160803291,0.0604340083133316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,37162,0.00601476513151676,0.00320591056493265,-0.000268819575751236,0.0122983498387848,0.0606577537674915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39455,-0.00439107124640624,0.00234125072053339,-0.00897992265865168,0.000197780165839192,0.0607401147585511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37221,-0.00613277799926891,0.00327214474762104,-0.0125461817046062,0.000280625706068335,0.0609204443819985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39531,-0.0103420542716924,0.00552081106072983,-0.0211628439507228,0.000478735407338081,0.0610483257661207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37221,-0.0112153710528479,0.00599734594005751,-0.0229701690953607,0.00053942698966478,0.061498944107558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39531,0.00689222045118024,0.00369049775055992,-0.000341155139917208,0.0141255960422777,0.0618430198784225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36823,-0.00927166389614649,0.00497281853430832,-0.0190183882233908,0.000475060431097822,0.0622795946930016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39495,-0.0109266448409937,0.0058646773502557,-0.0224214124474948,0.000568122765507512,0.0624637272920228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,37247,0.00898272425348966,0.00482715140297182,-0.000478492496335104,0.0184439410033144,0.0627847841963405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37221,-0.0076195977630121,0.00409474108500547,-0.0156452902896228,0.000406094763598631,0.0627918208723815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39485,-0.00954176063135523,0.0051291714129881,-0.0195949366008119,0.000511415338101435,0.0628636260645527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39123,-0.00812553078575341,0.00437008174337545,-0.0166908910027693,0.000439829431262478,0.0629969231698246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39462,0.00852485777453397,0.00459521853569567,-0.000481770555429539,0.0175314861044975,0.0635932180023333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36763,0.00717214617724462,0.00387464551100358,-0.000422159024322404,0.0147664513788116,0.0641869038474183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36823,0.00628995643396526,0.00339840678492861,-0.000370920864494812,0.0129508337324253,0.0642143113658498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36847,0.00996959647541409,0.0053884119028153,-0.000591690854103901,0.0205308838049321,0.064309667065952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36880,-0.00324616971256643,0.00175713151655514,-0.00669014748501449,0.000197808059881642,0.0647092346017665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36847,-0.010682696087303,0.00579420125166435,-0.0220393305405651,0.000673938365959166,0.0652525589121507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,39104,0.0131630836990519,0.00714355685778259,-0.000838287742201993,0.0271644551403058,0.0654001414310811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36880,0.00563729595990022,0.00306066189837046,-0.000361601360905872,0.0116361932807063,0.0655201482313941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39449,-0.00577782018197569,0.0031449196530409,-0.0119418627019359,0.000386222337984469,0.066201379945775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37164,-0.00841264262134425,0.00458451888707522,-0.0173982996400117,0.000573014397323183,0.0665274106831418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39123,0.00840040836488756,0.00457858831210895,-0.000573624726845974,0.0173744414566211,0.0665680450881412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36823,-0.0125746340411894,0.00685777780898891,-0.0260158785468077,0.000866610464428853,0.0667327967512248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36847,-0.00580749563102981,0.00316770910192421,-0.0120162054708013,0.000401214208741645,0.0667756244952876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39485,0.00426763548187401,0.00232786572453796,-0.000294981338220401,0.00883025230196842,0.0667803333425605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36916,0.0101433956951388,0.00553485047095031,-0.00070491122792378,0.0209917026182014,0.0668797705631002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36880,-0.0105054032266465,0.00573792158514709,-0.0217517295335348,0.000740923080241769,0.067143495667546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39654,-0.00544798833513161,0.0029803353029681,-0.0112894455289491,0.000393468858685859,0.0675723929676408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39355,0.00857144111713428,0.00468960875258288,-0.000620192037928168,0.0177630742721967,0.0676067844254934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39589,-0.0101746847690074,0.00556696128976978,-0.0210859288969561,0.000736559358941423,0.0676156219741727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,37143,0.00807403491961598,0.00441770821290348,-0.000584673177674832,0.0167327430169068,0.0676252068791277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37162,-0.00582179463085894,0.00318890987956662,-0.0120720579948095,0.000428468733091648,0.0679282807996318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36861,-0.00625678532640587,0.00342735116089459,-0.0129743936017593,0.000460822948947518,0.0679427814185277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,39194,-0.0229677392193728,0.0125969160340222,-0.0476576946460563,0.00172221620731074,0.0682808242337549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,37177,-0.00459156441178699,0.00252261041098948,-0.00953588081732638,0.000352751993752401,0.0687575289056044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,39123,-0.0225398574940132,0.0124165295732022,-0.0468762554574896,0.00179654046946314,0.0694966019260779
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37164,-0.00421745571836044,0.00232649086256197,-0.00877737780898189,0.000342466372261007,0.0698867102673177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36880,-0.0131782119887894,0.00727417118447839,-0.0274355875103671,0.00107916353278821,0.0700652770513377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39522,-0.0234415209524528,0.0129761601582818,-0.0488747948626852,0.00199175295777961,0.0708591600295009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39460,-0.00957809041267331,0.00530382172170316,-0.0199735809872115,0.00081740016186488,0.0709563811498073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39403,-0.00400147447460223,0.00221728958248975,-0.00834736205628214,0.000344413107077683,0.0711465574542031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39526,-0.00520781320139068,0.0028886803277113,-0.0108696266437048,0.000454000240923469,0.0714341389479855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36916,0.00493539015675198,0.00273910335115872,-0.000433252411519099,0.0103040327250231,0.0715967950041885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39462,-0.00406612945568199,0.00225703692231731,-0.00848992182342392,0.000357662912059946,0.0716387638935789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39462,-0.0058210457442725,0.00323442124870074,-0.0121605113917259,0.000518419903180957,0.0719252706881656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39541,-0.00652816877937317,0.00362964855929515,-0.0136422799555917,0.000585942396845321,0.0721070632506783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,37221,0.00709228842967548,0.00395434226008084,-0.000658222400082969,0.0148427992594339,0.0729095710879599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39541,-0.00407082985884771,0.00227856185535966,-0.00853681109535264,0.000395151377657219,0.0740256923412324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36763,0.0099896765463979,0.0055938493359321,-0.000974268152029018,0.0209536212448248,0.0741510289572204
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36894,0.00636408268438665,0.00356615198986493,-0.000625575215748615,0.0133537405845219,0.0743538637823159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36880,-0.012270123647401,0.0068894146031727,-0.0257733762696195,0.00123312897481745,0.0749350604286377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36861,-0.00757434856941132,0.00425618932718335,-0.0159164796506907,0.000767782511868056,0.0751646036997647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39541,-0.00659502225648662,0.00370705560977496,-0.0138608512516455,0.000670806738672311,0.0752523552044587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39485,0.0061057917755582,0.00343366737382825,-0.000624196277145168,0.0128357798282616,0.0753890943475307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36880,-0.0137805652051164,0.00775010668163252,-0.0289707743011162,0.00140964389088332,0.0754097459878555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36847,-0.00310896600848411,0.0017488264578649,-0.00653666586589931,0.000318733848931083,0.0754703961681243
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36916,-0.0104124875738309,0.00585727208013181,-0.0218927408508892,0.00106776570322747,0.0754770951702229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37221,-0.0121344770536067,0.00682694070033648,-0.0255152808262662,0.00124632671905282,0.0755196809038845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39104,-0.00757440170178969,0.00426159864252635,-0.0159271350411413,0.000778331637561948,0.0755295062182602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37221,0.00742481469432096,0.00417993208734272,-0.000767852196870779,0.0156174815855127,0.0757072368688917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39636,0.00937635591116485,0.00527889386034386,-0.000970276055109113,0.0197229878774388,0.0757204581767893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,39104,-0.00692788436508968,0.00390506234097728,-0.0145818065534052,0.000726037823225784,0.0760710470546353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36861,-0.0118413882398967,0.00667862015924605,-0.0249314837520189,0.0012487072722256,0.0762484014708641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36823,0.00849083689721688,0.00479623814354336,-0.000909789864128102,0.0178914636585619,0.0766998402680744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36831,0.00619297405348125,0.00349875073595333,-0.000664577388987266,0.0130505254959498,0.0767429310086402
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39462,-0.0101600000182596,0.00574634122840376,-0.021422828825931,0.00110282878941176,0.0770675784564346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36861,-0.00946647457665053,0.00536220826940638,-0.019976402784687,0.00104345363138597,0.0775201481957851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,39194,0.00729345879994251,0.00413476584634961,-0.000810682258902727,0.0153975998587877,0.0777636075725632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36847,-0.00753849455013321,0.00427657313964128,-0.0159205779038301,0.000843588803563705,0.0779686750107534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36861,-0.00655045412165968,0.00372472727632092,-0.0138509195832487,0.000750011339929321,0.0786633321112147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39415,0.0273711204320287,0.0155702075748508,-0.00314648641467892,0.0578887272787364,0.0787822098411843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37221,-0.00468955713765882,0.00266996170481317,-0.00992268207909264,0.000543567803774994,0.0790417754460668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39455,0.00643727633803615,0.0036654338273016,-0.000746973963474997,0.0136215266395473,0.0790727355412095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36880,-0.0141604543205369,0.00806591625640562,-0.0299696501830919,0.00164874154201811,0.0791828112599588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,39355,-0.00517620132990952,0.00295435463554369,-0.0109667364155751,0.000614333755756105,0.0797843626215825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39462,0.0118630706235424,0.00677584535943588,-0.00141758628095197,0.0251437275280367,0.0800028138503219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37162,-0.0162703984876127,0.00929987755737236,-0.0344981585000625,0.00195736152483715,0.080223883746887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39427,0.0104534380765457,0.00598122504873466,-0.00126976301897426,0.0221766391720656,0.0805350047715916
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,37221,0.00449271409606527,0.00257114144468747,-0.000546723135522164,0.00953215132765271,0.0805986542150764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37269,-0.0037827811155664,0.00216660710022819,-0.00802933103201365,0.000463768800880842,0.0808441247207439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37247,0.0119826462057518,0.00686447416169254,-0.00147172315116556,0.0254370155626692,0.08090397540824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39462,-0.00646155612917569,0.00370286189619978,-0.0137191654457273,0.000796053187375887,0.0810024130065185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,37221,-0.00567250914026908,0.0032514849685204,-0.0120454196785691,0.000700401398030895,0.0810802692547283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36823,-0.00871600980193228,0.00500199939853869,-0.0185199286230681,0.00108790901920355,0.0814449368140212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36823,0.0118016146598931,0.00677398267983626,-0.00147539139258602,0.0250786207123721,0.08149876908613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39462,-0.0126741869016203,0.00732287236942809,-0.0270270167456994,0.00167864294245872,0.0835138553266968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39462,-0.0123260312651008,0.00713031751706187,-0.0263014535985421,0.00164939106834044,0.0838870974616113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36916,-0.00449276233732512,0.00260162737067745,-0.00959195198385292,0.00060642730920269,0.0842095701442042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36955,-0.00756365820552481,0.00438420405883742,-0.0161566981608461,0.00102938174979653,0.0845149399098957
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36992,-0.0157793769639631,0.00915041904909644,-0.0337141983001921,0.00215544437226597,0.0846525261694704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36916,-0.0041919311466094,0.00243114251221454,-0.00895697047054989,0.000573108177331087,0.0846850168310754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,39123,-0.00843930398819528,0.00489553482036355,-0.0180345522361078,0.00115594425971727,0.0847509655971677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37221,-0.0109970272087289,0.00638255296721805,-0.0235068310244763,0.00151277660701848,0.0849158966156071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39104,-0.00991433393305715,0.00575738942373935,-0.0211988172035863,0.00137014933747198,0.0850871830999404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39123,0.012752824666775,0.00740748647403831,-0.0017658488223401,0.0272714981558901,0.0851607350562651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36880,-0.00602363201001618,0.00350035424903824,-0.0128843263381311,0.000837062318098776,0.0853004782659047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36916,0.0102863823555378,0.00598691468467749,-0.0014479704264301,0.0220207351375056,0.0857951639925137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36847,-0.00782894003927102,0.00456169950946078,-0.0167698710778141,0.0011119909992721,0.0861443599595851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,37162,0.00408308781816344,0.00238116588994968,-0.000583997326137934,0.00875017296246482,0.0864167117737201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36992,0.00542742214264955,0.00317673991645728,-0.000798988093606718,0.0116538323789058,0.0875705713790391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,37162,-0.0159712398166602,0.00936544245397744,-0.034327507026456,0.00238502739313556,0.0881559407320419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,39342,-0.00663938186975489,0.00389973990534155,-0.0142828720842243,0.00100410834471454,0.0886789637475547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39104,-0.0110856144531395,0.00651370693961372,-0.0238524800547824,0.00168125114850338,0.0887971546604716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39104,-0.00731251366745328,0.00430079057083692,-0.0157420631862937,0.00111703585138709,0.0891010023250479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,37247,0.00633765640050714,0.00373018182743047,-0.000973499981256581,0.0136488127822709,0.0893395800958003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36916,-0.00610687838066502,0.0035966825387546,-0.013156376156624,0.000942619395293992,0.0895478676757222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,39161,0.0106178132457879,0.00625431901947737,-0.00164065203238772,0.0228762785239636,0.0895899034737473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39549,0.00884264334745374,0.00521363117831129,-0.00137607376203639,0.0190613604569439,0.089894697463118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37255,0.00587544081391866,0.00346961138773258,-0.000924997506037194,0.0126758791338745,0.0904036324044623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36880,-0.00416165003268098,0.00246310503624937,-0.00898933590372974,0.000666035838367792,0.0911305387222472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39541,0.00857996530965656,0.00508270682447809,-0.00138214006632049,0.0185420706856336,0.0914184427304671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36861,0.0052043802450161,0.00308326670223713,-0.000838822491368669,0.0112475829814009,0.0914471885091175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39068,-0.0069923484159101,0.00414895823311569,-0.0151243065528169,0.00113960972099666,0.0919469816130461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36861,0.0106194733498269,0.00630284956500311,-0.00173411179757915,0.022973058497233,0.0920390709841427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36741,-0.00748404513266499,0.00444407245781665,-0.0161944271499856,0.00122633688465565,0.0921971885038047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39123,-0.00724157455990768,0.00430067533085896,-0.0156708982083912,0.00118774908857589,0.092237220869659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39428,0.00560504565114995,0.00333209568957073,-0.000925861900408674,0.0121359532027086,0.092562880232027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39428,0.00716293584440621,0.00426470843349089,-0.00119589268523594,0.0155217643740484,0.0930591509974863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36916,-0.0111392040118856,0.00664002746628939,-0.0241536578458128,0.00187524982204165,0.0934534061455471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39462,0.00797754224025707,0.0047598927613075,-0.00135184757190562,0.0173069320524198,0.0937605841378023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36955,-0.00970341304823027,0.00579711512194625,-0.0210657586872449,0.00165893259078439,0.0941880836111425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39462,-0.0104343972477998,0.00623578346905491,-0.0226565328471474,0.00178773835154782,0.0942871726373515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,37162,-0.0118633996168658,0.00709593406807934,-0.0257714303903013,0.00204463115656969,0.0945767895625237
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36823,-0.00681342806188033,0.00408410079114445,-0.0148182656125234,0.00119140948876279,0.0952852498120287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,39123,-0.024447548732142,0.0146680918125061,-0.053197008684654,0.00430191122036998,0.0955921621865524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39194,-0.00665219610173926,0.00399494986664736,-0.0144822978403681,0.00117790563688957,0.0959038163603622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37203,0.00896602483488109,0.00539090090876108,-0.00160014094629063,0.0195321906160528,0.0963014955629854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36823,-0.00717232240206238,0.0043129613152174,-0.0156257265798885,0.00128108177576372,0.0963439058909097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36861,-0.00758631264026079,0.00456545009500103,-0.0165345948264628,0.00136196954594123,0.0966024096739204
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39431,0.00911362830044974,0.00548869499280687,-0.00164421388545172,0.0198714704863512,0.0968476469485176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39520,0.00749659764399169,0.00452183543517712,-0.00136619980895546,0.0163593950969388,0.0973653134619425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,39104,-0.00710822723412073,0.00429241873813393,-0.0155213679608632,0.00130491349262178,0.09774409108487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39462,-0.0051825542861915,0.00313462197803938,-0.0113264133631487,0.000961304790765685,0.0982852992130552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39104,-0.00735910194139143,0.00445180475664345,-0.0160846392644126,0.00136643538162974,0.0983400053869429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36916,0.00291361363225164,0.00176481105306344,-0.000545416031752699,0.00637264329625598,0.0987741145643352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39636,-0.0058327302877677,0.00353572803404923,-0.0127627572345042,0.00109729665896879,0.0990342698091375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36847,-0.00965990499669012,0.00586473260693761,-0.0211547809062878,0.0018349709129076,0.0995592006086788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39601,0.00517242303936137,0.00315594517447959,-0.00101322950261863,0.0113580755813414,0.101245316783086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,37269,-0.00431171443406036,0.0026358350475079,-0.00947795112717584,0.000854522259055118,0.101904778000494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,37203,0.00531713981739519,0.00325089110377921,-0.00105460674601205,0.0116888863808024,0.101949150792692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36880,0.00427835583294364,0.00261637274615001,-0.000849734749510385,0.00940644641539766,0.102027397373747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36916,-0.00863867480842609,0.00528444938175779,-0.0189961955966714,0.00171884597981918,0.10212984741002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37162,-0.00580653304013552,0.0035527182475388,-0.0127698608053116,0.00115679472504052,0.102201405860569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,39194,0.00670217580775398,0.00410203910701235,-0.00133782084199022,0.0147421724574982,0.102308672377431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39485,0.00497141272518255,0.00304557315111717,-0.000997910651007097,0.0109407361013722,0.102628697698516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37164,-0.00593013293320046,0.00363433150143963,-0.0130534226760221,0.00119315680962122,0.102767805448923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39531,-0.00303464445603605,0.00186133185123804,-0.00668285488446262,0.000613565972390512,0.103045926485812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36861,-0.010199641990272,0.00625715711787164,-0.0224636699413005,0.00206438596075639,0.103110804124387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39458,0.014627517934422,0.00897534295114662,-0.00296415424982534,0.0322191901186694,0.103176446844197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36847,0.0065852642670899,0.00404639545068102,-0.0013456708162449,0.0145161993504247,0.103669180246671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37083,-0.00433070736422386,0.00266885709276203,-0.00956166726603744,0.000900252537589712,0.104682277345715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37203,-0.00558693967732694,0.00344695780203737,-0.0123429769693202,0.0011690976146663,0.105078389563055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37164,0.0059507933226684,0.00367586466337861,-0.00125390141755367,0.0131554880628905,0.105497334139004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37164,-0.006850055994538,0.00423165447618611,-0.0151440987678628,0.00144398677878678,0.105522549894553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36861,-0.0102012761160597,0.0063116679272419,-0.0225721452534538,0.00216959302133446,0.106064226195626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37221,-0.00670313913085135,0.00416071108130716,-0.0148581328502134,0.00145185458851068,0.107192203284424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39636,-0.0138736244164248,0.00862633992161803,-0.0307812506627961,0.00303400182994653,0.107793277667867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36880,0.00423102836049304,0.00263570893865037,-0.000934961159261682,0.00939701788024775,0.108459482677812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37247,-0.00892937530996417,0.00556539543154577,-0.0198375503557939,0.00197879973586554,0.108640503561185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36992,-0.0105282820288209,0.00656220156167788,-0.0233901970897096,0.00233363303206773,0.108654925677281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36880,-0.00376381326428611,0.00234882728551429,-0.00836751474389412,0.000839888215321909,0.109087666315069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,39194,-0.00715196348623446,0.00446342726783114,-0.0159002809311835,0.00159635395871457,0.109100114813982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36955,-0.0106429520463865,0.00664709361549291,-0.0236712555327526,0.00238535143997962,0.109370359430746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39636,-0.00940137270796496,0.00587898328425928,-0.0209241799451131,0.00212143452918322,0.109808212081977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39104,-0.0067727136483609,0.00423634210452748,-0.0150759441732348,0.00153051687651296,0.109904981636069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36916,0.00836122317204815,0.00525092231665228,-0.00193058456859031,0.0186530309126866,0.111334991458629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36955,-0.010148616637287,0.00637426014336664,-0.0226421665182856,0.00234493324371165,0.111381981362813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,39194,0.006876436724009,0.00432109681432092,-0.00159291303206,0.015345786480078,0.111549184316747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39433,-0.00374049307356438,0.0023517378199532,-0.00834989920067265,0.000868913053543897,0.111738067617927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39455,0.00404876420944371,0.00254802258239778,-0.000945360052055937,0.00904288847094336,0.112085333816274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36847,-0.00547138012325521,0.00344683840267351,-0.0122271833924953,0.00128442314598487,0.112456199374649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,39042,-0.00419515998864513,0.0026466914711373,-0.00938267527207423,0.000992355294783969,0.112974786638302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39194,-0.00551128741589596,0.00347733412452451,-0.012326862299964,0.00130428746817208,0.11300654807731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37269,-0.0026101877918845,0.00164887731022786,-0.0058419873199311,0.000621611736162104,0.113444062519551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36823,-0.00467575499567191,0.00295559973999998,-0.0104687304860719,0.00111722049472805,0.113675427108639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39654,-0.00443291423748811,0.00280378091370251,-0.00992832482834503,0.00106249635336881,0.113887701399747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36642,0.00671686328532472,0.00425361183221274,-0.00162021590581225,0.0150539424764617,0.11433988555134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38483,-0.00659425213997819,0.00417731398803706,-0.0147817875565308,0.00159328327657444,0.114453438869912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36763,-0.0121950024955863,0.00773432588923072,-0.0273542812384785,0.00296427624730586,0.114881607227598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39462,-0.0092541158543607,0.00587187656460415,-0.0207629939209848,0.00225476221226343,0.115045370993883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36926,-0.0113076463566246,0.00717984599094426,-0.0253801444988753,0.00276485178562615,0.115301451180643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39312,-0.00903095919154932,0.00573771189034267,-0.0202768744966209,0.00221495611352231,0.115516769612703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39455,0.012126100813468,0.00770729665337643,-0.00298020062714983,0.0272324022540858,0.11566411996039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39526,-0.00377639331063382,0.00240034386133615,-0.00848106727885266,0.000928280657585032,0.115676882781575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36992,0.00694966524872128,0.00441970196517457,-0.00171295060302088,0.0156122811004634,0.115876441818849
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39462,-0.0115818954162464,0.00737256019615443,-0.0260321134007091,0.0028683225682163,0.116216224155536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39187,0.00777538923971976,0.00496341079088907,-0.00195289591042281,0.0175036743898623,0.117243362630928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36916,0.00750738765430092,0.00480101334692807,-0.00190259850567809,0.0169173738142799,0.117911316855596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39462,0.00461351573259404,0.00295308255189853,-0.00117452606912708,0.0104015575343152,0.118245202568681
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37164,0.00647743378220868,0.00414637056413368,-0.00164945252349334,0.0146043200879107,0.118267267964381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39541,-0.0141210490622615,0.00904906744216273,-0.0318572212489005,0.00361512312437741,0.1186632815167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39622,-0.00733381867506707,0.00470383381639747,-0.0165533329552061,0.00188569560507196,0.118989983228231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36880,-0.011206077904927,0.00718978773107835,-0.0252980618578406,0.00288590604798653,0.119114083538411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39654,-0.00962940526503462,0.00618162159830157,-0.0217453835977057,0.00248657306763646,0.119313944663484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,39104,-0.0096122396222599,0.00617634690688874,-0.0217178795597618,0.00249340031524204,0.119658718498206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,39194,-0.015269598711741,0.00983032372708929,-0.034537033216836,0.003997835793354,0.120369136127675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37221,0.0035733663736698,0.0023006267119654,-0.000935861981782393,0.00808259472912199,0.120396722431389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37247,-0.0118163238074029,0.00763022477405125,-0.0267715643645433,0.00313891674973758,0.121497666130254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39403,0.0101140108469246,0.00653839976260302,-0.00270125268777729,0.0229292743816266,0.12191736989189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39428,0.0117900816613623,0.00762554251794197,-0.00315598167380394,0.0267361449965286,0.122094253787126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39455,-0.00782721345785506,0.00506266990808479,-0.0177500464777013,0.00209561956199113,0.12211011947067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39187,-0.00441048963101921,0.0028533337188894,-0.0100030237200424,0.00118204445800401,0.12219074749059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39636,0.00466686789650747,0.00302560528379021,-0.00126331845972135,0.0105970542527363,0.122983270403317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39428,-0.00354006364246261,0.00229518146667891,-0.00803861931715328,0.000958492032228064,0.123000116320773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36847,-0.00682338920861611,0.0044293568321498,-0.0155049285996297,0.00185815018239749,0.123465974127095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,39123,-0.00916468131857808,0.00595303585781762,-0.0208326315999006,0.00250326896274445,0.123704556811063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39541,0.00553930120488683,0.00360458299211922,-0.00152568145966684,0.0126042838694405,0.124378344038942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36823,-0.00998968040335833,0.00650145581848703,-0.0227325338075929,0.00275317300087625,0.124434076687898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39123,0.00817138416307591,0.00532158536998307,-0.00225892316209091,0.0186016914882427,0.124678478235204
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36861,0.00811861588797267,0.00529386637381769,-0.00225736220471001,0.0184945939806553,0.125156259416143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,39187,0.0155817874618384,0.0101684639356677,-0.00434840185207023,0.035511976775747,0.125454119028932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37203,-0.00715682448762285,0.00468708275395546,-0.0163435066853756,0.00202985771012986,0.126804430737998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37203,-0.00602012061953674,0.00394739930268148,-0.0137570232527925,0.00171678201371896,0.127262626267958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36861,0.00653522779984478,0.00429431432405882,-0.00188162827531052,0.0149520838750001,0.128076495657296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36823,-0.0037690836876287,0.00247848196456788,-0.00862690833818175,0.00108874096292434,0.128355006780493
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39355,0.00796109968107179,0.00525713148661957,-0.00234287803270257,0.0182650773948462,0.129960103099289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36992,0.00718869168373889,0.00475081620535937,-0.00212290807876547,0.0165002914462433,0.130267075616336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39641,-0.00444761293415808,0.002939420031875,-0.0102088761966331,0.00131365032831692,0.130277097388168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,39330,-0.00408051666195505,0.00269862403593596,-0.00936981977238953,0.00120878644847944,0.130536520664889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36893,-0.00446158681926757,0.00295126030061692,-0.0102460570084767,0.0013228833699416,0.130621229149781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39601,-0.00532759681278881,0.00352501640756396,-0.0122366289716142,0.00158143534603656,0.130715589330671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37162,-0.0123595393924559,0.00820285097104804,-0.02843712729571,0.00371804851079828,0.131902925636435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,37203,0.00736235835566689,0.00488800129252739,-0.0022181241776868,0.0169428408890206,0.132037943279425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37221,-0.00876344601747886,0.00582151964157478,-0.0201736245149654,0.0026467324800077,0.13225790575068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37221,-0.00884040793938153,0.00588714117062012,-0.020379204633797,0.0026983887550339,0.133213022701671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36861,-0.0090011017974744,0.00599593369244973,-0.0207531318346759,0.00275092823972706,0.133329018709045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36823,-0.00866359609622209,0.00577811378389107,-0.0199886991126486,0.00266150692020441,0.133800244215778
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36861,-0.00414642227224371,0.00276988815892031,-0.00957540306372752,0.00128255851924009,0.134428114216115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36847,-0.00627471028858621,0.00419370926229779,-0.0144943804426899,0.00194495986551746,0.134621880854382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37162,-0.00654995003555804,0.00438271006823743,-0.0151400617693034,0.00204016169818733,0.135070412818456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37203,0.00408468373694351,0.00273447726083245,-0.0012748916942881,0.00944425916817512,0.135260141027697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39531,0.00276763668907376,0.00185807458390371,-0.000874189495377504,0.00640946287352503,0.136371768462528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39498,0.00345413854230769,0.0023191004833158,-0.00109129840499127,0.00799957548960666,0.136395053208372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36847,-0.0036725156555364,0.00247624826035229,-0.00852596224582689,0.00118093093475409,0.13807414193789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36992,-0.00966987325724446,0.00652155577472571,-0.0224521225757069,0.00311237606121794,0.138164489809417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36763,0.00660579226234615,0.00445793300520264,-0.00213175642785101,0.0153433409525433,0.138417493274347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36955,0.00401392829701799,0.0027107323124122,-0.00129910703530992,0.0093269636293459,0.138697279213584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,39079,0.0046030195005336,0.00310996107857356,-0.00149250421347058,0.0106985432145378,0.138871006770159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39428,0.0101410953488141,0.00685588701112946,-0.0032964431929996,0.0235786338906279,0.139113074928044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,39231,-0.0053610548163039,0.00362860758378115,-0.012473125680515,0.00175101604790716,0.139578682827606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39462,-0.00439263701476607,0.00297401012776165,-0.0102216968651789,0.00143642283564677,0.139694448636848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36916,0.0334353635190939,0.0226488952948908,-0.0109564712588921,0.0778271982970799,0.139902861454348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36916,-0.00574220140093414,0.00389104385230594,-0.0133686473514538,0.0018842445495855,0.140036731776026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39455,0.00427553182552887,0.00289776152775892,-0.00140408076887861,0.00995514441993635,0.140109844012975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36763,0.00714994911080556,0.00488440349683561,-0.00242348174299224,0.0167233799646034,0.143265222406556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39499,-0.0042553701430859,0.00290883769580191,-0.00995669202685764,0.00144595174068584,0.143512669126373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36880,-0.00212947686014518,0.00145967131513958,-0.00499043263781875,0.000731478917528384,0.144625000329255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39458,0.00457643644490693,0.00314829409719947,-0.00159421998560404,0.0107470928754179,0.146071440122151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,39123,-0.0106645728167769,0.00733956882606219,-0.0250501277158588,0.003720982082305,0.146238358742654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39395,-0.00684940025533284,0.00471425781364104,-0.0160893455700693,0.0023905450594036,0.146269274820004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39499,-0.00433089236950008,0.00298098456128997,-0.0101736221096284,0.00151183737062826,0.1462891514141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39485,-0.0135605744625006,0.00933617826574982,-0.0318594838633703,0.00473833493836905,0.146390180522638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36880,0.00534254773549357,0.0036797607457661,-0.00186978332620798,0.0125548787971951,0.146561978053529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39123,0.00880925174972571,0.00607381452120986,-0.00309542471184561,0.020713928211297,0.146977967783492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,37162,0.00727445152552073,0.00503402098349156,-0.00259222960212272,0.0171411326531642,0.148466290869071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39654,0.00699531182621549,0.00484389954952125,-0.00249873129084615,0.0164893549432771,0.148717725837749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37203,0.010732793550289,0.0074350537264525,-0.00383991175355793,0.0253054988541359,0.148893127801416
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37162,-0.00561019239215473,0.00390235511929229,-0.0132588084259676,0.00203842364165815,0.150560074290229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36932,0.00459024230508363,0.00319328344205234,-0.00166859324133896,0.0108490778515062,0.150610171166223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36880,-0.00639182572284583,0.00445420797022679,-0.0151220733444903,0.00233842189879867,0.151309876254897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36992,-0.00435344864070642,0.00303400569373113,-0.0103000998004194,0.00159320251900658,0.151344867595667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39194,-0.00679395982930665,0.00475017656201306,-0.0161043058908522,0.00251638623223895,0.152665277225457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,39160,-0.00599708570518099,0.00419985307989197,-0.0142287977417692,0.00223462633140727,0.153333959758356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39187,-0.0113746541953328,0.00796595003937149,-0.0269879162725009,0.00423860788183535,0.153339157819485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,37243,0.00304018510625298,0.00212990558862186,-0.00113442984744586,0.00721480005995183,0.15349474067368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37162,0.00958717344815095,0.00673176481090938,-0.00360708558123142,0.0227814324775333,0.154421990667827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36992,-0.0105315394175151,0.00741154572454438,-0.0250581690376221,0.00399509020259184,0.155352100020733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39608,-0.00329703627206922,0.00232327138786127,-0.00785064819227731,0.00125657564813887,0.155880159897756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36287,0.00617606745173437,0.00435467413846976,-0.00235909385966636,0.0147112287631351,0.156140710651532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39123,0.00758212538389184,0.0053483518653716,-0.00290064427223649,0.0180648950400202,0.156312335427867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36847,-0.00761533274232546,0.00538529117680136,-0.0181705034488561,0.00293983796420521,0.157358068878366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39194,-0.00702642305373618,0.00497084537817485,-0.0167692799949589,0.00271643388748652,0.157522008279261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36916,-0.00651986167523881,0.00461811517347192,-0.0155713674152438,0.00253164406476615,0.158033396468361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36992,-0.0089269603971278,0.00632875827332931,-0.0213313266128532,0.00347740581859765,0.158405392375267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36847,-0.00481542362914666,0.00341619793159999,-0.0115111715750826,0.00188032431678932,0.158687151705037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37247,0.00397005557422964,0.00281907496519616,-0.00155533135755483,0.00949544250601412,0.159071560886952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37221,-0.00575982702581827,0.00409650431992267,-0.0137889754928667,0.00226932144123017,0.159738168237825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36992,-0.00814404935981088,0.00579395157482915,-0.019500194446476,0.00321209572685425,0.159864068556792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39428,-0.00537515676000636,0.00382603529104354,-0.0128741859304517,0.00212387241043897,0.160074884130671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36880,-0.00485674984209221,0.00346136662500955,-0.0116410284271109,0.00192752874292651,0.160602844497893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39123,0.0120057338763087,0.00856245480961155,-0.00477667755052997,0.0287881453031473,0.160895526282255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36847,-0.0102461483594932,0.00731608484547802,-0.0245856746566301,0.00409337793764368,0.161389839564797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39123,0.00809932946873535,0.00579709885028356,-0.00326298427782044,0.0194616432152911,0.162394120575863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39355,-0.00610181710552932,0.00436953980726938,-0.0146661151277773,0.00246248091671866,0.162601667425636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39123,-0.0111987310573662,0.00802586763946471,-0.0269294316307171,0.00453196951598462,0.162937575651093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37221,-0.00692669996778755,0.00496473244024121,-0.0166575755506603,0.00280417561508522,0.162985554097195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36880,-0.00561765635588564,0.00402813215700668,-0.0135127953836187,0.00227748267184746,0.163159680089433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39477,0.00434557209827406,0.00311721320096179,-0.00176416577561106,0.0104553099721592,0.163321083834165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37164,-0.0082857744866771,0.00595653765601468,-0.0199605882924659,0.00338903931911167,0.164238033067682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36823,-0.00541816230639473,0.003903289255441,-0.0130686092470591,0.00223228463426964,0.165131086828702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36899,-0.00676138656671161,0.0048711882544378,-0.0163089155454097,0.00278614241198648,0.165150807430501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39123,-0.00942700471909716,0.00679687287098748,-0.0227488755462326,0.0038948661080383,0.165474406802998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39606,0.00835885260557043,0.00602922377392461,-0.00345842599132181,0.0201761312024627,0.165648393434221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,39403,-0.009227181265191,0.00665726466380358,-0.022275420006246,0.00382105747586403,0.165757830574637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39541,-0.00460719397911704,0.00332418730039464,-0.0111226010878905,0.00190821312965645,0.165779291893277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36847,-0.00803449454588983,0.0057984572244356,-0.0193994707057836,0.00333048161400393,0.165885988785737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36823,0.00610798222946325,0.00441630003603074,-0.002547965841157,0.0147639303000835,0.166673213937473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39485,-0.00509959395949004,0.00368724661185494,-0.0123265973187257,0.00212740939974565,0.166674438640338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39541,0.00749605038556441,0.0054224380637494,-0.00313192821938441,0.0181240289905132,0.166865301694534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,37203,0.0064124200032782,0.00464260622028827,-0.00268708818848682,0.0155119281950432,0.167238216305901
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36763,0.00557359483885311,0.00403729426429068,-0.00233950191915663,0.0134866915968628,0.167449422234138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,39355,-0.00667261532246196,0.00484013293481099,-0.0161592758746915,0.00281404522976758,0.168038295758024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39516,-0.0103924622287209,0.00755703798405673,-0.0252042566774721,0.00441933222003031,0.169088931472571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37210,-0.00234713616451833,0.00170995004707474,-0.00569863825678482,0.00100436592774816,0.169890177126832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36847,-0.0086109606957526,0.00627677584715195,-0.0209134413561704,0.00369151996466522,0.170126745223058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36861,0.00548095698761066,0.00400031914327737,-0.00235966853321298,0.0133215825084343,0.170671133959928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37247,-0.012619277646255,0.0092286821044287,-0.0307074945709353,0.00546893927842522,0.171524737225372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,39104,-0.00793257104064226,0.00581506626092592,-0.0193301009120571,0.00346495883077255,0.172544106288724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37247,-0.00323031471009613,0.0023693790934841,-0.00787429773332497,0.0014136683131327,0.172793331050916
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,39104,0.0046567714969226,0.00341811812775578,-0.00204274003347872,0.0113562830273239,0.173099328159201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,37221,0.00251662842211689,0.00184864626678138,-0.00110671826077461,0.00613997510500839,0.173431602227479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,37203,0.00310724567552668,0.00228604725065854,-0.00137340693576405,0.00758789828681741,0.174100295814783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37247,-0.00861162135978106,0.00633961965006576,-0.02103727587391,0.00381403315434783,0.174366644836596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36857,-0.00418984872865051,0.00308875708459008,-0.0102438126144471,0.00186411515714605,0.174969995005858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36861,-0.00507047628808779,0.00374269025452634,-0.0124061491869594,0.00226519661078385,0.17551620869877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39531,-0.0103410382619668,0.00763368388674588,-0.0253030586799887,0.00462098215605515,0.175546535712568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39428,-0.0122940337784253,0.00907607953073646,-0.0300831496586687,0.00549508210181819,0.175580345271524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39485,-0.003563757048997,0.00263309820660424,-0.0087246295339413,0.0015971154359473,0.175933441408051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39460,0.00972911437623475,0.00719229640559791,-0.00436778657873714,0.0238260153312066,0.176167646338636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39428,-0.00223435163707867,0.00165405225908486,-0.005476294064885,0.00100759079072766,0.17676871151956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39037,-0.002164672391892,0.00160392580200108,-0.00530836696381412,0.000979022180030116,0.177162444032321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,37162,0.00590085177314612,0.00437699271398249,-0.00267805394625955,0.0144797574925518,0.177633502879738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39104,-0.00916828715014874,0.00681795701190626,-0.022531482893485,0.00419490859318753,0.178734404190581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,39032,-0.00987624143665652,0.0073548179660654,-0.0242916846501447,0.00453920177683166,0.179349197940756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39104,0.00376905132690304,0.00281615373736609,-0.00175060999833449,0.00928871265214057,0.180797124276113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36880,-0.00604782626176269,0.00452194045910626,-0.014910829561611,0.00281517703808558,0.18110337085162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36847,-0.00714602142814685,0.00534453599850155,-0.0176213119852099,0.00332926912891619,0.181224162252383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39355,-0.00900073673767174,0.00673919936519626,-0.0222095674934564,0.00420809401811293,0.181707140465684
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36823,-0.00576314806295531,0.00432174698767957,-0.0142337721588073,0.00270747603289666,0.182384856956848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36880,-0.00717108936057373,0.00538399935460968,-0.0177237280956087,0.00338154937446123,0.182908892598654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39520,-0.00823629533103495,0.00618432023632294,-0.0203575629942279,0.00388497233215801,0.182945125188027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37247,0.0120592791134585,0.00905804976847153,-0.00569449843274573,0.0298130566596627,0.183103236556976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36880,-0.00797446838703711,0.0059914535016099,-0.0197177172501925,0.0037687804761183,0.183222006858194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36847,-0.00832258110997273,0.00625988318595339,-0.0205919521544414,0.00394678993449593,0.183704035421124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39458,0.00342269290477215,0.00257605236929616,-0.00162636973904831,0.00847175554859262,0.183980990634877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39463,-0.00688586732906545,0.0051885181685344,-0.0170553629393929,0.00328362828126196,0.184484006014999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36916,0.00508910737614526,0.00383916067079692,-0.0024356475386167,0.0126138622909072,0.185003773396162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36823,-0.00489794096437039,0.0036980542952958,-0.0121461273831502,0.00235024545440938,0.185373352650195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39104,-0.00441578684959275,0.00333778278355164,-0.010957841105354,0.00212626740616846,0.185865964698963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39123,-0.00726097895609248,0.00549936987083767,-0.0180397439029343,0.00351778599074935,0.186745707876732
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39654,0.00377556887187006,0.0028611550438417,-0.00183229501405968,0.00938343275779979,0.186989797340817
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37221,-0.00702758585035619,0.00532590532023698,-0.0174663602780207,0.0034111885773083,0.187022294418367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,39029,-0.00800796791759765,0.00607120504047536,-0.0199075297969294,0.00389159396173406,0.187187162968241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,39194,-0.00606567075143428,0.00460308593881487,-0.0150877191915114,0.00295637768864287,0.187611155656525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,39187,-0.00511473886533613,0.00388214534276972,-0.0127237437371648,0.00249426600649252,0.187690498042803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36880,-0.00547255440742874,0.00416137657370888,-0.0136288524918981,0.00268374367704066,0.188506368165976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39319,-0.0126598365842904,0.00965256054860083,-0.0315788552595481,0.00625918209096722,0.189691538971918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36955,0.00644714080120928,0.00491584687669795,-0.0031879190771187,0.0160822006795373,0.189712452576069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,39180,0.00483724637741302,0.00369922630973292,-0.00241323718966351,0.0120877299444896,0.191016763603273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39485,-0.00778968006954117,0.0059579636302032,-0.0194672887847394,0.00388792864565711,0.191083309506653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39440,0.00278275126939987,0.00213117241274205,-0.00139434665957455,0.00695984919837428,0.191661956564545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36916,-0.00531181370018584,0.00407271860970503,-0.0132943421752077,0.00267071477483602,0.192174913683704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38842,-0.00530975680630521,0.00408391181314784,-0.013314223960075,0.00269471034746456,0.193565448423591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36847,0.0108482664254901,0.00835834995695442,-0.00553409949014054,0.0272306323411208,0.194347330971133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39420,-0.00492391395871591,0.00379465578632888,-0.0123614392999205,0.00251361138248868,0.194447663293879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39601,0.00740890025210734,0.00571297987679717,-0.00378854030641512,0.0186063408106298,0.194701211581247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39485,0.00601190030100902,0.00463940879037483,-0.00308134092812565,0.0151051415301437,0.195052825562503
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,39123,-0.0109559178632449,0.00845944794210031,-0.0275364358297615,0.00562460010327171,0.195302573979571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36861,-0.00437303503676109,0.00338138754329322,-0.0110005546216158,0.00225448454809362,0.195942997479734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39589,-0.00650950268231004,0.00504393337455901,-0.0163956120964457,0.00337660673182561,0.196875728745032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37181,-0.00662868840584327,0.00513828193560035,-0.0166997209996199,0.00344234418793341,0.197053504552045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39258,-0.0194940924066855,0.0151381022944798,-0.049164772903866,0.0101765880904949,0.197853102112441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,37221,0.00483267565269691,0.00376314865857746,-0.00254309571811492,0.0122084470235087,0.199091552969069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39485,0.00798235084695235,0.0062162123240607,-0.00420142530820662,0.0201661270021113,0.19912042061342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37162,0.00564640809345084,0.00440377468731678,-0.00298499029369006,0.0142778064805917,0.199804786114424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39636,0.0044735898807251,0.0034918867330615,-0.00237050811607544,0.0113176878775256,0.200164654144599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36763,0.00823251453818342,0.00643501252992429,-0.0043801100204682,0.020845139096835,0.200804438890526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37164,0.00513599815342817,0.00401842142363551,-0.00274010783689742,0.0130121041437538,0.201232791954695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36847,-0.00770110036945625,0.00602624315653345,-0.0195125369562618,0.00411033621734932,0.20129900911612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39187,0.0096893421443835,0.00760948319652235,-0.0052252449208003,0.0246039292095673,0.202922967957672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37126,0.00587827690974797,0.00461772002397144,-0.00317245433723606,0.014929008156732,0.203047591387794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39123,-0.0084803162036795,0.00667078578717979,-0.0215550563465519,0.00459442393919287,0.203655625434093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37162,-0.00939459211072091,0.00739256517289197,-0.0238840198495892,0.00509483562814735,0.203817277482852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39330,0.00437081371286827,0.00343995582560775,-0.00237149970532291,0.0111131271310595,0.203890250197506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37221,-0.0101574388022526,0.00800664188938173,-0.0258504569054408,0.00553557930093554,0.204597402439567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36880,0.00350983433279579,0.00276759329315464,-0.00191464852178731,0.00893431718737889,0.204753838211535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39169,0.00462164757301479,0.00366048564378003,-0.00255290428879406,0.0117961994348237,0.206760988692611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39606,0.00364931586240208,0.0028914891337647,-0.00201800283977674,0.0093166345645809,0.206936281957607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39194,0.0045893050665065,0.00363683314952531,-0.00253888790656311,0.0117174980395761,0.207006189581773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37247,-0.0035354109581305,0.00280458040932067,-0.00903238856039901,0.001961566644138,0.207481526157468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36847,0.00392631353752866,0.00312365561952211,-0.00219605147673468,0.010048678551792,0.20879141464984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39194,0.00759583967505932,0.00604856798296497,-0.00425935357155203,0.0194510329216707,0.209205516177197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39428,0.00840214581332836,0.00669994615003005,-0.00472974864073054,0.0215340402673873,0.209839156414453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39636,-0.00843370830041726,0.00672570265195212,-0.0216160854982434,0.00474866889740891,0.209878756934975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36763,0.00370284486326208,0.00295358761774368,-0.00208618686751554,0.0094918765940397,0.209983237510824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36861,-0.00910144550991438,0.00726174027684483,-0.0233344564525303,0.00513156543270149,0.210104812268461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39477,-0.00252700123325289,0.00201655341769165,-0.00647944593192853,0.00142544346542276,0.2101783246497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39187,0.00540883610005061,0.00431664005584483,-0.00305177840940526,0.0138694506095065,0.210218330311572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36880,-0.00590493519580603,0.0047352140275416,-0.0151859546897876,0.0033760842981755,0.212411449814644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39104,-0.00428863967719305,0.00344046066367068,-0.0110319425779876,0.00245466322360149,0.212589570790358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36763,-0.00517190400008241,0.00414993032113869,-0.0133057674295143,0.00296195942934943,0.212691624625264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36741,0.00440538121835355,0.00353644022812875,-0.00252604162877881,0.0113368040654859,0.212894395362895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36847,0.00439344393062303,0.00353477427193649,-0.0025347136423725,0.0113216015036186,0.213920586799452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37221,-0.00811876299697138,0.0065335269939259,-0.0209244759050661,0.00468694991112339,0.214026670169356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36861,-0.00590452618911385,0.00475530917019747,-0.0152249321627009,0.00341587978447319,0.214381698910104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39462,-0.0095908070527007,0.00773243933265711,-0.0247463881447086,0.00556477403930724,0.214871286429997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36916,-0.00880977056944049,0.00710669064749756,-0.0227388842385357,0.00511934309965474,0.215130221893928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36847,-0.00702265650377154,0.00566723448120417,-0.0181304360869317,0.00408512307938863,0.215306693820132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39526,0.00326826111890149,0.00264388496912316,-0.0019137534205799,0.00845027565838287,0.216418880869841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37221,-0.00525464020846728,0.00425292383614422,-0.01359037092731,0.0030810905103754,0.216653843437032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36852,-0.0062936928123668,0.00509772752531486,-0.0162852387619839,0.00369785313725033,0.216999998483103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,39194,-0.00519099476917748,0.00420513538837482,-0.0134330601303921,0.00305107059203717,0.217058009213023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,37203,-0.0101944307105554,0.00826006254776279,-0.0263841533041704,0.0059952918830597,0.217157379056626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39123,0.0129737688530644,0.010522100888047,-0.00764954888750781,0.0335970865936365,0.217594865720479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36928,-0.00908059894341751,0.0073721559373338,-0.0235300245805918,0.00536882669375674,0.218068445257721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,39194,-0.0084678562936676,0.00687597582078075,-0.0219447689023979,0.00500905631506267,0.218150556296736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36916,-0.00276852368691141,0.00225182796888941,-0.00718210650593466,0.00164505913211184,0.218924046670355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37255,0.00377598508876812,0.00307572057684973,-0.00225242724185736,0.0098043974193936,0.219591586516575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36847,0.012716194575398,0.0103826113009846,-0.00763372357453179,0.0330661127253277,0.220689386862302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39589,-0.00608977568516814,0.00497693696153851,-0.0158445721297836,0.00366502075944735,0.221122538223908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36763,-0.0101539811891165,0.00832767483662482,-0.0264762238689011,0.00616826149066816,0.222751555828347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39104,-0.00588888607899783,0.00483140459092578,-0.0153584390772124,0.00358066691921671,0.222910649407397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36719,0.00564042757277109,0.00462866559275033,-0.00343175698901955,0.0147126121345617,0.223024760137354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39589,0.00242882612624021,0.0019975412302164,-0.00148635468498394,0.00634400693746436,0.224038976740291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39462,-0.00408830425596767,0.00336341121200167,-0.0106805902314909,0.0025039817195556,0.224185735100805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36763,0.00490002464936214,0.00403397332048077,-0.00300656305878018,0.0128066123575045,0.22450787259963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36992,-0.00663861269831132,0.00546645294119241,-0.0173528604630484,0.00407563506642581,0.224607253786999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,37203,-0.0111644394890563,0.00921344155947667,-0.0292227849456306,0.00689390596751794,0.225628399712651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39187,0.00663735335039899,0.00548350091749342,-0.00411030844788812,0.0173850151486861,0.226136195818289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37255,-0.0145057869254795,0.0119968356103721,-0.0380195847218089,0.00900801087084985,0.226633533741217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,39355,0.00128072536805943,0.00105960213361828,-0.000796094813832396,0.00335754554995126,0.226803004139642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39485,-0.0070929395899941,0.00588464785697177,-0.0186268493896588,0.00444097020967058,0.228095102573589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36880,0.00368319229247457,0.00306478657096777,-0.00232378938662227,0.00969017397157141,0.229472549730838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36861,-0.0106477979652613,0.00886031343388143,-0.0280140122956689,0.00671841636514633,0.229486997931932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39289,-0.00365486693423376,0.00304671744736178,-0.00962643313106285,0.00231669926259533,0.230310734293521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36929,-0.0144458958198788,0.01204647374592,-0.038056984361882,0.00916519272212443,0.230480559909177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39635,-0.00247058452685198,0.00206364560389873,-0.0065153299104935,0.00157416085678954,0.231249565253467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39462,-0.00444248014638283,0.00371190214320798,-0.0117178083470705,0.00283284805430482,0.231395473899037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37247,-0.00796121602213432,0.00665491516679911,-0.0210048497490606,0.00508241770479194,0.231605133960708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39123,-0.0037224714135925,0.0031124427941442,-0.00982285929011513,0.00237791646293014,0.231717163095629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,39194,0.00792887071360961,0.00663243800330809,-0.00507070777287424,0.0209284492000935,0.231923265863371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,39194,-0.00864100457212661,0.00722889228809501,-0.0228096334567928,0.0055276243125396,0.231972340163483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39445,0.00251568607304016,0.00210611715544446,-0.00161230355163097,0.00664367569771129,0.232314491634793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,39104,-0.00472392727263378,0.00395755293820487,-0.0124807310315153,0.00303287648624776,0.232634805149826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39104,-0.0038489448804713,0.00323248604619393,-0.0101846175310114,0.00248672777006881,0.233787783031323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36789,0.00355056478648756,0.0029822321357747,-0.00229461019963086,0.00939573977260598,0.233844199982786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36847,-0.0090957883574853,0.00764669926386871,-0.024083318914668,0.00589174219969738,0.234263720133585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39123,-0.00455964170541988,0.00383647590684973,-0.0120791344828454,0.0029598510720056,0.234656734732241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39654,-0.00504981217285974,0.00425065374459223,-0.0133810935122605,0.00328146916654104,0.234848677196126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36651,0.00397948026281239,0.00335276616320433,-0.00259194141706809,0.0105509019426929,0.235280519874026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,39355,-0.00382838844426309,0.00322689918972069,-0.0101531108561156,0.00249633396758945,0.235483866245642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,39319,0.00520874290575727,0.00439363503912489,-0.00340278177092752,0.0138202675824421,0.23583079741483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36823,-0.0122830362435038,0.0103675171332317,-0.032603369824638,0.00803729733763039,0.236134476862894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39194,0.00562105831530026,0.00474847124468475,-0.00368594532428186,0.0149280619548824,0.236526500743449
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39654,-0.00319287317798072,0.00269784594682244,-0.00848065123375271,0.00209490487779127,0.236633590197687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,37269,-0.00202445092916973,0.00171868144671082,-0.00539306656472294,0.00134416470638349,0.238854621019318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,37243,0.00736095278853485,0.00625171293392411,-0.00489240456195641,0.0196143101390261,0.239045929495902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36968,0.00653558828042932,0.00555152659242699,-0.00434540384072758,0.0174165804015862,0.239114271137009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37162,-0.00586735637851539,0.00499138504140671,-0.0156504710596725,0.00391575830264175,0.239818096997929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39599,0.00221795986475944,0.0018926383430765,-0.00149161128767051,0.00592753101718939,0.241260520814457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36880,0.00397837354326981,0.00339716043660534,-0.00268006091247665,0.0106368079990163,0.241585892310747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36847,-0.00393739873777238,0.00337057944428621,-0.0105437344485733,0.00266893697302858,0.242761989425419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36955,-0.00838335928889211,0.00717675757769093,-0.0224498041411663,0.00568308556338211,0.242778095821928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39187,-0.00334919133344609,0.00286874910153082,-0.00897193957244649,0.00227355690555431,0.243037704264765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36971,0.00566417235804974,0.00485393426236188,-0.00384953879617955,0.015177883512279,0.243263291907451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38905,-0.00939853759143214,0.00807261289263389,-0.0252208588609946,0.00642378367813027,0.244342029307487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36847,-0.00493088564348217,0.00423543230549938,-0.013232332962261,0.00337056167529662,0.244365822375728
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36823,-0.00280931852984102,0.00241707074244866,-0.00754677718504039,0.00192814012535835,0.245143237557092
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39642,0.00554273972333585,0.00477516032646015,-0.00381657451652603,0.0149020539631977,0.245764176557486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39428,-0.00219093435545866,0.00188914782029382,-0.00589366408323455,0.00151179537231723,0.246170136864559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39428,-0.00450609530461815,0.00388608305100167,-0.0121228180845814,0.00311062747534513,0.246251843897979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,39187,-0.00728733580051074,0.00628520276745274,-0.0196063332247181,0.00503166162369662,0.246294351714212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,39194,-0.00795978269048104,0.00687380105077025,-0.0214324327499907,0.00551286736902864,0.246887482019095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36847,0.0052528179097855,0.0045367219748483,-0.00363915716091716,0.0141447929804882,0.24694987035129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37143,0.00415155092830045,0.00358658383407564,-0.00287815338648781,0.0111812552430887,0.247080800126986
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,39194,-0.00337026185975367,0.00291805682392759,-0.00908965323465174,0.0023491295151444,0.2481223065383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39440,-0.00403372779729304,0.00350511830041926,-0.0109037596661148,0.00283630407152871,0.249828463193131
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37247,-0.00399266906684298,0.00347035882215178,-0.0107945723582605,0.00280923422457451,0.24995697582208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39194,-0.00596528353467226,0.00519683760340123,-0.0161510852373387,0.00422051816799414,0.251041690878749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39194,-0.00379922619537116,0.00331242564483089,-0.0102915804592397,0.0026931280684974,0.251415959307142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36992,0.00448176259690636,0.00391016343873425,-0.00318215774301276,0.0121456829368255,0.251741339237923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39568,-0.00582062098027935,0.00508114431568445,-0.0157796638390209,0.00413842187846217,0.252006366117491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39623,0.00526253989960509,0.00459473677840512,-0.00374314418606894,0.0142682239852791,0.252086041996831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,39085,-0.00683943665389555,0.00598515700762717,-0.0185703443888448,0.0048914710810537,0.253168144214883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39654,0.00168644290243152,0.0014775639484785,-0.00120958243658634,0.00458246824144938,0.253735161736163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36880,-0.0043841789960572,0.00384197283369105,-0.0119144457500917,0.00314608775797725,0.253839057832351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,39194,-0.00308164392614148,0.00270092476016486,-0.0083754564560646,0.00221216860378164,0.253905594342997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36955,0.00534122284131366,0.00468283546950369,-0.00383713467891358,0.0145195803615409,0.254059980010124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39123,-0.00648324204216777,0.00568641956243164,-0.0176286243845338,0.00466214030019826,0.254251892607785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39123,0.00292255041956257,0.00256584149063877,-0.00210649890208942,0.00795159974121455,0.25471249242447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36861,0.00673581820304201,0.00591578431538187,-0.00485911905510645,0.0183307554611905,0.254884519853526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36861,-0.00411669186861783,0.00361740419695701,-0.0112068040946536,0.00297342035741792,0.255132539184212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39583,0.0093970881611231,0.00826192776422335,-0.00679629025675466,0.0255904665790009,0.255390558292736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37203,-0.0064132746526893,0.00564567696978623,-0.0174788015134703,0.00465225220809171,0.255993806941878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37203,0.00276547935081525,0.0024399645287637,-0.0020168511255616,0.0075478098271921,0.257063571723911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,39123,-0.00916395899168537,0.00809462117489879,-0.025029416494487,0.00670149851111626,0.257608905752031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36847,0.00467444608368296,0.00412919977811079,-0.00341878548141418,0.0127676776487801,0.25763679235782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39428,-0.0110875276284252,0.00982640898135099,-0.0303472892318731,0.00817223397502275,0.259194547060436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36668,-0.003110019194547,0.0027672483474972,-0.00853382595564151,0.0023137875665475,0.261091522269338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39654,0.00269093052291761,0.00239483221445898,-0.002002940617422,0.00738480166325722,0.261183300968843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36848,0.00276971126769762,0.00246556072379101,-0.00206278775093276,0.007602210286328,0.261306562846225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39355,-0.00285511560258092,0.00254952963200903,-0.00785219368131862,0.00214196247615678,0.262791582238507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36847,-0.00390341945956209,0.0034930953378791,-0.0107498863218051,0.00294304740268094,0.263816276159882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36823,-0.00943702179232483,0.00846769787697958,-0.0260337096312048,0.00715966604655514,0.265097914505265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39654,0.00542426400790484,0.00487376495434245,-0.00412831530260636,0.014976843318416,0.265746858733685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36688,-0.00330987827316121,0.00298362101871524,-0.00915777546984307,0.00253801892352066,0.267301271534084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,37247,-0.00514606770324836,0.00464129991859963,-0.0142430155437036,0.00395088013720691,0.267556429294795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37221,-0.010284539207214,0.00927796210645402,-0.0284693449358638,0.00790026652143593,0.267670622083699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,37247,-0.00659731857039613,0.00595918148303055,-0.018277314277136,0.00508267713634376,0.268278127630631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36880,-0.00493078362200749,0.0044577752764905,-0.0136680231639289,0.00380645591991389,0.268700922216328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39589,0.0063783965146261,0.0057686016454254,-0.00492806271040767,0.0176848557396599,0.268869934547836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37162,0.00338389980298874,0.00306054048555824,-0.00261475954870542,0.0093825591546829,0.268897097545895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39187,-0.005990214542373,0.00542970136875326,-0.0166324292251294,0.0046520001403834,0.269944905569778
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36847,-0.00367261589443758,0.00333080224263084,-0.010200988289994,0.00285575650111887,0.270212751840353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36992,0.00387149525314003,0.00351121249841398,-0.00301048124375137,0.0107534717500314,0.270218067327162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39654,-0.00371954140532638,0.00337533433642337,-0.0103351967047162,0.00289611389406343,0.270489039785938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36861,-0.00475439852244926,0.00431969871465225,-0.0132210080031677,0.00371221095826915,0.271078213556544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37203,-0.00356765966758966,0.0032484158456655,-0.00993455472509405,0.00279923538991472,0.272104389407292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,37162,0.00367997865034746,0.00335689246112354,-0.00289953057345468,0.0102594878741496,0.272992071479659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37164,-0.00480217029485128,0.00438219719965548,-0.013391276806176,0.00378693621647347,0.273171226840569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39104,-0.00409890945482701,0.00375514712099436,-0.011458997811976,0.00326117890232194,0.275051396271123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39496,-0.00538926612947965,0.00493780790598333,-0.015067369625207,0.00428883736624768,0.275101691556598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36763,0.00285554729679751,0.00261927462721685,-0.00227823097254751,0.00798932556614254,0.275644020805116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39433,-0.00517267935054182,0.00475542467946949,-0.014493311722302,0.00414795302121838,0.276726130209142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39455,0.00420835066197437,0.00386945633485551,-0.00337578375434242,0.0117924850782912,0.27679719739849
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39289,0.00432210742399455,0.00397418263478918,-0.00346729054019225,0.0121115053881814,0.276813136414558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36709,0.00411059871471201,0.00379949480918562,-0.00333641111129181,0.0115576085407158,0.279326988338042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36968,-0.00476452087486315,0.00440712992013583,-0.0134024955183294,0.00387345376860307,0.279676216682825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36880,0.00405917361739426,0.00375546279015122,-0.00330153345130214,0.0114198806860907,0.279775142456765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,37164,-0.00549579229503804,0.00509039354805713,-0.01547296364923,0.00448137905915394,0.28032302258861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39472,0.0025924206887541,0.00240248304220683,-0.00211644607397128,0.00730128745147949,0.280578802938829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36880,-0.00541650521892457,0.00503139702772139,-0.0152780433932585,0.00444503295540936,0.281706268724013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36916,0.00288951162650743,0.00268839824386801,-0.00237974893147388,0.00815877218448873,0.282481555926648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39526,0.00385095327828014,0.0035886792509195,-0.00318285805352208,0.0108847646100824,0.283250733044769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39455,0.00293192526748078,0.00273391756706079,-0.00242655316395837,0.00829040369891993,0.283545822642828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39549,-0.00574162616352295,0.00535979572286992,-0.016246825780348,0.00476357345330209,0.284078773061895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,39123,0.00426758148656765,0.00399277912586637,-0.00355826560013043,0.0120934285732657,0.285166192193314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39104,-0.00786120701937824,0.00735964795885899,-0.0222861170187418,0.00656370297998538,0.285470510684759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36864,-0.00634778342065842,0.00594656989623794,-0.0180030604172848,0.00530749357596794,0.285780532423101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37162,-0.0079554070229593,0.00747849993633855,-0.0226132668981829,0.00670245285226425,0.2874529236663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36823,-0.00570011968049292,0.00535895574244965,-0.0162036729356942,0.00480343357470839,0.287502428656783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36763,0.00320111455605833,0.0030096341217834,-0.00269776832263713,0.00909999743475379,0.287520609129529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37164,0.0159461710128938,0.0150064769980951,-0.0134665239033726,0.0453588659291603,0.287974849298783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39359,-0.00236609787289045,0.00222758507872237,-0.0067321646271863,0.00199996888140539,0.288170867968376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39268,0.013555571473338,0.0127873924892318,-0.0115077178055564,0.0386188607522324,0.289128601199979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39531,-0.00527586625225757,0.00498415345173967,-0.0150448070176673,0.00449307451315218,0.28983172412825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37164,0.00501568464887465,0.0047384129556088,-0.0042716047441186,0.0143029740418679,0.289840496391012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36880,0.0039644433294467,0.00374594776462737,-0.00337761428922295,0.0113065009481163,0.289926267201638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37221,0.00503957822193458,0.00476275928334423,-0.00429542997342012,0.0143745864172893,0.290020048500634
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39396,-0.00210426239901124,0.00199044178630571,-0.00600552830017044,0.00179700350214795,0.290444895282339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36916,-0.00384990407037173,0.00364408240431031,-0.0109923055828199,0.00329249744207649,0.29076896216836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39123,-0.0041795525850043,0.00395633312967163,-0.0119339655191607,0.0035748603491521,0.290793405295319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39582,0.00560034388320823,0.0053028314439423,-0.00479320574691869,0.0159938935133351,0.290937360483542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36955,0.00378073370735343,0.00358015730760143,-0.00323637461554538,0.0107978420302522,0.29097744167484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37221,0.00487023243795042,0.00461226186934326,-0.00416980082596236,0.0139102657018632,0.291019504477411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36855,-0.00448884043191474,0.00425241148238951,-0.0128235669373982,0.00384588607356871,0.291172113116522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37203,0.00803864653041816,0.00762558130277812,-0.00690749282302696,0.0229847858838633,0.291825817732538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,37203,-0.00680659830376561,0.00646270186869709,-0.0194734939664119,0.00586029735888069,0.292263574259991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39428,-0.00283349324535289,0.00269239192105479,-0.00811058141062028,0.00244359491991449,0.292629644106856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36861,-0.0054112705332454,0.0051518267899799,-0.015508851041606,0.0046863099751152,0.293573284767308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38875,-0.00288701772095422,0.00275775136244246,-0.00829221039134145,0.00251817494943301,0.295175318153448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39530,0.0021968707318502,0.00209952007556902,-0.00191818861626508,0.00631193007996548,0.295407910482435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36992,-0.00540484104773549,0.00516608634686653,-0.0155303702875939,0.00472068819212291,0.295481585170414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37162,0.00520376784127847,0.00497598161322872,-0.00454915612064982,0.0149566918032068,0.295683823679623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36880,-0.00400713724329675,0.00384042495656593,-0.011534370158166,0.00352009567157247,0.296778806801903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39462,0.00654662137903901,0.00628269684988658,-0.00576746444673869,0.0188607072048167,0.297424678685955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39531,-0.00284661063262034,0.00273951269747759,-0.00821605551967642,0.00252283425443573,0.298777779643337
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39636,-0.00334967487989722,0.00322860633646791,-0.00967774329937433,0.00297839353957989,0.299520022260748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39123,-0.00416963371956996,0.00402009759869274,-0.0120490250130077,0.0037097575738678,0.29966108647665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36955,0.00272523366719495,0.00262760422103302,-0.00242487060602977,0.00787533794041967,0.299683539963606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36929,-0.00481667647406693,0.00465470342673948,-0.0139398951904763,0.00430654224234246,0.300783445358259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,39270,0.00682715624137712,0.00659807808610803,-0.00610507680739462,0.0197593892901489,0.300817082719972
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,37243,-0.00611991684504271,0.00591867561282465,-0.017720521046179,0.00548068735609361,0.301155217323402
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39428,0.00236864538741356,0.0022935381615341,-0.00212668940919327,0.00686398018402038,0.301738840021782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36823,-0.00299289066211684,0.00289803320581893,-0.00867303574552193,0.00268725442128826,0.301749678397692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39589,-0.00369443825330255,0.00357786096478407,-0.0107070457442793,0.00331816923767422,0.30181560457588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37164,0.0114997092764898,0.0111407295108627,-0.0103361205648011,0.0333355391177808,0.3019876349871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36880,0.00343010252949567,0.00332320214027638,-0.00308337366544604,0.00994357872443738,0.302013561308671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39104,-0.0127481261965642,0.012356853346433,-0.0369675587555728,0.0114713063624444,0.302246369535091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36861,-0.00724638217553703,0.00703777746087577,-0.0210404259988535,0.00654766164777948,0.303198766091066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39589,-0.00685350060464534,0.00666134988844225,-0.0199097463859922,0.00620274517670147,0.303568668427063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37203,-0.00230606224790422,0.00224297788939599,-0.00670229891112036,0.00209017441531192,0.303910407356602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36763,-0.00528739806203856,0.00514840153302391,-0.0153782650667654,0.0048034689426883,0.304441584907451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36916,0.00251786021482298,0.00245701748680978,-0.00229789405932418,0.00733361448897014,0.305494992432565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39194,-0.00259432554275143,0.00253195792857691,-0.00755696308276217,0.00236831199725931,0.305553592591805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36880,-0.00786074321606235,0.00767485864505287,-0.022903466160366,0.00718197972824128,0.305751340372087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36861,-0.00773721677101273,0.00756476274027542,-0.0225641517419525,0.00708971819992709,0.306423766877922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36823,-0.00698775559450925,0.00683949839573443,-0.0203931724501487,0.00641766126113024,0.306953959284003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36916,0.00727733604757772,0.00714037045111009,-0.00671779003659804,0.0212724621317535,0.308136418137049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36861,-0.00702613650809767,0.00689398740614621,-0.0205383518241442,0.0064860788079489,0.3081427303843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36823,-0.0040601420689511,0.00399130824313274,-0.0118831062254913,0.00376282208758907,0.309056344460077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36741,0.00784482790816288,0.0077138131897816,-0.00727424594380906,0.0229639017601348,0.309180857599617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37162,-0.00599227755919134,0.00590593544043161,-0.0175679110224373,0.00558335590405461,0.310306530184141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37164,0.00287594235589431,0.00283685325212146,-0.00268429001826376,0.00843617473005237,0.310707495540907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39618,-0.00462599557761128,0.00456478434580001,-0.0135729728953793,0.00432098174015673,0.310880796131759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,37255,0.00380852526314053,0.00375987422048811,-0.00356082820901617,0.0111778787352972,0.311108182692386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36847,-0.00416829396927606,0.00411851858525348,-0.0122405903963729,0.00390400245782076,0.311516811127877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36763,-0.00285984817611082,0.00282688893254072,-0.00840055048389063,0.002680854131669,0.311720915335299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37203,0.00542697417869023,0.00538024967029182,-0.00511831517508174,0.0159722635324622,0.313145132053077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36538,-0.00605264558318552,0.00600280236249637,-0.0178181382136784,0.00571284704730735,0.313329052985895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36823,-0.00948489068957053,0.00940803188046623,-0.0279246331752843,0.00895485179614329,0.313392821037941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39636,0.0045844068139003,0.00455302111504177,-0.00433951457158156,0.0135083281993822,0.314002059319263
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36847,-0.00279019370742505,0.00277306239075235,-0.00822539599329965,0.00264500857844956,0.314349709410769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36763,-0.00707598620738754,0.00703303701453413,-0.0208607387558744,0.00670876634109935,0.314383982853147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36823,-0.00303649711407745,0.00302104959689354,-0.00895775432398879,0.00288476009583389,0.314861957925995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39415,-0.00299189195887153,0.00298116713666516,-0.00883497954673524,0.00285119562899218,0.315588877272657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37247,-0.00409379202375597,0.00407993751162914,-0.0120904695465491,0.00390288549903715,0.315688921358855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36955,-0.00507919948259367,0.00506352595088583,-0.0150037103463299,0.00484531138114257,0.315834256525807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36823,-0.0079092505067014,0.00790267073510328,-0.0233984851475038,0.00757998413410102,0.316927320860753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36763,0.0101307929881192,0.0101327165520493,-0.00972933145389751,0.0299909174301359,0.317422037256687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39104,-0.00700712302920309,0.00701931518151958,-0.0207649807849815,0.00675073472657528,0.318168302255858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39431,-0.00350527925857671,0.0035195680275338,-0.010403632592543,0.00339307407538953,0.319295293200608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39428,0.0046887124231556,0.00471344968423882,-0.00454964895795249,0.0139270738042637,0.319873079915603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39123,0.00674763825756185,0.00678369068687368,-0.00654839548871056,0.0200436720038343,0.319905690057079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37190,-0.00929603625683543,0.00935438591596485,-0.0276306326521265,0.00903856013845569,0.320357470848124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36861,0.00361887908459757,0.00364430615436494,-0.00352396097795772,0.0107617191471529,0.320718208459017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36847,0.00402033524749719,0.00406965073356018,-0.00395618019028076,0.0119968506852751,0.323229659992739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36861,0.00445173666841325,0.00451773399120846,-0.00440302195435533,0.0133064952911818,0.324451016193827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,37162,0.00379452505696982,0.0038665949030258,-0.00378400095296075,0.0113730510669004,0.326433479557868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39601,-0.00286435064570662,0.00292405096615706,-0.00859549053937447,0.00286678924796122,0.327307638191061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39124,-0.00662641319731215,0.00676777065121644,-0.0198912436736964,0.00663841727907206,0.327540221827007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36823,-0.00496929668187726,0.00507578896081256,-0.0149178430450699,0.00497924968131536,0.327589458866554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36808,0.00810531087945622,0.00828509892942075,-0.00813348302220844,0.0243441047811209,0.3279452070995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37164,-0.00181121852439263,0.00185395239832038,-0.00544496522510058,0.00182252817631532,0.328612569698408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36763,-0.00516780656119349,0.00529139356696426,-0.0155389379524434,0.00520332483005646,0.328764732143921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36880,-0.00488676049518601,0.00500574441990618,-0.0146980195582021,0.0049244985678301,0.328969241740241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39428,-0.0103300881746753,0.0105833816598595,-0.031073516228,0.0104133398786494,0.329047095223489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36880,-0.00534450053728352,0.00547675528311566,-0.0160789408921902,0.00538993981762316,0.329156991718591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39462,0.00840528917330275,0.0086168080904968,-0.00848365468407098,0.0252942330306765,0.329351447086524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39355,-0.0032026510989817,0.00328351600536313,-0.00963834246949344,0.00323304027153005,0.329391368568479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39187,-0.0044585143306485,0.00457581871363489,-0.0134271190093729,0.00451009034807588,0.329891691016737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39123,-0.00695473826152621,0.00714222667663642,-0.0209535025477336,0.00704402602468117,0.330197084263992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39601,0.00247779944013811,0.00254916921264306,-0.00251857221664229,0.00747417109691851,0.33106470845461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37164,0.00643395688429444,0.00662240109431239,-0.00654594926055784,0.0194138630291467,0.331295725778889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39383,0.00489257547928903,0.00503956509263735,-0.00498497210228018,0.0147701230608582,0.331647234080069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,39194,-0.00374774342245888,0.00386188509277573,-0.0113170382042993,0.00382155135938155,0.331841120543954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36880,0.00234758425162507,0.00242060206639662,-0.00239679579851232,0.00709196430176245,0.332147690248676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36880,-0.00276177648669903,0.00284908507007994,-0.00834598322405572,0.00282243025065765,0.332386675291601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37162,-0.00440485182059799,0.00454696914677795,-0.0133169113482828,0.0045072077070868,0.332691065977736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39390,0.00651432893368852,0.00672777407807854,-0.00667210825934541,0.0197007661267225,0.3329232064853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36880,-0.00526585938092824,0.00544544597733839,-0.0159389334965115,0.005407214734655,0.333552466203621
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39462,0.00711238829269004,0.00737275250303293,-0.00733820661325451,0.0215629831986346,0.334717843277268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37162,-0.00459769842021109,0.00477594468109814,-0.0139585499951634,0.00476315315474127,0.335727292292749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39187,-0.00489087035580381,0.00508095426806512,-0.0148495407212114,0.00506780000960382,0.335769648719664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36847,-0.00380553811115681,0.00395397201786167,-0.0115553232661657,0.00394424704385205,0.335837590377945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36763,0.00220709498626331,0.00229596651414951,-0.00229299938146974,0.00670718935399635,0.336424086066336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39592,-0.00193613189118432,0.00201955164937833,-0.00589445312396584,0.0020221893415972,0.337728270274658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36955,-0.00357932266505876,0.00373552786776163,-0.0109009572858716,0.00374231195575404,0.337988561099647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36861,-0.00402504401379859,0.00420097174390003,-0.0122589486318426,0.00420886060424546,0.3380198418011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36955,-0.00316058016455609,0.00329970321669028,-0.00962799846926903,0.00330683814015685,0.338163122160399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39578,-0.00336414114746239,0.0035128369261488,-0.010249301522714,0.00352101922778925,0.338244120541484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36880,0.00225340970368975,0.00235412395727188,-0.00236067325256313,0.00686749265994263,0.338475879539193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36847,-0.00460154333798542,0.00480832316129625,-0.0140258567341261,0.00482277005815523,0.3385882215092
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36880,-0.00360438193280238,0.00376826565154451,-0.0109901826098296,0.00378141874422487,0.338833487267545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,39194,-0.00237373632059764,0.00248401439358061,-0.00724240453201563,0.00249493189082035,0.33928755567083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36880,0.00369917337988397,0.00387181264640521,-0.00388957940707024,0.0112879261668382,0.339388347598155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39441,-0.0105806806319267,0.0110790455146433,-0.0322956098406276,0.0111342485767742,0.339584327083891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36823,-0.00531626880546986,0.00557095314775904,-0.0162353369750776,0.00560279936413786,0.33995879110333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36847,-0.00549469870014216,0.00576515651720481,-0.0167944054738636,0.00580500807357928,0.34056431654711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39654,-0.00135305415557278,0.00141976957708302,-0.0041358025266555,0.00142969421550995,0.340600316669207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39187,0.00336942453950254,0.00354419134625917,-0.00357719049916543,0.0103160395781705,0.341777750213707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39541,-0.00232778874332059,0.00245203045044844,-0.00713376842619953,0.00247819093955834,0.342467449519432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37164,-0.00532334096433725,0.00561272590327085,-0.0163242837347481,0.00567760180607362,0.342922880166351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36763,-0.00524948353400363,0.00553519965500902,-0.0160984748578213,0.00559950778981405,0.342953652126789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36763,-0.00605134993745465,0.00638816874448568,-0.0185721606766466,0.00646946080173729,0.343517467438968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36847,0.00382526777002795,0.00404858014906302,-0.00410994932213558,0.0117604848621915,0.344758063242421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,37255,0.0091401840047917,0.00969883418963343,-0.00986953100688981,0.0281498990164732,0.34600552830224
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,39354,-0.00233898727150558,0.00248340866547082,-0.00720646825582838,0.00252849371281722,0.346287014887632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36763,-0.0044379376424661,0.0047123029198779,-0.0136740513654268,0.00479817608049459,0.346325396372308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37164,0.00353979173400701,0.00376274602821565,-0.00383519048129566,0.0109147739493097,0.346852444338281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39123,0.00305893146308901,0.00325824433717708,-0.00332722743777808,0.00944509036395609,0.347834445474579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36880,0.0045494643409822,0.00484646462408491,-0.00494960632222421,0.0140485350041886,0.347893711289692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39393,-0.00326522642528716,0.00348278916871131,-0.0100914931959613,0.003561040345387,0.3485001062487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,39104,-0.00424819798137676,0.00453377083411432,-0.0131343888162408,0.0046379928534873,0.348767794792836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36847,0.00421933914496176,0.00451320017946916,-0.0046265332067978,0.0130652114967213,0.349863953960597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39428,-0.00616705615294943,0.00660635200335265,-0.0191155060795206,0.00678139377362175,0.350574845881255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37164,-0.00410863280048448,0.00441201993667602,-0.0127561918763695,0.00453892627540052,0.351749066810199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39531,0.00278108353345652,0.0029916222497835,-0.00308249607611914,0.00864466314303219,0.352580731507866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39168,0.00309905298524531,0.00333628634419176,-0.00344006824937054,0.00963817421986115,0.352959783827757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39654,-0.00329247247056256,0.00355054612318849,-0.010251542872012,0.00366659793088688,0.353778053141382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36992,-0.00363396824139258,0.003929522332116,-0.0113358320123399,0.00406789552955478,0.355094896899834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39423,-0.00227218491896137,0.00246330191689496,-0.00710025667607549,0.00255588683815275,0.356327377182085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,37050,-0.00869381376658595,0.00943331702206843,-0.0271831151298401,0.00979548759666818,0.35675110114406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36847,-0.00271100853461654,0.00294290974438737,-0.0084791116336158,0.00305709456438271,0.35696393322919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39462,-0.00375263069588969,0.00407372176268739,-0.011737125350757,0.00423186395897758,0.356971303966507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36763,0.0039764893301244,0.0043220844839007,-0.00449479625832097,0.0124477749185698,0.357570038079239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36916,-0.00270174882181749,0.002939046795738,-0.00846228054146397,0.00305878289782899,0.35797726574619
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39330,-0.0070508914093444,0.0076720253001481,-0.0220880609976347,0.00798627817894586,0.358090007952269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39654,0.00454058477763392,0.00494588842574572,-0.00515335653682769,0.0142345260920955,0.358605994173544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36992,-0.00235911366132447,0.0025728251069354,-0.00740185087091787,0.00268362354826892,0.359194280327741
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36823,0.00601897140198516,0.00656672095817768,-0.00685180167604308,0.0188897444800134,0.3593769392726
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37162,0.00306505734241172,0.00334523401435917,-0.00349160132573226,0.0096217160105557,0.359555258373716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37164,-0.00213648091859914,0.00234289817784617,-0.00672856134717763,0.00245559950997935,0.3618404357881
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39428,0.0053255901078418,0.00585606231292403,-0.00615229202548929,0.0168034722411729,0.363145814213034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,39187,0.00465974572782397,0.00512790226583946,-0.00539094271322138,0.0147104341688693,0.363521210202088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36482,0.00383082845842512,0.00421810389730737,-0.00443665518029732,0.0120983120971476,0.363797456729536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36861,-0.00817435767061731,0.00900702465518843,-0.0258281259947866,0.00947941065355201,0.364131741017114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36880,0.00272272341908214,0.00300683285982029,-0.00317066898616563,0.0086161158243299,0.365211727291531
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,39068,0.00349218160374607,0.00386160363203139,-0.00407656151503545,0.0110609247225276,0.365832934091308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36861,-0.00337309793523513,0.00373134093086153,-0.0106865261597237,0.00394033028925346,0.366017819794725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37221,-0.00274120988112673,0.00303260233948876,-0.00868511046652469,0.00320269070427123,0.366058377532177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37186,0.00318259988046838,0.00352285493160993,-0.00372219578548708,0.0100873955464238,0.36632278733527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39477,0.00207113336760091,0.00229971665814168,-0.00243631128235678,0.00657857801755859,0.367813492905786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,39187,-0.00369942194681921,0.00410917979907445,-0.0117534143530051,0.00435457045936671,0.367984737346992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37203,-0.00277343694742827,0.00308308857204275,-0.00881629054863206,0.00326941665377552,0.368369058166929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36916,0.00660693389221892,0.00734584091521789,-0.00779091430160815,0.021004782086046,0.368450884548583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36763,0.00286122106740373,0.00318501936731235,-0.00338141689252848,0.00910385902733595,0.369023426877951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39516,0.00438058379023221,0.00491504742543699,-0.00525290916362428,0.0140140767440887,0.372804087669801
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36880,-0.00265995148441212,0.00299752985833951,-0.00853511000675755,0.00321520703793331,0.374890902167523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36823,0.00491203512207009,0.00555289908195312,-0.00597164707855803,0.0157957173226982,0.376395370502224
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36847,0.00255689177726768,0.00289314304986416,-0.00311366860046608,0.00822745215500144,0.376834027205695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,39321,-0.00360142037001461,0.00408255698927819,-0.0116032320689999,0.00440039132897064,0.377710920747591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36955,0.0021777386199867,0.00248004319985949,-0.0026831460517379,0.00703862329171131,0.379903550725331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36847,-0.00327036348111133,0.00372712751599717,-0.0105755334124658,0.00403480645024312,0.3802599358565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36861,-0.00368982126377537,0.00421849728530599,-0.0119580759429751,0.00457843341542438,0.381766772254038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37255,-0.00188983304786254,0.00216159466446458,-0.00612655859021312,0.00234689249448804,0.381983682317802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36955,0.00530305901096654,0.00607095045370221,-0.00659600387828978,0.0172021219002229,0.382399863115505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37162,-0.00307643843511316,0.00352404197103805,-0.00998356069834774,0.00383068382812142,0.382687335174763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37221,-0.00494531039020822,0.0056676995644708,-0.016054001536571,0.00616338075615454,0.38292874202248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39104,-0.00493423634649909,0.00565550692960845,-0.0160190299285317,0.00615055723553346,0.382968617579677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36880,-0.00265461091175089,0.00304458575552138,-0.0086219989925728,0.00331277716907101,0.383273220045149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,37164,-0.00781425794171689,0.00896357807284785,-0.0253828709644987,0.00975435508106491,0.383345489646646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39477,-0.00224689875058696,0.00258222010339893,-0.00730805015324886,0.00281425265207493,0.384236584680112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36823,0.00410777662899003,0.00472397165419777,-0.0051512078132376,0.0133667610712177,0.384557794812329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36847,-0.00286014763775619,0.00329546365404443,-0.00931925639968328,0.00359896112417089,0.38546343398822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39428,-0.00511733060530501,0.00590100597268054,-0.0166833023117589,0.00644864110114885,0.38584835194763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36823,-0.00372571104162512,0.00430109985307008,-0.0121558667536425,0.00470444467039224,0.386384755270326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37162,-0.00508694092398095,0.00588280216949155,-0.0166172331761844,0.00644335132822248,0.387212146871864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37162,0.00325454949018229,0.00377206401814845,-0.00413869598538868,0.0106477949657533,0.388261873732314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36880,-0.00310786817681013,0.0036127746157097,-0.0101889064236011,0.00397317006998089,0.389671074217467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36992,0.00571331717204202,0.00664619658006978,-0.00731322812489475,0.0187398624689788,0.390005548959208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39389,0.00221457010000393,0.00257905303631743,-0.00284037385117823,0.00726951405118609,0.390533254720872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36847,0.00591407338376483,0.00693623881522036,-0.00768095469406708,0.0195091014615967,0.393878749243352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36928,0.00265718408559954,0.00312049844662661,-0.00345899286978862,0.00877336104098769,0.394493832982029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39123,0.00366766431926045,0.00430909389617202,-0.00477815971723672,0.0121134883557576,0.394702625687058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37162,0.00395944680361292,0.0046527155037764,-0.00515987558378882,0.0130787691910147,0.394787066913295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36847,-0.00250849079791936,0.00295061955810862,-0.00829170513181225,0.00327472353597353,0.395254051505387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,39374,-0.0037460935586879,0.00440871258366076,-0.012387170222663,0.00489498310528719,0.395504209168653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39485,0.00258629470092102,0.00304586948459375,-0.00338360948888272,0.00855619889072476,0.395830600327489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36763,-0.00456800010446295,0.00540686930648998,-0.0151654639451833,0.0060294637362574,0.398210333280587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,39187,-0.00446147505820223,0.00529271914309967,-0.0148352045786776,0.00591225446227312,0.399272472812539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39589,0.00190809354830894,0.00226382639439799,-0.00252900618471112,0.00634519328132901,0.399318870158433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39485,0.00254907541340531,0.00302711322182652,-0.00338406650137466,0.00848221732818528,0.399755847948446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39485,0.00484317364965328,0.00575471740147478,-0.00643607245723728,0.0161224197565438,0.400024937527723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37243,-0.00250865906070607,0.00298174488620211,-0.0083528790376622,0.00333556091625006,0.400173626117586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36861,0.00356129182751698,0.00424599715073188,-0.00476086258791749,0.0118834462429515,0.401630830834813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37221,-0.00266474467944367,0.00317783879301915,-0.00889330871376121,0.00356381935487387,0.401743235212051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37247,-0.0036148182210951,0.00432020791951249,-0.0120824257433396,0.00485278930114938,0.402763798488063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,37164,-0.00507213920052366,0.00606531921878789,-0.0169601648693479,0.00681588646830062,0.403028509805958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36823,-0.007153404909729,0.00856173466339763,-0.0239344048499883,0.00962759503053035,0.403447413296019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,37269,-0.00300509562608444,0.00359977169839314,-0.010060648154935,0.00405045690276612,0.403844913551237
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36861,-0.00502475470977664,0.00602019368661575,-0.0168243343355435,0.00677482491599023,0.403930864515732
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37203,-0.0033133401082404,0.00398002168439591,-0.0111141826096564,0.00448750239317558,0.405146330971551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36880,0.00445211482166607,0.00534966807199598,-0.00603323459944606,0.0149374642427782,0.405299284515436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39411,-0.00259956711198541,0.00312464183923368,-0.00872386511688342,0.0035247308929126,0.405446594043997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39434,-0.0065812360399136,0.00791639993108268,-0.0220973799048357,0.00893490782500845,0.405793682752912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,39194,-0.00352840883207156,0.00424500426108179,-0.0118486171837919,0.00479179951964874,0.405879267384054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37203,-0.00425810679562642,0.0051260868668518,-0.0143052370546559,0.0057890234634031,0.406173402691181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,37255,-0.00219993523446248,0.00265522214682224,-0.00740417064223407,0.00300430017330911,0.407384998210411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36916,-0.00302738007651232,0.00365549179912895,-0.0101921440028051,0.00413738384978042,0.407588317178245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36763,-0.00301403255095154,0.00364735456242183,-0.0101628474932983,0.00413478239139525,0.408615200897628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39654,-0.00502238929448569,0.00609076531033515,-0.0169602893027426,0.0069155107137712,0.4096168603024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36861,0.00477997333963102,0.00579942937498949,-0.00658690823534838,0.0161468549146104,0.409833574462497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,37162,0.00449704291398104,0.00546796484932566,-0.00622016819069726,0.0152142540186593,0.410845081880353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36847,-0.00436429950624169,0.00531410513151876,-0.0147799455640184,0.00605134655153507,0.411509960579629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,37255,-0.0026726000780936,0.0032574922956091,-0.00905728497748743,0.00371208482130023,0.411976554193051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37221,-0.00438831448315127,0.00535119428613935,-0.0148766552839844,0.00610002631768186,0.412195709226758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36880,-0.00413832465312319,0.00505255293630316,-0.0140413284082774,0.005764679102031,0.412770072909054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36992,-0.00375860769986232,0.00459168566236111,-0.0127583115980901,0.00524109619836545,0.413048391849052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,37255,0.00638045775123482,0.00781921048090602,-0.00894519479134099,0.0217061102938106,0.41451663335655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,39355,-0.00304577128347456,0.00373753132802502,-0.0103713326864036,0.00427979011945449,0.415133844435934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39466,-0.00399386413915545,0.00491819365179568,-0.013633523696675,0.00564579541836408,0.41677056820035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36989,0.00175907696797095,0.00217376397180769,-0.00250150041677212,0.00601965435271403,0.418397703370557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36861,-0.0035234502105243,0.00435475173915082,-0.0120587636192599,0.00501186319821131,0.418470423219034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36861,0.0037911776320357,0.00468700072379066,-0.005395343786594,0.0129776990506654,0.418605022392169
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36847,-0.00464327052800306,0.00574467319225425,-0.0159028299848214,0.00661628892881527,0.41894832375662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36955,-0.00482739482291862,0.00597596078874413,-0.0165402779688571,0.00688548832301987,0.4192197734513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36861,-0.00470519068194034,0.00584753049391549,-0.0161663504500147,0.00675596908613401,0.421039537076697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36861,0.00205973145101232,0.00256084919996273,-0.00295953298091463,0.00707899588293926,0.421230028376171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36823,0.00420885330833261,0.00523616009295809,-0.00605402047386526,0.0144717270905305,0.421524864825413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36763,-0.00210311381201901,0.00261786139407229,-0.0072341221444007,0.00302789452036268,0.421775867070454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,39123,-0.00283137359666503,0.00353280850258257,-0.00975567826172688,0.00409293106839681,0.422883467273481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39531,-0.00178275442122873,0.00223444123351404,-0.00616225923891624,0.00259675039645879,0.424968681627999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39104,-0.00469591828081105,0.00588739219508238,-0.0162352069831725,0.00684337042155041,0.425102338506211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39455,0.00198561446313935,0.00248965320492116,-0.00289410581850613,0.00686533474478484,0.4251462689283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39123,0.00409639392765579,0.00513770414631935,-0.00597350619913015,0.0141662940544417,0.425278150043765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39568,-0.00156141256311578,0.00196381723186846,-0.00541049433757796,0.00228766921134641,0.42657330315933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36880,0.00327738901495605,0.00413690825115972,-0.004830951157317,0.0113857291872291,0.428240827949469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39485,0.00813446876727898,0.0102688274743966,-0.0119924330825384,0.0282613706170964,0.428284748509869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36847,-0.00357064013693077,0.00451402388683641,-0.0124181269551301,0.0052768466812686,0.428953019197432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36847,-0.0035076673052489,0.00443503868507209,-0.0122003431279902,0.0051850085174924,0.42901811127056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39496,-0.00194694449508737,0.00246310245393449,-0.00677462530479896,0.00288073631462422,0.429280988629083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37030,0.00305223519047707,0.00386159685053338,-0.00451649463656835,0.0106209650175225,0.429304713489024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39194,-0.00453251200103211,0.00574320586987463,-0.0157891955059864,0.00672417150392218,0.430010466772026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36880,-0.00305080171211747,0.00386886530458081,-0.0106337777090959,0.00453217428486093,0.430388899836305
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36976,-0.006870688203041,0.0087230387829849,-0.0239678442176914,0.0102264678116094,0.430917257434003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39455,-0.00132460480023342,0.00168623670698108,-0.00462962874591634,0.0019804191454495,0.432149982486731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39187,0.00455210159188632,0.00581719509767082,-0.00684960079954849,0.0159538039833211,0.433918573262493
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39104,-0.00576092640734797,0.00736563577710008,-0.0201975725304641,0.00867571971576818,0.434147490112838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36847,-0.00474462906913959,0.00608008570249554,-0.0166615970460308,0.00717233890775166,0.435196482147413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36916,-0.00520502446764776,0.00667445412761406,-0.0182869545577713,0.00787690562247581,0.435498264710224
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37243,0.00265087423851026,0.00341047780326939,-0.00403366225589774,0.00933541073291827,0.437011762889144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37247,-0.00318088821464286,0.00410240941676639,-0.011221610671505,0.00485983424221926,0.438134951068544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39589,0.00313961232295169,0.00406085619288961,-0.00481966581511194,0.0110988904610153,0.439451316718696
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39428,0.00648710593408265,0.00842672506026495,-0.0100292751840366,0.0230034870522019,0.441415687092714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39378,-0.00296374898679701,0.00385870481968343,-0.0105268104333765,0.0045993124597825,0.442458738712323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36992,-0.00205079446144626,0.00267869073654044,-0.00730102830506552,0.003199439382173,0.443931234764448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36992,-0.0019246393331507,0.00251742535322878,-0.0068587930254791,0.0030095143591777,0.444567714629311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37203,-0.00263360539455076,0.00344738721002053,-0.00939048432619101,0.00412327353708948,0.444915680640144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36763,-0.00568340470410941,0.00744422350329937,-0.0202740827705762,0.00890727336235736,0.445200709406511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36916,-0.00458780767938679,0.00601735597488117,-0.0163818253901539,0.00720621003138029,0.445818334079508
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36715,-0.00230683020625375,0.00303654591694845,-0.00825846020347271,0.0036447997909652,0.447455172946455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36916,0.00413713504173861,0.00544919384280475,-0.0065432848901587,0.0148175549736359,0.447735531136592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39499,0.00159260918196581,0.0020978447776847,-0.00251916658229621,0.00570438494622783,0.447766079753484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39355,0.00236222780022047,0.00311576333246581,-0.00374466833141253,0.00846912393185347,0.448370905799442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,39104,0.00400416584474956,0.00528544580830793,-0.00635530793953399,0.0143636396290331,0.4487126224894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36847,-0.00314614368599799,0.00415429721497894,-0.0112885662273567,0.00499627885536074,0.448870935632427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37102,0.00214978061397911,0.00284134603024758,-0.00341925760530614,0.00771881883326436,0.449299791502731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37145,0.00271596275917437,0.00358981289134174,-0.00432007050785544,0.00975199602620418,0.449318553857233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,37221,0.00247964683672044,0.00328021697702321,-0.00394957843824505,0.00890887211168592,0.449699185359842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39509,0.00254014272479122,0.00336591953477177,-0.00405705956336145,0.00913734501294389,0.450461626035473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36992,-0.00298903244538651,0.00397589775534466,-0.010781792045862,0.00480372715508903,0.452192635140611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39118,0.00318892759152928,0.0042467698544069,-0.00513474132310824,0.0115125965061668,0.452720904549994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36880,0.00169495499306333,0.0022648609761775,-0.00274417252024457,0.00613408250637122,0.454250912250106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,37255,-0.00179806361666299,0.00240422305808474,-0.00651034081050908,0.0029142135771831,0.454547965594021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36955,0.00508884985211802,0.00681466152241012,-0.00826788673180583,0.0184455864360419,0.455228403034606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,37167,-0.00619529816408332,0.00830120434237173,-0.0224656586751319,0.0100750623469653,0.45549205283338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39531,0.00240618638520445,0.00322497301199662,-0.00391476071830892,0.00872713348871783,0.455612268420946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36847,-0.00646961029492734,0.00867371211184758,-0.0234700860341486,0.0105308654442939,0.455749740898618
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36847,-0.00339097856317892,0.00455184240601216,-0.0123125896789628,0.00553063255260492,0.45630497325488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,37164,0.00225538900983193,0.00304493426599267,-0.0037126821515137,0.00822346017117757,0.458887805688243
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39532,0.00428537647239694,0.00579990372888934,-0.00708243483622617,0.0156531877810201,0.459997272374919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36861,0.00314721921451549,0.00425956418456622,-0.0052015265872343,0.0114959650162653,0.460006327372799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39194,-0.00435131788816411,0.0058976667148768,-0.0159107446493226,0.00720810887299441,0.460645739129167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,37269,-0.00143982293528552,0.00195196816447275,-0.00526568053765211,0.00238603466708107,0.460755109789327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37164,-0.00538137600532137,0.00731026555779028,-0.0197094964985903,0.00894674448794759,0.461659325225792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36880,-0.00553779100510889,0.00755301331947008,-0.0203416971112703,0.00926611510105247,0.46345661118865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36763,-0.002678922459561,0.00365385354870313,-0.00984047541501915,0.00448263049589714,0.463464261991646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,37162,0.00310737014486739,0.00424803769842707,-0.00521878374404968,0.0114335240337844,0.464497269859037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36880,-0.00278438843229365,0.00383810961698154,-0.0103070832815775,0.00473830641699017,0.468184585128034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36880,-0.00262854198681731,0.00363225437547521,-0.00974776056274873,0.0044906765891141,0.469283926034078
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36763,-0.00399447683963187,0.0055251114128732,-0.0148236952088633,0.00683474152959961,0.469713490891505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37162,-0.00274253609876826,0.00379784617748514,-0.0101863146066391,0.00470124240910261,0.470228255168198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39123,-0.00278268400302464,0.00385619055343208,-0.0103408174877515,0.00477544948170223,0.470542864711044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39654,-0.00143138684030293,0.00198504448487355,-0.00532207403065508,0.00245930035004922,0.470867986454074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36916,-0.0046347992936144,0.00642835372384521,-0.017234372592351,0.00796477400512222,0.47092722390804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39187,0.00501544157796006,0.00696342740316073,-0.00863287613223497,0.0186637592881551,0.471379592187438
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37162,0.0020674706431151,0.00288176833842187,-0.00358079530019177,0.00771573658642197,0.4731212317041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,37164,-0.00360284022492159,0.00502841496252796,-0.0134585335514764,0.00625285310163322,0.473698174157219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36992,-0.00456684825922633,0.00638662165187455,-0.0170846266969004,0.00795093017844778,0.474582322621581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36916,0.00303490269802811,0.00424701613705066,-0.00528924893059119,0.0113590543266474,0.474871815687068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36847,-0.00255704860384862,0.00358263897998609,-0.00957902100462135,0.00446492379692411,0.475405573371772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36880,-0.00311844506444452,0.00437620712566248,-0.011695811030743,0.00545892090185394,0.476112366165323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39485,0.00195877356493607,0.00275067365657012,-0.00343254680194137,0.00735009393181351,0.476409661085111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37162,0.00179058036059745,0.00251622792613247,-0.0031412263746222,0.0067223870958171,0.476717549932683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36992,-0.00211037069045387,0.00297487878351164,-0.00794113310613669,0.00372039172522896,0.478091211678841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36861,-0.00229335115083246,0.00324702906703167,-0.00865752812221454,0.00407082582054962,0.480019732616385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,39342,0.00781248216055962,0.0110830938892418,-0.0139103818623544,0.0295353461834736,0.480882974689777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37255,-0.00179791634487525,0.00255545447922368,-0.00680660712415366,0.00321077443440315,0.481719430349176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,39055,-0.00693422576995405,0.00986625571225349,-0.0262720869659709,0.0124036354260628,0.482177623467254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37247,-0.00180189833693953,0.00256745478523667,-0.0068341097160034,0.00323031304212435,0.482802436012059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,37164,0.00275290386257308,0.00393527185313669,-0.00496022896957483,0.010466036694721,0.484223647767317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37162,-0.00227339433293251,0.00325014761184004,-0.00864368365213898,0.00409689498627396,0.484268544689143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,37203,0.00140131990526492,0.00200407833950316,-0.00252667364016128,0.00532931345069111,0.484418500246537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,39187,-0.00329835279999547,0.00472103510859184,-0.0125515816128355,0.00595487601284453,0.484781599858277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39355,-0.00209875761988436,0.00300716516788577,-0.00799280134894047,0.00379528610917174,0.48523875810163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36847,0.00218109827654877,0.00313511300835333,-0.00396372321982374,0.00832591977292129,0.486629737424124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39428,0.00322643558764833,0.00464122870145106,-0.00587037266719574,0.0123232438424924,0.486960551151926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36880,0.00375326694512565,0.00541090542667639,-0.00685210769116007,0.0143586415814114,0.487915574604145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39104,0.00405263968716571,0.00584874986776389,-0.00741091005365152,0.0155161894279829,0.488378902779754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39455,-0.00262722188511062,0.00379791742338212,-0.0100711400349396,0.00481669626471834,0.48910297726495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36861,-0.00140931775116501,0.00204368548183628,-0.00541494129556412,0.00259630579323409,0.490461049967016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36861,-0.00304706294300659,0.00443019934617128,-0.0117302536615023,0.00563612777548912,0.491595596107232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,37203,0.00559857802203875,0.00815859456007765,-0.0103922673157134,0.0215894233597909,0.492587849286101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36847,-0.00577506088743787,0.00842832190626528,-0.0222945718237178,0.0107444500488421,0.493232429830476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36992,-0.00441424778173648,0.00646605588006099,-0.017087717306656,0.00825922174318306,0.494821607353583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36823,-0.0045390236167481,0.00666780459600745,-0.0176079206249227,0.00852987339142649,0.496050440242818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36992,-0.00234439764108682,0.00344877261331236,-0.00910399196317904,0.0044151966810054,0.496657973972707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36880,0.00285130952976883,0.00420302211038802,-0.00538661380659168,0.0110892328661293,0.497533857423488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39541,-0.00120393567131734,0.00177483606246909,-0.00468261435375676,0.00227474301112208,0.497568910365277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36823,-0.00200347503353567,0.00295762233030617,-0.00780041480093577,0.00379346473386443,0.498168797412812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37164,-0.00613405873846485,0.00906621591311564,-0.0239038419281715,0.0116357244512418,0.498682096006769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39412,0.00204016727914225,0.00301682088935622,-0.00387280166399595,0.00795313622228045,0.498883517072698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37201,0.00129619281369346,0.00192169357398671,-0.00247032659132048,0.00506271221870741,0.500002244188793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37221,-0.00454969953542604,0.00677449725261048,-0.0178277141505426,0.0087283150796905,0.501855492760229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37255,-0.00128532134179151,0.00191747432745733,-0.00504357102360787,0.00247292834002485,0.502665927108309
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38979,0.00503247045485709,0.00751337115478065,-0.00969373700851298,0.0197586779182272,0.502994712895345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,39068,-0.00198382220559873,0.00296648661654637,-0.00779813597402962,0.00383049156283215,0.503668908935081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36880,0.00324190213221102,0.00485297313035674,-0.00626992520328819,0.0127537294677102,0.504130729346852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,39319,0.00373050348783576,0.00558527596386121,-0.0072166374013322,0.0146776443770037,0.504196632293359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39123,-0.00174581121888701,0.00261568764635035,-0.00687255900573369,0.00338093656795968,0.504502437139595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39428,-0.00187101788126364,0.00280371796037561,-0.00736630508359983,0.00362426932107256,0.504568740287625
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39526,-0.00246274235765259,0.00369088747681522,-0.00969688181221041,0.00477139709690524,0.50462307202629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36992,-0.00430161941796628,0.0064621032191924,-0.0169673417275834,0.00836410289165082,0.505635170457533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36880,-0.00210301216857959,0.00318119829634041,-0.00833816082940678,0.0041321364922476,0.50857616792618
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36847,-0.00274066055748851,0.00414862928956673,-0.0108719739650393,0.00539065285006228,0.508869387187395
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39355,0.00665689060210339,0.0100999818507541,-0.0131390738253746,0.0264528550295814,0.509842211845753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36861,-0.00257323661682097,0.00390577991376501,-0.0102285652478004,0.00508209201415844,0.510018539893434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",37269,-0.000928899146774678,0.00141103220164445,-0.0036945222619978,0.00183672396844844,0.510349622170942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36880,-0.00445770138274576,0.00677314664991947,-0.0177330688165879,0.0088176660510964,0.510458217314292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39531,0.00469951130492446,0.00714927426258192,-0.00931306624973609,0.018712088859585,0.510971693274998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,39319,0.00195242146102162,0.00297287942706216,-0.0038744222160202,0.00777926513806345,0.511355543913117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36861,-0.00198942860272397,0.00303209730385503,-0.00793233931827983,0.00395348211283189,0.511757189801988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37164,0.00288313154233169,0.00440791825807213,-0.00575638824348968,0.0115226513281531,0.513072044355688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39531,-0.00327575939288115,0.00501328530000327,-0.0131017985808876,0.00655027979512526,0.513498274070321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39187,-0.0019255888124977,0.00294931406313966,-0.00770624437625143,0.00385506675125604,0.513834944030652
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37221,-0.00151662910317208,0.00233363320412332,-0.00609055018325379,0.00305729197690963,0.515768264754406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,39194,-0.00217520598665636,0.00334946197763294,-0.00874015146281692,0.00438973948950421,0.516077368697565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39481,0.0035202721293076,0.00542180483873994,-0.00710646535462268,0.0141470096132379,0.516167012813119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36825,0.00230284374184907,0.00356465441950204,-0.00468387892037494,0.00928956640407308,0.518277349730842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36992,0.00433993336234989,0.00673022506882715,-0.00885130777255131,0.0175311744972511,0.519041226346133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37162,-0.00237297636722392,0.00368280435734429,-0.00959127290761872,0.00484532017317089,0.519366926072387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37247,0.0030876178422274,0.00480569941030638,-0.0063315530019731,0.0125067886864279,0.520566047884382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36763,0.00460563752865769,0.00716948251789002,-0.00944654820640674,0.0186578232637221,0.5206289061878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37127,-0.00239418273023148,0.00374255702810272,-0.00972959450531281,0.00494122904484986,0.522367229306868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,37269,0.0011998682375279,0.00188074769244847,-0.00248639723967111,0.00488613371472691,0.523501964719759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39601,-0.00337977199173674,0.00530146861177542,-0.0137706504708166,0.00701110648734308,0.52379831222874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36763,0.00197263382912259,0.00310703815818748,-0.00411716096092487,0.00806242861917006,0.525510620435736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36847,-0.00210536471922371,0.00333203530776118,-0.00863615392243563,0.00442542448398821,0.527492979671769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36955,0.00341187852973755,0.00541381661296925,-0.00719920203168219,0.0140229590911573,0.528564224407366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,39130,-0.00490423510471911,0.00778358068220302,-0.020160053241837,0.0103515830323988,0.52865570132223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36763,0.0027689388164737,0.00440115081917319,-0.00585731678910575,0.0113951944220532,0.529269258915362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39104,0.00191822635617849,0.00304908568878315,-0.00405798159383649,0.00789443430619347,0.529283404468207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,39123,0.00585578965174948,0.00932142632600937,-0.0124142059472289,0.0241257852507278,0.529877816031999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36861,-0.00168344116278858,0.00270304550000341,-0.00698141034279527,0.0036145280172181,0.533431189921087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,37203,-0.00197444932011796,0.00317219944622185,-0.0081919602347128,0.00424306159447687,0.533675009969334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36847,-0.00327205554382949,0.00527228946545247,-0.0136057428961163,0.00706163180845736,0.53486517531498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37269,-0.00158565145581827,0.00255937516833463,-0.00660202678575414,0.00343072387411761,0.535567532977411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39462,-0.0029916927167563,0.00484484980578375,-0.0124875983360925,0.00650421290257986,0.536914626137659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36880,-0.00151129041910729,0.00244756822347161,-0.00630852413711165,0.00328594329889707,0.536938643899396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37184,-0.00442746043402757,0.00719785640585271,-0.0185352589894989,0.00968033812144374,0.538494266344284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36847,0.00169107318676051,0.00275201602400804,-0.00370287822029525,0.00708502459381626,0.538906012224618
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36955,0.00198903679305671,0.00323861370765922,-0.00435864607395536,0.00833671966006877,0.539118778381367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36992,0.00288760463972469,0.00470408786195219,-0.00633240756970161,0.012107616849151,0.539325545273464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37221,0.00198525077469865,0.00323776450045651,-0.00436076764619612,0.00833126919559342,0.539784923556665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,37221,0.00252985795100128,0.00412699238457143,-0.00555904712275873,0.0106187630247613,0.539885395749292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,37247,-0.00394718730238966,0.00644855731159861,-0.0165863596331229,0.00869198502834362,0.540479871305685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39578,0.00338095569525224,0.00552988776321489,-0.00745762432064895,0.0142195357111534,0.540946107286706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37164,-0.00138042708380032,0.00225966225799798,-0.00580936510947637,0.00304851094187573,0.541276880159441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36763,0.00242499618961068,0.00397340264314372,-0.00536287299095101,0.0102128653701724,0.541669602533512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36916,0.00224639358615571,0.00368331803608783,-0.00497290976457644,0.00946569693688786,0.541950337015617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36823,-0.00265968351981291,0.00436889752491492,-0.0112227226686462,0.00590335562902034,0.542683561459423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37117,-0.00152060671580386,0.00250496347684052,-0.00643033513041128,0.00338912169880356,0.543836921415274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36861,-0.00321821036950239,0.00530303909609167,-0.0136121669978421,0.00717574625883727,0.543953919213573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39194,0.00336573652664422,0.00555268304723726,-0.00751752224594081,0.0142489952992293,0.544427151105553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36847,-0.00314421634543215,0.0052016128841375,-0.0133393775983416,0.00705094490747735,0.545542604360221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37085,0.00140061435060806,0.00231982497656442,-0.00314624260345821,0.00594747130467433,0.546014968251955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36992,0.0029013077126233,0.00480948785620691,-0.00652528848554223,0.0123279039107888,0.546355490275024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39123,-0.00173661554191638,0.00289077174657085,-0.00740252816519525,0.00392929708136249,0.548019382770357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36992,-0.0019582390873225,0.00326470738613835,-0.00835706556415366,0.00444058738950866,0.548636570483163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36823,0.00285089305802092,0.00476246477824604,-0.00648353790734131,0.0121853240233832,0.549439181862286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36847,-0.00289062320444015,0.00484952440157975,-0.0123956910315365,0.00661444462265617,0.551143867815477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,39104,0.00169838824868009,0.00285237996952362,-0.0038922764915862,0.00728905298894638,0.551566294136776
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36823,0.00449494323483158,0.00757404264624988,-0.0103501803518182,0.0193400668214814,0.552879611466545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36861,-0.0015350779767356,0.00259038369193042,-0.00661223001291922,0.00354207405944802,0.553455387582919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36861,0.00217856282330343,0.00368483186724443,-0.00504370763649564,0.00940083328310251,0.554380788038126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39123,-0.00289297384902914,0.00489469583816573,-0.012486577691834,0.0067006299937757,0.554500970402868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36823,-0.00175318385619918,0.0029721455240062,-0.00757858908325133,0.00407222137085297,0.555287594303627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39428,0.00956028518082736,0.0162326664864722,-0.0222557411326581,0.0413763114943128,0.555901373502325
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36861,0.00265303847419757,0.00451763216826158,-0.00620152057559513,0.0115075975239903,0.557037733589275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36880,0.00224852138081423,0.0038318032846539,-0.00526181305710742,0.00975885581873587,0.557345327521913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37224,0.00533970445169113,0.00912761753912692,-0.0125504259249976,0.0232298348283799,0.558554501155051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36880,0.00238943837926743,0.00408790203450545,-0.00562284960836325,0.0104017263668981,0.558884762641972
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36916,-0.00133907309000947,0.0022984456715917,-0.0058440266063292,0.00316588042631027,0.560173542330094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39428,-0.00221724382368929,0.00380765309617645,-0.00968024389219514,0.00524575624481655,0.560365003558517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37162,-0.00254400291301341,0.00437568387791641,-0.0111203433137296,0.00603233748770276,0.560984240192845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36992,0.00461574201197222,0.0079482224562398,-0.0109627740022578,0.0201942580262022,0.561435352836365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39428,0.00162664089622757,0.00280267207364611,-0.0038665963681188,0.00711987816057395,0.561660848382636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39187,-0.00136274876092427,0.00235117870806275,-0.00597105902872727,0.00324556150687872,0.562191652948393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36992,-0.00330597235900614,0.00573539614775193,-0.0145473488085999,0.00793540409058764,0.564344583557153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37162,0.00359655502778497,0.00624229852659409,-0.00863835008433944,0.0158314601399094,0.564518073815159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37247,0.0015259714503812,0.00265643713605813,-0.00368064533629274,0.00673258823705514,0.565678228881216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36763,0.00125991499502288,0.00219612723862738,-0.00304449439268679,0.00556432438273255,0.566182295091146
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39428,0.00313340073089922,0.0054645216576573,-0.0075770617181091,0.0138438631799075,0.566377048205196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39123,-0.00364911036119126,0.00639535244134711,-0.0161840011462316,0.00888578042384908,0.568287799157369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39499,0.00162461790264437,0.00285609665408514,-0.0039733315393625,0.00722256734465123,0.569483699948872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,39123,0.0020499217406373,0.00360637952658226,-0.00501858213146393,0.00911842561273853,0.569761620850788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,37255,-0.00218746633235594,0.00385698958158608,-0.00974716591226466,0.00537223324755278,0.570626675976731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37203,0.00229163952219338,0.00404108545526889,-0.00562888797013364,0.0102121670145204,0.570666319067293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39455,-0.00225279575110887,0.00397283214863274,-0.0100395467624291,0.0055339552602113,0.570688476240812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36847,-0.00200967439703518,0.003547012310025,-0.00896181852468418,0.00494246973061383,0.57100826110217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37162,0.00556025288538719,0.00983995285277222,-0.0137260547060464,0.0248465604768207,0.572036767086349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36763,-0.0027765083713049,0.00491541671593161,-0.0124107251345309,0.00685770839192106,0.572181210248631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,37091,0.00217201834546024,0.00384661289218836,-0.00536734292322896,0.00971137961414943,0.572316851561759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37255,0.0018834149415514,0.00334598168274172,-0.00467470915662237,0.00844153903972517,0.573520600524226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39123,-0.00174256850873425,0.00312105652656355,-0.00785983930079881,0.00437470228333032,0.576629985494184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36880,-0.00301469621389932,0.00539999761117332,-0.013598691531799,0.00756929910400039,0.576665084153709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39654,-0.00141891339363373,0.00254319335309045,-0.00640357236569102,0.00356574557842356,0.576903213160062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39601,0.00164788703535215,0.00296153587585027,-0.00415672328131437,0.00745249735201868,0.577925239917982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39428,0.00267155126370585,0.00481935452179669,-0.00677438359901567,0.0121174861264274,0.579355837973592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37203,-0.0019307148834828,0.00348296523442774,-0.00875732674296117,0.00489589697599557,0.579362201156142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36880,0.00150848584069713,0.00272397277309323,-0.0038305007945656,0.00684747247595987,0.57973832534487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36992,-0.00327217664595987,0.00591046885142236,-0.0148566955947477,0.00831234230282796,0.579846156337142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39082,-0.0027755495646691,0.00501460751153104,-0.0126041802872699,0.00705308115793173,0.579934411428058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36861,-0.00376314731387987,0.00680523062578798,-0.0171013993404243,0.00957510471266457,0.580287984086151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36955,0.00216624765489661,0.00392063367267993,-0.00551819434355605,0.00985068965334927,0.580598669217232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39589,0.00130827984809062,0.00236828637236059,-0.00333356144173614,0.00595012113791737,0.580671364473891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39309,-0.0019502380459163,0.00354140165941417,-0.00889138529836807,0.00499090920653547,0.581849918533768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36763,0.00344494645131763,0.00626455916611041,-0.00883358951425876,0.015723482416894,0.58239078305106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36880,-0.00172548078284224,0.00314046391822591,-0.00788079006256503,0.00442982849688054,0.582716834592339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39068,0.00313765940728084,0.00572324043613172,-0.00807989184753734,0.014355210662099,0.583541482127139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37221,0.00287551746185115,0.00526300235753679,-0.00743996715892095,0.0131910020826232,0.584824978319854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36847,0.00310557002267951,0.00568420035485934,-0.0080354626728448,0.0142466027182038,0.58483434100399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39513,-0.00186790458828922,0.00342397965092426,-0.00857890470410077,0.00484309552752233,0.585392921561143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37164,-0.00483918284115869,0.00887088643978909,-0.0222261202631453,0.0125477545808279,0.585410393636405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36847,0.00164445589016944,0.00302917829459967,-0.00429273356724591,0.0075816453475848,0.587227739756748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39531,0.00112106775231105,0.00206850119824104,-0.00293319459624138,0.00517533010086348,0.587846462381755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39355,-0.00209821558160989,0.00388268850666652,-0.00970828505467627,0.0055118538914565,0.588927381163693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39104,-0.00276857422705122,0.0051296669064667,-0.012822721363726,0.00728557290962351,0.589399637306566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,37203,-0.00180087323539987,0.00334007560672042,-0.00834742142457189,0.00474567495377215,0.589778007431842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36823,0.00343490602297532,0.00637536102933937,-0.00906080159452985,0.0159306136404805,0.590049549816464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36880,0.00406399645738352,0.00756449410008631,-0.0107624119787856,0.0188904048935527,0.59110711251749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39462,-0.00435688800796673,0.00813285438280029,-0.0202972825982553,0.0115835065823218,0.592163819257277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37164,0.00132466451085463,0.00249553567054305,-0.00356658540340976,0.00621591442511901,0.59555716187802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36847,0.0022044920389134,0.0041540090016232,-0.00593736560426807,0.0103463496820949,0.595642957412835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39455,0.00137027344135923,0.00259204267032905,-0.00371013019248571,0.00645067707520418,0.597058742648918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39601,-0.000933978576707436,0.00176845730986458,-0.00440015490404201,0.00253219775062714,0.597415583175929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,37076,-0.00139137386608138,0.00263757987372881,-0.00656103041858984,0.00377828268642708,0.597842399385999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36847,-0.00215308755905051,0.00409003679947523,-0.010169559686022,0.00586338456792094,0.598604077828679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,39194,-0.00147964978603207,0.00281110443845785,-0.00698941448540946,0.00403011491334531,0.598646798267514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37243,0.00213313383154189,0.00406793918569307,-0.00584002697241653,0.0101062946355003,0.600025422607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36763,-0.00169341577107788,0.00325049623143084,-0.00806438838468233,0.00467755684252657,0.602396022448907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,39319,0.00247014851637772,0.00474927812936986,-0.0068384366171872,0.0117787336499426,0.602994437797613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,37164,0.0116398962534341,0.0224571536897238,-0.0323761249784245,0.0556559174852927,0.604247013236388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39104,-0.0027467749862367,0.00530057742900639,-0.0131359067470892,0.00764235677461582,0.604324484924813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39566,-0.00216964730776471,0.00420572979670484,-0.0104128777093062,0.00607358309377677,0.60594653036708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39545,-0.000940983872645193,0.00182405988437073,-0.00451614124601183,0.00263417350072144,0.605950429063225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36763,0.00205168716249166,0.00400650956016136,-0.00580107157542461,0.00990444590040793,0.608598312433284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39123,-0.00393897476007657,0.00772704482110819,-0.0190839826094486,0.0112060330892955,0.610223980207388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39636,0.00132375661245937,0.0025979465003194,-0.00376821852816666,0.00641573175308539,0.610381455737035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36880,-0.0023358033054067,0.00458502570356042,-0.0113224536843851,0.00665084707357173,0.610451696106993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36742,-0.00216328225746239,0.00424887141759385,-0.0104910702359463,0.00616450572102155,0.610661279462254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39571,-0.00131878058138709,0.00259299242854683,-0.00640104574133887,0.00376348457856468,0.61104420511607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39549,0.00210102793359373,0.00414148474475495,-0.00601628216612597,0.0102183380333134,0.611942817983064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36992,0.00231078103506961,0.00455508766893629,-0.00661719079604552,0.0112387528661847,0.611955560439834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,37200,-0.001022158647327,0.00201909363605457,-0.00497958217399395,0.00293526487933995,0.612692522437808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,39194,-0.00222710701014293,0.00440500607417852,-0.0108609189155328,0.00640670489524697,0.613155251843729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38999,-0.00290504885242162,0.00575982247297232,-0.0141943008994474,0.00838420319460413,0.614013036511748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,37019,-0.00122126728180304,0.00243351026189592,-0.00599094739511904,0.00354841283151297,0.615778894583106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36992,0.0073209956759872,0.0148178199716041,-0.0217219314683568,0.0363639228203312,0.621267525311279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39455,0.00134804275316915,0.00273896847555531,-0.00402033545891926,0.00671642096525756,0.622605174720759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,37221,-0.00349540153228871,0.00710893907316366,-0.0174289221156895,0.0104381190511121,0.622946236442452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37164,0.00459447856682494,0.00938893124401067,-0.013807826671436,0.0229967838050859,0.624601989836088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36992,-0.00181245018968509,0.00370952410163292,-0.00908311742888562,0.00545821704951544,0.625137902164004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36763,0.00259525503631256,0.00531540580022964,-0.00782294033213753,0.0130134504047627,0.625380382037382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36847,0.00171400125639887,0.00352557575512001,-0.00519612722363635,0.0086241297364341,0.626860846374053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36847,-0.00155398654890206,0.00320728478228252,-0.0078402647221758,0.00473229162437169,0.628027000172758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36880,0.0017842452370909,0.00369033311942032,-0.00544880767697292,0.00901729815115473,0.628755207370535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36823,-0.00295898806634025,0.00616559332594948,-0.0150435509852012,0.00912557485252074,0.631293165825545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36847,0.0024100514497608,0.0050439560934041,-0.00747610249331123,0.0122962053928328,0.63279403980163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39566,0.00127222863094305,0.0026648991760937,-0.00395097375420062,0.00649543101608671,0.633082677546081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36880,-0.00432309954967663,0.0090571601423538,-0.0220751334286901,0.0134289343293368,0.633147706009834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36763,-0.00377189357101025,0.00790893412351834,-0.0192734044531062,0.0117296173110857,0.633430732420463
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39392,0.00254569577994524,0.00534678967337893,-0.00793401197987746,0.0130254035397679,0.633998212313486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39187,-0.00133163898730205,0.00280082956611995,-0.00682126493689715,0.00415798696229306,0.634477236946802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39187,-0.00378305866712438,0.00799709327935021,-0.0194573614946508,0.011891244160402,0.63618150918105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36847,-0.00199305354576793,0.0042181918694975,-0.010260709609983,0.00627460251844716,0.636585384855458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39330,0.00137568321524499,0.00291485485800437,-0.00433743230644357,0.00708879873693356,0.636965122543485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,39136,0.00195357933847494,0.00415606184790175,-0.00619230188341249,0.0100994605603624,0.638322414078477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39104,-0.00262289953259826,0.00558318530188336,-0.0135659427242896,0.00832014365909313,0.638515261983165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39123,-0.00214563040138159,0.00457166481858895,-0.0111060934458159,0.00681483264305276,0.638839037374761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36880,-0.00119604041265102,0.00255153318135268,-0.00619704544810228,0.00380496462280023,0.6392539777752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36992,0.00179253749650151,0.0038303954969924,-0.00571503767760359,0.00930011267060662,0.639809076670865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36847,0.00299542826084122,0.00643497029815121,-0.00961711352353515,0.0156079700452176,0.641587224234561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36880,0.00151203155652063,0.00324842679641772,-0.0048548849644581,0.00787894807749935,0.641606083551694
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,37269,-0.00266498303056913,0.00572800454208992,-0.0138918719330654,0.00856190587192712,0.641756725977411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36861,-0.00125718885599443,0.0027118284515935,-0.0065723726211177,0.00405799490912883,0.642946400141466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36823,-0.00252778226784749,0.00548479627664805,-0.0132779829700777,0.00822241843438268,0.644899427612617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39104,0.00152348322013429,0.00330816382958129,-0.00496051788584504,0.00800748432611362,0.645148202286183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37247,0.0010014839506436,0.00217815957062276,-0.00326770880777702,0.00527067670906421,0.645678741320946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,37224,-0.00222855558441293,0.00485723578132603,-0.0117487377158119,0.00729162654698609,0.646377350597905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39457,0.000868847089188277,0.00190022722532707,-0.00285559827245278,0.00459329245082933,0.647510013961578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36736,0.00281221446614616,0.0061544708248567,-0.00925054835057297,0.0148749772828653,0.647723353746063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36880,-0.00213090516954054,0.00469447966795556,-0.0113320853187334,0.00707027497965236,0.649896333820541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39462,-0.00206996481369125,0.00456792358829961,-0.0110230950467585,0.00688316541937599,0.650445669748677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38907,-0.00120604468777973,0.00267003870125241,-0.00643932054223445,0.00402723116667498,0.651495077677828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39104,-0.00257810346949545,0.00571995489881353,-0.01378921507117,0.00863300813217907,0.65219735519596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37162,0.00181496820933432,0.00402737988863998,-0.00607869637240003,0.00970863279106867,0.652244238039491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37162,-0.00240394337553391,0.0053369647078362,-0.0128643942028929,0.00805650745182505,0.652406160312165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39526,-0.00107027841718326,0.00239790376417041,-0.00577016979495726,0.00362961296059073,0.655358664875198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36823,-0.00251613820048561,0.00564656914236428,-0.0135834137195196,0.00855113731854837,0.655890554785578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39589,0.0025227045938701,0.00566715335762781,-0.00858491598708042,0.0136303251748206,0.656221385238561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39123,-0.00125245349670727,0.00281584629936074,-0.00677151224345432,0.00426660525003979,0.656479823170231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36992,-0.0026106637518344,0.00589573376184118,-0.0141663019250431,0.00894497442137431,0.657914011655786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,39194,0.00169262620536988,0.0038252297288153,-0.0058048240631081,0.00919007647384787,0.658141099561347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37221,0.00111164409041665,0.00253732179982083,-0.00386150663723219,0.00608479481806549,0.661308804047731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37162,-0.00132729167923191,0.00303481003938936,-0.00727551935643506,0.00462093599797124,0.661860786929499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39636,-0.00168298268405303,0.00385571227970353,-0.00924017875227194,0.00587421338416588,0.662486926715024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38959,0.00133585547861254,0.00306740018542645,-0.00467624888482331,0.00734795984204839,0.663205379997362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39462,0.00358970240268708,0.00824646666362807,-0.0125733722580239,0.0197527770633981,0.663349582843137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36847,0.00197381694438682,0.0045426287902869,-0.0069297354845755,0.0108773693733491,0.663925808961182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39485,0.000970641011922445,0.00223747183520838,-0.00341480378508597,0.00535608580893086,0.664431555491511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36823,0.00215597383680851,0.00497850297479489,-0.00760189199378947,0.0119138396674065,0.664981162339696
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,37164,-0.0012886662891545,0.0030047466453643,-0.00717796971406853,0.00460063713575953,0.668020112518338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,39194,-0.00199706739862474,0.00467155788147776,-0.0111533208463211,0.00715918604907166,0.669025107212759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39194,-0.00245650593729795,0.00577154162164348,-0.0137687275157192,0.00885571564112327,0.670388150042494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37221,0.00127581767040473,0.00300072195361621,-0.00460559735868304,0.00715723269949251,0.670719742327524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39485,-0.00115917086436206,0.00273504891811065,-0.00651986674385893,0.00420152501513481,0.671702506469224
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37221,-0.00124155121353097,0.00292951792120038,-0.0069834063390837,0.00450030391202177,0.671713459492758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36763,0.00207957924969807,0.0049125572191343,-0.00754903289980516,0.0117081913992013,0.672069863051506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,39194,0.00235208527792042,0.00555853496058957,-0.00854264324483514,0.013246813800676,0.672193150527124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36916,-0.0033781062180442,0.00798558195793286,-0.0190298468555926,0.0122736344195042,0.672283825087882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39068,-0.00159793756988474,0.00378663760057937,-0.00901974726702031,0.00582387212725082,0.673035753498636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36847,0.00191023381272865,0.00452901617990487,-0.0069666378998849,0.0107871055253422,0.673195278075738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39462,0.00377193066996849,0.00895455600313242,-0.0137789990961711,0.021322860436108,0.673592922992029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36763,-0.00115925983076332,0.00275835375432581,-0.0065656331892419,0.00424711352771527,0.674293837138614
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36992,-0.0016452186310824,0.0039154230503147,-0.00931944780969922,0.00602901054753442,0.674354414862252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36763,-0.00227518955813052,0.0054394910772951,-0.0129365920696289,0.00838621295336789,0.675755185730065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39455,0.00175456864087206,0.00419685835959127,-0.00647127374392684,0.00998041102567095,0.67590400060889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36823,-0.00132296736481593,0.00316677780293167,-0.00752985185856201,0.00488391712893015,0.676126554654837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36823,-0.00204616561410903,0.0049091414881397,-0.0116680829308628,0.00757575170264479,0.676826653134863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39455,0.000969428248759867,0.00233102437931612,-0.00359937953469973,0.00553823603221947,0.677503188964367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36847,-0.00146488110692371,0.00353677977616514,-0.00839696946820739,0.00546720725435997,0.67874579828908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36763,0.00289927332005215,0.00700927219605078,-0.0108389001842074,0.0166374468243117,0.679149371702232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,37221,0.00225034568722019,0.0054631165469944,-0.00845736274488884,0.0129580541193292,0.680407830579511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36823,-0.00181060771815394,0.00441190498073315,-0.0104579414803909,0.00683672604408304,0.68152598492062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,39341,-0.00240796765623054,0.00587639462710273,-0.0139257011253519,0.0091097658128908,0.681980891125052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36880,-0.00240973820773337,0.00589354659383022,-0.0139610895316406,0.00914161311617387,0.682636655583782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37162,0.00141660992009206,0.00347908020998454,-0.00540238729147765,0.00823560713166176,0.683883060450338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39194,-0.00132258916743413,0.00324958121646411,-0.0076917683517038,0.00504659001683553,0.684011724651643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39462,0.00208208696755471,0.00513228649677375,-0.00797719456612183,0.0121413685012313,0.684980517638936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36861,0.00131938590427428,0.00325332488103972,-0.00505713086256357,0.00769590267111214,0.685080265478746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36992,0.00156252830439323,0.00385591078927815,-0.00599505684259194,0.0091201134513784,0.685315830101829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,37164,0.00118465440110685,0.00292688044016824,-0.0045520312616229,0.00692134006383661,0.685668210133452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36763,-0.00201889026039956,0.00502421523007594,-0.0118663521113484,0.00782857159054929,0.687814673861158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,37269,-0.000711832451818882,0.00177407935544821,-0.00418902798849738,0.00276536308485962,0.688249769343111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36880,-0.000997742889160391,0.00249360408576355,-0.00588520689725694,0.00388972111893616,0.689074413676585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39123,0.00121870777304617,0.00305288237570534,-0.00476494168333628,0.00720235722942863,0.689752346768239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36992,-0.00145435776262091,0.0036460967429495,-0.00860070737880194,0.00569199185356012,0.689987874069304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37221,-0.00269371374258739,0.00677433003764874,-0.0159714006163789,0.0105839731312041,0.690905575579591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36992,-0.00101187871094649,0.00254943852343991,-0.00600877821688872,0.00398502079499573,0.691446060773461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36992,-0.00237705740571381,0.00601312565040552,-0.0141627836805086,0.00940866886908102,0.69261977624153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39462,-0.00136904848698504,0.00346450890604183,-0.00815948594282703,0.00542138896885696,0.692727625671811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,39104,0.00133003930186817,0.00336617018123707,-0.00526765425335648,0.00792773285709283,0.692760489071404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,39355,0.00178129214289305,0.00451973093266667,-0.00707738048513361,0.0106399647709197,0.69350203958339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36861,-0.0029278207974842,0.00746556602757622,-0.0175603302115336,0.0117046886165652,0.694934418773769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36847,0.00180044957825398,0.00460398184357615,-0.00722335483515527,0.0108242539916632,0.695756968818469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37221,0.00110991203007231,0.00283828381292698,-0.00445312424326457,0.00667294830340919,0.695766504149703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,39123,0.00284476500552048,0.00728811612157811,-0.0114399425927726,0.0171294726038136,0.696298753106162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36819,-0.00296874050856285,0.00763433235834918,-0.0179320319309272,0.0119945509138015,0.697381172617778
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36880,-0.000710402481283073,0.00183218104573509,-0.00430147733092385,0.0028806723683577,0.698218079836654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36763,0.00139999621161753,0.00361291964528611,-0.00568132629314324,0.0084813187163783,0.698394863393813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36880,0.000970302158965729,0.00251305467904964,-0.00395528501197157,0.00589588932990303,0.699425757310651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36955,0.000720523868877325,0.00187056081777211,-0.00294577533395601,0.00438682307171066,0.700102195173064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36823,0.00153762416872641,0.0040079985980777,-0.00631805308350589,0.0093933014209587,0.701252697695147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39455,-0.00301767998593876,0.0078729474245754,-0.0184486569381065,0.012413296966229,0.70150472513878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36847,-0.00157762490090319,0.00413691337528901,-0.00968597511646964,0.00653072531466327,0.702947764663705
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39404,0.00161685416697761,0.0042424162408698,-0.0066982816651272,0.00993198999908242,0.703122335276713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36847,-0.0019606965444726,0.00517184350532096,-0.0120975098149017,0.00817611672595649,0.704612824900192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36992,0.00175562106948743,0.00463675560729184,-0.00733241992080457,0.0108436620597794,0.704968042938802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,39123,-0.00315971760312148,0.00837966454967206,-0.0195838601204787,0.0132644249142358,0.706127261285405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39104,0.00130806272982555,0.00348056658545964,-0.00551384777767535,0.00812997323732644,0.707056971585659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36763,-0.00195786475372171,0.00521147288636383,-0.0121723516109948,0.0082566221035514,0.70715862459442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36861,0.00215589746517235,0.00576074366230906,-0.0091351601129534,0.0134469550432981,0.708232580105899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36992,0.00139897166729632,0.00373899678379905,-0.00592946202894981,0.00872740536354245,0.70829386976672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36916,-0.00161748745199019,0.00433819871786799,-0.0101203569390114,0.00688538203503107,0.709268132535809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36847,0.00225809909618565,0.00605932187042868,-0.00961817176985457,0.0141343699622259,0.709403925962595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36763,-0.00249684193275571,0.00672471694554342,-0.0156772871460208,0.0106836032805094,0.710425522777787
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37162,0.00141708320066463,0.00384348521132416,-0.00611614781353072,0.00895031421485999,0.712359389810751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36823,0.00234729082875727,0.00639082130621972,-0.0101787189314334,0.0148733005889479,0.713408286635018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39104,-0.00148392018365153,0.00404569780653961,-0.00941348788446916,0.0064456475171661,0.713781206477673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37247,-0.00107925254126743,0.00294287841774543,-0.00684729424004848,0.00468878915751361,0.713823768651889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36861,0.00134091906026841,0.0036568711553331,-0.00582654840418448,0.00850838652472129,0.713860399508406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36992,-0.000728213574352328,0.00198816923138447,-0.0046250252678659,0.00316859811916124,0.714167229022764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37203,-0.00218219924212919,0.00595838056847737,-0.0138606251563448,0.00949622667208646,0.714191829781998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37243,0.000819841102688731,0.00224076347954941,-0.00357205531722811,0.00521173752260557,0.714463814912863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36763,-0.00182616661361484,0.00500276131366311,-0.0116315787883945,0.00797924556116485,0.715093992017406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39194,-0.00379938406199897,0.0104191330035727,-0.0242208847490015,0.0166221166250036,0.715374534020561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39187,0.000956682838847755,0.0026286342207676,-0.00419544023385674,0.00610880591155225,0.715903007597664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39462,-0.00171074664422112,0.00470070646029312,-0.0109241313063956,0.0075026380179534,0.715912462134383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36880,0.00170391963336762,0.0047482758881368,-0.00760270110738051,0.0110105403741158,0.719713270699356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39428,0.000656644971158081,0.00184650419502866,-0.00296250325109809,0.00427579319341425,0.722133762396127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36861,-0.00210387084083084,0.00594043924212215,-0.0137471317553903,0.00953939007372858,0.72322438077118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39462,-0.00123458305431507,0.00349013442598101,-0.00807524652923786,0.00560608042060772,0.72354238253522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37164,-0.000803510418875893,0.00228979735875817,-0.00529151324204191,0.00368449240429012,0.725662461327862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36847,0.0013652724417924,0.00389211435385397,-0.00626327169176137,0.00899381657534617,0.725760025398282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,37140,-0.0017269630695106,0.00492771017467964,-0.0113852750118827,0.00793134887286148,0.725999662988711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37221,-0.000714239102819624,0.00203862033011766,-0.00470993494985024,0.00328145674421099,0.726078706761335
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39526,0.00140053096439095,0.00402888306104376,-0.00649607983525481,0.00929714176403672,0.728128455071354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39485,0.0021788419015652,0.00628364116052638,-0.0101370947730665,0.0144947785761969,0.728785272644903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36916,0.00155372270376077,0.00448959528537468,-0.00724588405557362,0.0103533294630951,0.729294533111773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,39194,-0.00270036449568477,0.00783032354921332,-0.0180477986521429,0.0126470696607733,0.730204627822799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,39355,-0.00126586444995182,0.00368211665513033,-0.00848281309400727,0.00595108419410364,0.731011202629665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39636,0.00162087044291615,0.00471838270818677,-0.00762715966512992,0.0108689005509622,0.731210202073886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36992,-0.00199650897664077,0.00581691471912447,-0.0133976618261247,0.00940464387284319,0.731435156133521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36955,0.00107713130931904,0.00315532908620206,-0.005107313699637,0.00726157631827508,0.732831599758044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36955,-0.000637886246010954,0.00187816109612708,-0.00431908199442004,0.00304330950239813,0.734138324020655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39485,-0.00289332407869501,0.00854065421819817,-0.0196330063463634,0.0138463581889734,0.734787147786589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36823,-0.000930277266854968,0.00275009592620116,-0.00632046528220925,0.00445991074849932,0.735164834356589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39194,0.0016431090394898,0.00487531441113733,-0.00791250720633938,0.011198725285319,0.736101893327921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39601,0.00109601200303871,0.0032852519388329,-0.00534308179707378,0.0075351058031512,0.738674100164421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39462,-0.00262264777994432,0.0078761471339065,-0.018059896162401,0.0128146006025124,0.739149401037291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37128,-0.00089376118184484,0.00270167352838784,-0.006189041297485,0.00440151893379532,0.740787725596639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,37162,-0.000915638588184924,0.00276938712282592,-0.00634363734892373,0.00451236017255388,0.740930490042507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39431,0.00194483901717295,0.00588725311948566,-0.00959417709701894,0.0134838551313649,0.741142068484282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36847,0.00110034034580917,0.00333253524624342,-0.00543142873682793,0.00763210942844626,0.74126866334265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39579,0.0012334591127125,0.00373614336906133,-0.00608938189064771,0.00855630011607271,0.741296984484588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39428,0.000938795469046503,0.00285846499722834,-0.00466379592552104,0.00654138686361404,0.742593849910917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36861,0.00162370098708926,0.00494499256630704,-0.00806848444287254,0.0113158864170511,0.742650645330399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36967,0.00148989098809455,0.00454127662764485,-0.00741101120208935,0.0103907931782785,0.742858503282203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39355,-0.00137802070390886,0.00420781096993655,-0.00962533020498449,0.00686928879716677,0.743301062438471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39123,0.00163397670241254,0.00500859992734154,-0.00818287915517689,0.011450832560002,0.744251804088299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,39187,-0.00299952838011457,0.00930194733391792,-0.0212313451545937,0.0152322883943645,0.747106983483064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37162,0.0014096127051687,0.00440633378670585,-0.00722680151677475,0.0100460269271122,0.749044832382226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,39104,0.00144981558965468,0.00454557904140351,-0.00745951933149621,0.0103591505108056,0.749768448623852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,37203,-0.00164168901169849,0.00515546891086197,-0.011746408076988,0.00846303005359097,0.750159138667879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36847,0.00110243502253954,0.00349326561889416,-0.00574436559049302,0.00794923563557209,0.752320057853245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39485,0.000769234967171408,0.00244818016173744,-0.00402919814983397,0.00556766808417678,0.753368303526171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36880,0.00061116288211262,0.00195017151751632,-0.00321117329221936,0.0044334990564446,0.753990173450093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39455,-0.00117454529854505,0.00375628034157463,-0.00853685476803134,0.00618776417094123,0.754521753702373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36880,0.0012427933482512,0.00397494088273308,-0.00654809078190563,0.00903367747840803,0.754546464616709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38760,0.000748998055113387,0.00241627691495177,-0.00398690469819209,0.00548490080841886,0.756580510961635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,39123,0.00158782532188967,0.00512753338747229,-0.00846214011755602,0.0116377907613354,0.756818977830303
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39194,-0.00180864979596893,0.00597041127172543,-0.0135106558885508,0.00989335629661292,0.761943256268768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36861,-0.000962578925863048,0.0031937670238755,-0.00722236229265903,0.00529720444093293,0.763119905256191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36992,-0.00141821332096498,0.00472195625616799,-0.0106732475830542,0.00783682094112429,0.763919415307853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39355,-0.00152555235315054,0.00510379891381605,-0.01152899822423,0.00847789351792892,0.765016499556267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37221,0.00116713314727487,0.00391034183117993,-0.00649713684183779,0.00883140313638753,0.765346707299443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38957,-0.000681299222898271,0.00228719017459734,-0.00516419196510906,0.00380159351931252,0.765802018170748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37162,-0.00072594527770715,0.00244203495024448,-0.00551233378018633,0.00406044322477203,0.766264757672404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36880,-0.000766482288967105,0.00258308505906754,-0.00582932900473949,0.00429636442680528,0.766676587472133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36763,0.00203466382211753,0.00687748068092551,-0.0114451983124965,0.0155145259567315,0.767353939245079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39531,-0.00203328378029033,0.00688956082099274,-0.0155368229894361,0.0114702554288554,0.767902218153081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36823,-0.00186535528406101,0.00635044266762837,-0.0143122229126126,0.0105815123444906,0.768964371365958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39462,-0.00210292927833912,0.00717866448922189,-0.016173111677214,0.0119672531205358,0.769570859674288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,37052,-0.000607141905598811,0.00207320921707123,-0.00467063197105842,0.00345634815986079,0.769640677078017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37164,0.00114073920428116,0.00392310312971508,-0.0065485429299604,0.00883002133852272,0.771228366367918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36763,0.0010970790683695,0.00378056104565696,-0.00631282058111814,0.00850697871785715,0.771676166471403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39636,-0.0022165196391242,0.00765358260480914,-0.0172175415445501,0.0127845022663017,0.772122010881529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36763,-0.00129814643100828,0.00450998662440589,-0.0101377202148438,0.00754142735282725,0.77347544016273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39104,0.00172233837800594,0.00601332354164498,-0.0100637757636182,0.0135084525196301,0.774560221423962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36992,0.00174611610251004,0.00612189531050298,-0.0102527987060758,0.0137450309110959,0.775476664913745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36880,-0.00159069817409679,0.00557989317880903,-0.0125272888045625,0.00934589245636891,0.775590042821228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39123,-0.00148750351711866,0.00523054206183055,-0.0117393659583066,0.00876435892406922,0.776117050050307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39526,-0.000669934878105903,0.00235749736861013,-0.00529062972058175,0.00395075996436994,0.776282431096164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36861,-0.000975764466561538,0.00343812742599941,-0.00771449422152038,0.00576296528839731,0.776563061253866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,37164,-0.00166715897804778,0.00588276597168583,-0.013197380282552,0.00986306232645645,0.776877045058155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39104,-0.00135454963224955,0.00480342531662953,-0.0107692632528434,0.00806016398834433,0.777950096214603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36847,-0.00163029125372807,0.00579803584537118,-0.0129944415106556,0.00973385900319945,0.778577098778477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39355,0.00087450846960628,0.00312068153918973,-0.00524202734720559,0.00699104428641814,0.779304970239793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37203,0.000802166029375154,0.00286295362428539,-0.00480922307422421,0.00641355513297452,0.779337609131155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37221,-0.00105506919318998,0.00378472648969011,-0.0084731331129826,0.00636299472660263,0.780425652289795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36861,0.00126790763767875,0.00456093062257041,-0.00767151638255926,0.0102073316579168,0.781022220478872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39187,0.00133244746137317,0.00481380122935588,-0.00810260294816435,0.0107674978709107,0.781939592593106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37119,-0.00114621916493741,0.00414750527959504,-0.0092753295129437,0.00698289118306887,0.782273380397894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36880,0.000520507507756197,0.0018855302316659,-0.00317513174630896,0.00421614676182136,0.782511447726908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36861,-0.000837235573482059,0.0030418402439178,-0.00679924245156094,0.00512477130459682,0.783136575512631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36916,0.0014637167138595,0.00533687200620728,-0.00899655241830676,0.0119239858460258,0.783885594833714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39462,-0.000830308444664147,0.00302906178356129,-0.00676726954044427,0.00510665265111598,0.784000735857133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36916,0.00119088290527871,0.00439404500735123,-0.00742144530912971,0.00980321111968712,0.786378592879127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36763,0.000595714147106226,0.00224132761344603,-0.003797287975248,0.00498871626946045,0.790408254522503
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39104,-0.00137936819653084,0.00519280258861146,-0.0115572612702093,0.00879852487714762,0.790527315955158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36880,-0.00211099715373598,0.00797901297468001,-0.0177498625841088,0.0135278682766368,0.791346116024115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36847,0.000932571287551934,0.00353154808194284,-0.00598926295305603,0.00785440552815989,0.791731377100915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39287,0.000865878935581664,0.0032804114725363,-0.00556372755058949,0.00729548542175281,0.791818747830255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39123,-0.00153737094062847,0.00584479661353491,-0.0129931723031569,0.00991843042189996,0.792529292291673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39194,-0.000797731247221881,0.0030364117996258,-0.00674909837448846,0.0051536358800447,0.792768766993529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36823,0.000915025979055673,0.00349441722701363,-0.00593403178589104,0.00776408374400239,0.793438618288958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37229,0.00109485482943107,0.00418380661672154,-0.00710540613934315,0.00929511579820529,0.793565687025088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37203,-0.000831327577878486,0.00321535140555371,-0.00713341633276376,0.00547076117700679,0.795987005677372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36763,-0.00143160188489084,0.00557363136926645,-0.0123559193686531,0.0094927155988714,0.797296830744923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36823,0.00190905408660247,0.00744574942704821,-0.012684614790412,0.016502722963617,0.797649991160764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36823,-0.00120662035171407,0.00476046179723531,-0.0105371254742953,0.00812388477086714,0.799911508944925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,37221,-0.00350545612445102,0.0138839200976457,-0.0307179395158366,0.0237070272669346,0.800671687031924
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37247,-0.000603241872777562,0.00238953957959971,-0.00528673944879299,0.00408025570323787,0.800696469177203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39344,-0.00105234785480681,0.00417282305827578,-0.00923108104902734,0.00712638533941373,0.800897019261991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36763,-0.000784786306143607,0.0031194456603133,-0.00689889980035767,0.00532932718807046,0.801370868240746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37203,-0.000576683410617888,0.0022958505591924,-0.005076550506635,0.00392318368539922,0.801675065451423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36861,-0.00126829987201701,0.00505020814976298,-0.0111667078455524,0.00863010810151842,0.801711468877306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,39355,-0.00193351907780041,0.00770348352567494,-0.0170323467881233,0.0131653086325225,0.801823118282022
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36880,-0.000710811606664546,0.00284274098331428,-0.00628258393396053,0.00486096072063143,0.80255710663934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,39123,-0.000929266990960465,0.00373154423301847,-0.00824309368767667,0.00638455970575574,0.803340951676179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39654,-0.000958673162159677,0.00385492423288722,-0.00851432465861864,0.00659697833429928,0.803605538552754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36880,0.0020185921615216,0.00812860987722299,-0.0139134831978355,0.0179506675208787,0.803881814921978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37247,-0.000723613118897869,0.00292207741019214,-0.00645088484287446,0.00500365860507872,0.804419615294972
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39428,0.000885517945707181,0.00359377961105752,-0.00615829009196557,0.00792932598337993,0.805373689619061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,37203,-0.00146050006245647,0.00594270329248758,-0.0131081985157321,0.0101871983908192,0.805869203506121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36763,0.00118171032695804,0.00481946625359207,-0.00826444353008243,0.0106278641839985,0.806309325902063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36823,-0.00127902285561095,0.00523609527895545,-0.0115417696023636,0.00898372389114174,0.807025491913326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39428,-0.000501228607031634,0.00206037097245832,-0.00453955571304994,0.00353709849898667,0.807798762531895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39601,0.00113162522241055,0.00466827192134841,-0.00801818774343233,0.0102814381882534,0.808467523025253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36955,-0.000707856815162841,0.0029316692377743,-0.00645392852120046,0.00503821489087478,0.80920892876898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36823,0.00135466820152906,0.00562332242427507,-0.00966704375005007,0.0123763801531082,0.809635259493838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39187,0.00127060687323954,0.00527847070821405,-0.00907519571486,0.0116164094613391,0.809779391254467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36880,-0.000863487779502371,0.00361169127037159,-0.00794240266943068,0.00621542711042594,0.811046497956377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36763,0.00141270345634374,0.0059311530732123,-0.0102123565671524,0.0130377634798399,0.811742651968351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36861,0.000562117150371085,0.00236208072058784,-0.00406756106198107,0.00519179536272324,0.811904088127425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,39187,0.00100523969204903,0.00423193017156137,-0.00728934344421125,0.00929982282830931,0.812243577000285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36880,-0.000601991943074946,0.00253700628813871,-0.00557452426782681,0.00437054038167692,0.812440096677181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36763,-0.000693813047869955,0.00293323850253649,-0.00644296051284148,0.00505533441710157,0.813021624727653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39485,0.000716794970440813,0.00305905009609967,-0.00527894321791455,0.00671253315879617,0.814740169568613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37181,0.000771458817123249,0.00329815553188022,-0.00569292602536199,0.00723584365960849,0.81506161096196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,37196,-0.000636336566579101,0.00272458392135073,-0.00597652105242654,0.00470384791926833,0.815335252366512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39455,-0.000703187798826438,0.00302498979468614,-0.00663216779641128,0.0052257921987584,0.816184263631545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39636,-0.000174144500948496,0.000750550332494619,-0.00164522315263795,0.00129693415074096,0.81652373074112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36861,0.000658912600934311,0.00287500903870246,-0.00497610511492251,0.00629393031679113,0.818727919768608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,39104,0.00104870264014398,0.00460651103328166,-0.00798005898508807,0.010077464265376,0.81991639107417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39654,-0.000969242340432792,0.00427904374782931,-0.00935616808617823,0.00741768340531265,0.820808529210702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36847,-0.00123486295036867,0.00545949979031918,-0.0119354825393943,0.00946575663865692,0.821060412780582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36992,-0.00164241039939071,0.00736151357895615,-0.0160709770141448,0.0127861562153634,0.823455315788862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36880,0.000938910929609481,0.0042104874394342,-0.00731364445168156,0.00919146631090052,0.823544304306748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36880,0.000566276740662528,0.00255142847730897,-0.00443452307486305,0.00556707655618811,0.82436036191724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39123,-0.00154317303791228,0.00698105218541806,-0.0152260353213317,0.0121396892455071,0.825055300304694
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,37255,-0.00173283087786374,0.00785224849387862,-0.0171232379258658,0.0136575761701384,0.825345453319225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36955,-0.00128359393335951,0.00583476796779706,-0.0127197391502417,0.0101525512835227,0.825882090106267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36763,-0.0010205244568939,0.00469921231992992,-0.0102309806039565,0.00818993169016874,0.828080039592868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37247,-0.00137261135937782,0.00632903780927716,-0.0137775254655611,0.0110323027468054,0.82830906061076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,39123,-0.00114848759404927,0.00531095613170685,-0.0115579616121947,0.00926098642409615,0.828796866432267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,37224,-0.00082937459102992,0.00384106296139361,-0.0083578579953614,0.00669910881330156,0.829051063820117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39123,-0.00119918853950858,0.00556269141003824,-0.0121020637031835,0.00970368662416637,0.82932045247026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36741,0.000655540987049793,0.00305181144100894,-0.00532600943732773,0.00663709141142732,0.829923779599065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36976,0.0018346769560891,0.00855341996252092,-0.0149300261704519,0.0185993800826301,0.830163542194356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38998,0.00165503791899828,0.00771756115761061,-0.0134713819499185,0.0167814577879151,0.83019846014086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36847,0.000885436659503555,0.00415420960464824,-0.007256814165607,0.00902768748461411,0.831219689515659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,39194,-0.000867671299274753,0.00407237625693064,-0.0088495287628588,0.00711418616430929,0.831281038588901
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,39187,-0.000981688324030955,0.00463048685200007,-0.0100574425539511,0.00809406590588919,0.832105735791836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36847,-0.000834583906695684,0.00394255026295866,-0.00856198242209465,0.00689281460870328,0.832355251576967
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36847,-0.000668941826833313,0.00317364442184417,-0.00688928489364788,0.00555140123998125,0.833062150963581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39355,-0.000584127878413912,0.00277258740750745,-0.00601839919712851,0.00485014344030069,0.833140097852359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39194,-0.000539220605375727,0.00256806961606417,-0.00557263705286151,0.00449419584211005,0.833693068959934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36861,-0.000847041475631796,0.00404784602000926,-0.00878081967484994,0.00708673672358635,0.834250790163052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36823,0.000581497294567464,0.00282755937003956,-0.00496051907071008,0.00612351365984501,0.837065019022964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39194,0.0011905084297256,0.00579265824171221,-0.0101631017240303,0.0125441185834815,0.837168535190362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37221,-0.00103791545507918,0.00506637736754658,-0.0109680150954705,0.00889218418531211,0.837682091616337
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39485,0.000479542881745107,0.00243336443772433,-0.00428985141619459,0.0052489371796848,0.84377550351345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36899,-0.00135117967677337,0.00691955577057623,-0.0149135089871028,0.0122111496335561,0.845184992604009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39428,-0.00145701543325585,0.00757572354704191,-0.016305433585458,0.0133914027189463,0.84748875544032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36763,-0.000695034752414581,0.00366424328020153,-0.00787695158160958,0.00648688207678041,0.849562788597939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,39194,-0.000805824285512255,0.00425150034382228,-0.00913876495940392,0.00752711638837941,0.849673155369664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39654,-0.000495755101030602,0.00263075364611983,-0.00565203224742547,0.00466052204536426,0.850529528560168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,37093,-0.000468849641692205,0.00253212853314585,-0.00543182156665807,0.00449412228327366,0.853106288684315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39623,0.000323683934623865,0.00175463164572889,-0.00311539409100477,0.0037627619602525,0.853644080478833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37221,-0.000587274520020397,0.00319193914035589,-0.00684347523511794,0.00566892619507715,0.854026768195995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37243,0.00228376280744285,0.0124710133756126,-0.0221594234087579,0.0267269490236436,0.854702309017334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36847,0.000854045827830997,0.00468110564269106,-0.00832092123184347,0.0100290128875055,0.855236244236491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36763,-0.0009869066801534,0.00543295553707584,-0.011635499532822,0.00966168617251524,0.855858908921153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36992,-0.000552208261470941,0.00304622657515435,-0.00652281234877348,0.00541839582583159,0.856153745886665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36880,-0.00152705125829671,0.00845014517817229,-0.0180893358075144,0.015035233290921,0.856595784874367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36823,-0.000559939890133286,0.00310211261352427,-0.00664008061264086,0.00552020083237429,0.856760844099035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39462,0.000669934295566125,0.00373764739949707,-0.00665585460744812,0.00799572319858037,0.857752017310968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37162,-0.00100634287146895,0.00561667621357632,-0.0120150282500785,0.0100023425071406,0.857806656414767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39526,-0.000773029304024223,0.00434645920089354,-0.00929208933777556,0.00774603072972711,0.858841084443328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36741,0.00126318588395805,0.00710980985308062,-0.01267204142808,0.0151984131959961,0.858986625283719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,37255,-0.000879263012672513,0.00495441662892948,-0.0105899196053743,0.00883139358002926,0.859141608200267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36992,-0.00125575317349303,0.00722301669479707,-0.0154128658952953,0.0129013595483092,0.861982703141843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39343,0.00141564070244102,0.0081584727488124,-0.0145749658852313,0.0174062472901133,0.862246751962468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36763,0.000621515775711447,0.00358213806321817,-0.00639947482819617,0.00764250637961907,0.862258028376735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36880,-0.000715889076416329,0.00414469880549302,-0.00883949873518265,0.00740772058235,0.862871167952832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36763,-0.000611274284470042,0.00354855134260031,-0.00756643491596665,0.00634388634702656,0.863235777227211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36763,0.00105705112003995,0.00615030134148382,-0.0109975395092683,0.0131116417493482,0.863542706827165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36847,-0.00110097169193729,0.00641123299010154,-0.0136669883525363,0.0114650449686617,0.863656202072677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,37221,-0.000959771018329674,0.00569952801139616,-0.0121308459206661,0.0102113038840068,0.866275346606081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39482,0.000554214484298436,0.00329849282189193,-0.00591083144660974,0.00701926041520661,0.866569395400399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36861,-0.00114064268741516,0.00681988969014918,-0.0145076264801076,0.0122263411052772,0.867174207765055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39485,0.00111765387681312,0.00668341490267888,-0.0119818393324375,0.0142171470860637,0.867192930237511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,39355,0.000884514912494886,0.00532879600506504,-0.0095599252574326,0.0113289550824224,0.868168834280758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36880,0.0011323778072503,0.00684437635737886,-0.0122825998532123,0.0145473554677129,0.868595282399718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36823,0.00131657125209904,0.00796406604260614,-0.014292998191409,0.0169261406956071,0.86869957695481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39477,0.00420317195397421,0.025427462988598,-0.0456346555036779,0.0540409994116264,0.868709701291322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39123,0.000677393834736026,0.0041153506425369,-0.00738869342463629,0.00874348109410835,0.869259737219384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39531,-0.000378292849171136,0.00230040264569798,-0.00488708203473918,0.00413049633639691,0.869381971874289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,39194,-0.000425717075497489,0.00258969959103245,-0.00550152827392108,0.00465009412292611,0.86942749558055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39123,0.000428123375386183,0.00268300749684833,-0.00483057131843654,0.0056868180692089,0.873223222186941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36861,-0.000501176480552388,0.00316141645527992,-0.00669755273290104,0.00569519977179626,0.874042477993982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39455,-0.000717763477594752,0.00458926729403924,-0.00971272737391167,0.00827720041872217,0.875719485539868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39123,-0.000474421258653516,0.00305414060340004,-0.00646053684131759,0.00551169432401055,0.876557728128878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39428,-0.00102326500464286,0.0066648560566165,-0.0140863828756112,0.0120398528663255,0.877981260554301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36847,0.000565806501866149,0.00369038937386838,-0.00666735667091587,0.00779896967464817,0.878149279292329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36992,0.000715092411445311,0.0046688384994377,-0.00843583104745258,0.0098660158703432,0.878272351400758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,37187,0.000251754891653151,0.00164975469451557,-0.00298176430959737,0.00348527409290367,0.878715030981474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39187,0.000575880626905278,0.00379054823310482,-0.00685359390998017,0.00800535516379072,0.879247839845381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36763,-0.000733673948831577,0.00493250652356835,-0.0104013867350255,0.00893403883736238,0.881759164765297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,37269,-0.000349670407153344,0.00238602155512314,-0.0050262726551947,0.00432693184088802,0.883489874433681
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36992,0.000709798622874407,0.00487044450922285,-0.00883627261520239,0.0102558698609512,0.884132220763365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36823,-0.000515626771460117,0.00361093642037283,-0.00759306215539087,0.00656180861247063,0.886453732383323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36763,-0.000552970043823743,0.00388235010705737,-0.00816237625365618,0.0070564361660087,0.886741290744227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37255,0.000399398774077068,0.00281792181420843,-0.00512372798177146,0.00592252552992559,0.887291382668781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36861,-0.000803295774996634,0.00572403680860864,-0.0120224079198696,0.0104158163698763,0.88839578575392
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39404,0.000311706454169145,0.00222492170191698,-0.00404914008158814,0.00467255298992643,0.88858467029692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36823,0.000525104387421332,0.00377680165970285,-0.00687742686559626,0.00792763564043892,0.889425430850189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36992,0.00073472291724147,0.00532205396291561,-0.00969650285007312,0.0111659486845561,0.89020113302508
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36847,0.000454241964755411,0.00329359886322008,-0.00600121180715594,0.00690969573666677,0.890308569272325
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39104,0.000765098587856129,0.00554803204926188,-0.0101090442286972,0.0116392414044094,0.890317788607837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,37031,-0.000391917514591446,0.00284642285499759,-0.00597090631038673,0.00518707128120384,0.890489417207031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36880,0.000363221265263091,0.00264115901818631,-0.00481345041038207,0.00553989294090825,0.890619296694895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39187,-0.000400333084739295,0.00291979066492799,-0.00612312278799815,0.00532245661851956,0.890945562724844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36849,-0.000446710690662793,0.00330682267074873,-0.00692808312533031,0.00603466174400473,0.892544818581957
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39123,-0.000419142013462193,0.00311545059050025,-0.00652542517084268,0.00568714114391829,0.892980146603661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36763,-0.000304566573827164,0.00227993005732914,-0.00477322948619228,0.00416409633853795,0.893732195290681
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39104,-0.000353970429219133,0.00265397689691257,-0.00555576514716778,0.00484782428872951,0.893899761764759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36763,0.00101525256773272,0.0077578530404651,-0.0141901393915789,0.0162206445270443,0.895882086165251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39589,0.000533480511723375,0.00408577491405169,-0.00747463831981794,0.00854159934326469,0.89611704050469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36916,-0.00054557329680134,0.00422086873161338,-0.00881847601076357,0.00772732941716089,0.897157042862566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36992,0.000712174941736922,0.00559169604972772,-0.0102475493157294,0.0116718991992033,0.898655175862628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,39355,0.000738529904407973,0.00580829959040422,-0.0106457372927843,0.0121227971016002,0.898822765360742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39428,0.000361196485318563,0.00284713783982933,-0.00521919368074692,0.00594158665138405,0.899050524410738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36823,0.000713751516435385,0.00566620515829307,-0.010392010593819,0.0118195136266898,0.899760561460007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36823,0.000709279189470898,0.00564159995411536,-0.0103482567205952,0.011766815099537,0.899953193257175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39559,0.00088358916703978,0.00703164956112906,-0.0128984439727732,0.0146656223068527,0.900003629560244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39428,-0.000649021832858142,0.00516601869922998,-0.0107744184833489,0.00947637481763261,0.900024217155845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36992,-0.000708691310050706,0.00572031431521383,-0.0119205073678698,0.0105031247477684,0.901404139168396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36861,-0.000728577109954454,0.00604456560104146,-0.0125759256879957,0.0111187714680868,0.904061910643359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39654,0.00036332429405328,0.00302107427655512,-0.00555798128799475,0.00628462987610131,0.904276182538748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36861,0.000651892794343726,0.00555257084071416,-0.010231146053456,0.0115349316421435,0.906541990448644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,39187,-0.00129986019184801,0.0111273636133247,-0.0231094928739644,0.0205097724902684,0.907007023148865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36847,0.000436841437230692,0.0037489248083395,-0.00691105118711472,0.00778473406157611,0.907238790003628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39194,-0.000616934225795989,0.00532628510440747,-0.0110564530304346,0.00982258457884265,0.907790247039446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39589,-0.000658754986048168,0.0056931224675001,-0.0118172750223484,0.010499765050252,0.907883388563116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37164,-0.000540450751290305,0.00467143815559786,-0.00969646953626211,0.0086155680336815,0.907898011289819
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39485,-0.000356432712881688,0.00309537998045033,-0.00642337747456434,0.00571051204880097,0.908327841840666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37162,-0.000435052280066178,0.00381250045336226,-0.0079075531686562,0.00703744860852384,0.909150764670857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39432,0.000645594713512604,0.00568326590544507,-0.0104936064611597,0.0117847958881849,0.90955979828007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37247,-0.000716571540004292,0.00641036053452015,-0.0132808781876638,0.0118477351076552,0.910996947354969
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36847,-0.000344657909912881,0.00320811316508116,-0.00663255971347196,0.0059432438936462,0.91444704437678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36916,-0.000615842300760163,0.00586589334425853,-0.0121129932555069,0.0108813086539866,0.916387846536661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37221,-0.000252139008886466,0.00240411615570821,-0.00496420667407456,0.00445992865630162,0.916474225549175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,39104,0.000436247465804195,0.00419786088712906,-0.00779155987296876,0.00866405480457715,0.917233168318048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36992,-0.000527673759198057,0.00512991043530548,-0.0105822982123968,0.00952695069400069,0.91807400095758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36880,-0.000511260590170049,0.0049706581268938,-0.0102537505188819,0.00923122933854179,0.918079145898892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39589,-0.000428524457447246,0.00417920255344273,-0.00861976146219499,0.0077627125473005,0.918331506834177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36847,-0.00055044341311608,0.00544032215257834,-0.0112134748321696,0.0101125880059375,0.919410432506123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39455,0.000284279943024995,0.00281908461869921,-0.00524112590962545,0.00580968579567544,0.919677849211182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37164,-0.000712682675736253,0.00721249593816553,-0.0148491747145407,0.0134238093630682,0.921288930406993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39541,-0.000235804269225561,0.00241493621896472,-0.00496907925839641,0.00449747071994529,0.922216203441367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36861,-0.000363367242843492,0.00374824189655244,-0.00770992136008627,0.00698318687439929,0.922772923439594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36823,0.00037902158465866,0.00394259144527013,-0.00734845764807078,0.00810650081738811,0.923414799222975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36880,-0.000312268118710656,0.00329383198013255,-0.00676817879977045,0.00614364256234914,0.924472117214855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36880,0.000331371727874227,0.00351718418855623,-0.00656230928169599,0.00722505273744444,0.924939838730269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39428,-0.000122308567339865,0.0013149970654566,-0.0026997028156348,0.00245508568095507,0.925896443942353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39617,-0.000382031991436357,0.00412592413701449,-0.00846884329998476,0.00770477931711204,0.926228070791927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36909,-0.000516756669097894,0.00570613093300374,-0.0117007732977852,0.0106672599595894,0.927842356463194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39428,-0.000159852590044629,0.0017725785241129,-0.00363410649730592,0.00331440131721666,0.928144729294312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37164,0.00023290518956736,0.00258603807144007,-0.00483572943045518,0.0053015398095899,0.92823892592855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36992,0.000643970778901028,0.00717499169929106,-0.0134190129517094,0.0147069545095115,0.928485623664242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36763,0.000225063970154278,0.00252972101295496,-0.00473318921523744,0.005183317155546,0.929108866919342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39485,0.000337166906230105,0.00381490347864792,-0.00714004391191981,0.00781437772438002,0.92957463887236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39415,-0.000828125366100552,0.00942724824519907,-0.0193055319266907,0.0176492811944896,0.930001995676215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37221,0.000683268378858304,0.00780496086459531,-0.0146144549157485,0.0159809916734651,0.930241413715098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36763,-0.000235281954584736,0.00269644162988514,-0.00552030754915961,0.00504974363999014,0.930469079985422
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36823,-0.00029178620313573,0.003358668024722,-0.00687477553159084,0.00629120312531938,0.93077182347539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39636,-0.000700504890750659,0.00813069233963636,-0.0166366618764379,0.0152356520949366,0.931343840563609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,39187,-0.000226551839347937,0.00263007525789124,-0.00538149934481476,0.00492839566611889,0.931357156148263
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36847,0.000503651444416996,0.00585643929544457,-0.0109749695746544,0.0119822724634884,0.931468123229568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36916,0.000296270549840573,0.00351191921135035,-0.00658709110440611,0.00717963220408726,0.932770421962919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36847,0.000198459356131203,0.00242956775204444,-0.00456349343787591,0.00496041215013831,0.934898488243676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39462,-0.000572452849095073,0.00707040520814349,-0.0144304470570563,0.0132855413588662,0.93547114866452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36763,-0.00041904670689752,0.0053281319346817,-0.0108621852988736,0.0100240918850786,0.937313917364265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39499,-0.000329273250670372,0.00422953361832171,-0.00861915914258093,0.00796061264124018,0.937947644692853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39104,0.000562882614841393,0.00725259363554336,-0.0136522009108236,0.0147779661405064,0.938138379570578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,37162,0.000303027957099406,0.00392969028477242,-0.00739916500105454,0.00800522091525336,0.938535320515887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37255,-0.000390099080050159,0.00507992504053214,-0.0103467521594932,0.00956655399939284,0.938789983748377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39462,0.000703131392790267,0.00917053310993309,-0.0172711135026786,0.0186773762882591,0.938884783480802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36880,0.000379111009854913,0.00496307429509643,-0.00934851460853408,0.0101067366282439,0.939112977845842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36992,-0.000368933058912999,0.00499225861917215,-0.0101537599524904,0.00941589383466441,0.941090314197961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36847,-0.000258012070024631,0.00367140218535611,-0.0074539603533226,0.00693793621327334,0.943974985959508
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36847,-0.000269349004935962,0.00394591734423628,-0.00800334699963907,0.00746464898976715,0.945579627648425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39428,-0.000139405105999569,0.00207811758894584,-0.00421251558033342,0.00393370536833428,0.946517004169905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,37162,-0.000664324072856017,0.0101595450099492,-0.0205770322923565,0.0192483841466445,0.947865186311098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36763,-0.000308507975137102,0.00481640489356109,-0.00974866156651684,0.00913164561624264,0.948928603812294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36823,-0.000278039552373708,0.0043634269759318,-0.00883035642520003,0.00827427732045262,0.949193846593038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36880,-0.000238634636838052,0.00377028030262122,-0.00762838402997564,0.00715111475629953,0.94953372493852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,37162,-0.000523596650989059,0.00848834890309736,-0.0171607605010599,0.0161135671990818,0.950815326294356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36916,0.000443279798282475,0.00726496862164935,-0.0137960587001502,0.0146826182967152,0.951347393094043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39194,0.000320843700038703,0.00531101648363285,-0.0100887486078817,0.0107304360079591,0.951829134324613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39123,0.000298057648574263,0.00496172346301976,-0.00942692033894447,0.010023035636093,0.952099590734098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39636,-0.000182413321806411,0.00315798950233308,-0.00637207274637925,0.00600724610276643,0.953938580834019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36763,-0.000180382143755235,0.00315499802258785,-0.00636417826802741,0.00600341398051694,0.95440794968038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39462,0.000729266913410925,0.013004817455369,-0.0247601752991123,0.0262187091259341,0.955281472243425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36928,-0.000152047142951537,0.00275468045697117,-0.00555122083861502,0.00524712655271195,0.955983257154949
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39194,0.000273503631567403,0.00516067945132552,-0.00984142809303062,0.0103884353561654,0.957734537080382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36861,0.000166481879052425,0.00314452772363591,-0.00599679245927395,0.0063297562173788,0.957777884776824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36861,-0.000289369638051212,0.00606977740204302,-0.0121861333460555,0.0116073940699531,0.961976944821101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37221,0.000269875288407063,0.00587306632128956,-0.0112413347013205,0.0117810852781346,0.963349749686518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36916,6.93523161237975e-05,0.0015439070842545,-0.00295670556901503,0.00309541020126262,0.96417178973567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36861,-0.000232530041884549,0.00521682894057856,-0.0104575147654185,0.00999245468164944,0.964448331608268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36880,0.000106102566665652,0.00244306455030144,-0.00468230395192517,0.00489450908525647,0.965359372266864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39455,8.84544903845858e-05,0.00205880103488054,-0.00394679553798128,0.00412370451875045,0.965730739921129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36992,-0.000223333823245699,0.00523409627662883,-0.0104821625254382,0.0100354948789468,0.965966045035575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,37247,0.000332009493042224,0.00790044651188561,-0.0151528656702536,0.015816884656338,0.966480107596755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39462,-0.000161580363431017,0.0038998217306289,-0.00780523095546366,0.00748207022860162,0.966951450524085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36880,0.000114966826090297,0.00282513785337475,-0.0054223033665242,0.0056522370187048,0.967540310604604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39601,8.73322102230037e-05,0.00219489889982035,-0.00421466963342488,0.00438933405387089,0.968262096301469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36763,-0.000229438506414538,0.00576699334795833,-0.0115327454684129,0.0110738684555838,0.968265363178299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,39104,0.000235415314905165,0.00593173396783384,-0.0113907832620492,0.0118616138918595,0.96834285876639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37221,-0.000144385322733142,0.00364920263045598,-0.00729682247842687,0.00700805183296058,0.968439540594551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39104,-0.000167859607023914,0.00430400445627766,-0.00860370834132813,0.0082679891272803,0.96889028399281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,39104,-0.000193002673856625,0.0054047280295457,-0.0107862696117662,0.0104002642640529,0.971514107457203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37164,-0.0001210777661491,0.00342699250680228,-0.00683798307948157,0.00659582754718337,0.971816662966096
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39492,0.000103882770316695,0.00320961860578248,-0.00618696969701696,0.00639473523765035,0.974180542588085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36742,6.81017235743568e-05,0.0021978145756632,-0.00423961484472552,0.00437581829187423,0.975281120348266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39568,7.31825308356244e-05,0.00240581975041576,-0.00464222417997927,0.00478858924165052,0.975733326849629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36823,0.000138266861276573,0.00497167765089696,-0.00960622133448147,0.00988275505703462,0.977813415957258
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38698,-6.13573584675389e-05,0.0024871911994178,-0.00493625210932642,0.00481353739239134,0.980319058495043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39123,0.000109376588574104,0.004580839734923,-0.00886906929187497,0.00908782246902318,0.980951066326077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,39187,-5.64583584291577e-05,0.00240240417106542,-0.00476517053371738,0.00465225381685907,0.981251138999452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39104,-8.98590800164751e-05,0.00436524555075451,-0.00864574035949532,0.00846602219946237,0.983576895063018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37162,-6.21016783164e-05,0.00340793422008057,-0.00674165274967432,0.00661744939304152,0.985461499495444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36861,6.92724347804043e-05,0.00384126063221743,-0.00745959840436575,0.00759814327392656,0.985612198164571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,37162,4.84259427923741e-05,0.00305863139995325,-0.005946491601116,0.00604334348670075,0.987368226903999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36992,4.90389000973034e-05,0.00312972450975473,-0.00608522113902198,0.00618329893921658,0.987498899651827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39589,0.000169733418393725,0.0114279303124569,-0.0222290099940218,0.0225684768308092,0.988150045164137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39601,-0.000147971156160296,0.0113090559983937,-0.022313720913012,0.0220177786006914,0.989560703936675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39319,8.07440666816483e-05,0.00639088156545039,-0.0124453838016011,0.0126068719349644,0.989919755798103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,39194,-7.15688498864991e-05,0.00606392809109888,-0.0119568679084403,0.0118137302086673,0.99058343282405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37099,-5.67573273675292e-05,0.00505836427039532,-0.00997115129734235,0.00985763664260729,0.991047708836719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36861,3.7238447866293e-05,0.00368119965796382,-0.00717791288174279,0.00725238977747538,0.991929023137139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36763,3.23743893739957e-05,0.00363696828755434,-0.00709608345423251,0.0071608322329805,0.992897886999341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36861,7.0388112159322e-05,0.00804433766322902,-0.0156965137077696,0.0158372899320882,0.993018724205016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,39093,6.5981015236008e-05,0.00770248394687068,-0.0150308875206305,0.0151628495511025,0.993165361859434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,39104,-3.53572636016693e-05,0.00485498282086643,-0.00955112359249988,0.00948040906529654,0.994189416306848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36847,-3.57694087703496e-05,0.00576437766039921,-0.0113339496231528,0.0112624108056121,0.995049057869497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37221,2.09192428573948e-05,0.00408772176840932,-0.00799101542322487,0.00803285390893966,0.995916859757501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39416,-9.04083194137535e-06,0.00270912509672249,-0.00531892602151746,0.00530084435763471,0.997337366839288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36847,2.05406935730872e-05,0.00728562545134162,-0.0142592851910565,0.0143003665782027,0.997750536297689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36823,-6.49986878885466e-06,0.00261985652278822,-0.00514141865345377,0.00512841891587606,0.998020488990683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36763,8.88190489999028e-06,0.00426141090775631,-0.00834348347430238,0.00836124728410236,0.998337032991381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39485,-8.0879398235652e-06,0.00451875856959222,-0.00886485473622431,0.00884867885657718,0.998571923803467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36763,8.18952618654885e-06,0.00494396830724185,-0.00968198835600747,0.00969836740838057,0.998678357056685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,37221,2.81597129586667e-06,0.00317585674711491,-0.00622186325304937,0.0062274951956411,0.999292544999412
